Hold Me Ltd F-1, filed Apr 23, 2021
Hold Me Ltd (HMELF)
F-1
2021-04-23
View Original
Added on
October 26, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM F-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Hold Me Ltd.
(Exact name of Registrant as specified in its charter)
|
Israel
|
|
7372
|
|
Not applicable
|
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
|
30 Golomb Street
Ness Zioyna, Israel 7401337
972-50-222-2755
|
|
(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
|
|
|
|
Mark E. Crone, Esq.
The Crone Law Group P.C.
500 Fifth Ave, Suite 938
New York, NY 10110
Phone: (646) 861-7891
|
|
(Name, address, including zip code, and telephone number, including area code, of agent for service)
|
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on the Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933. ☒
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
|
TITLE OF EACH CLASS OF
SECURITIES TO BE REGISTERED |
AMOUNT TO BE
REGISTERED |
PROPOSED
MAXIMUM OFFERING PRICE PER SHARE(1) |
PROPOSED
MAXIMUM
AGGREGATE
OFFERING PRICE
|
AMOUNT OF
REGISTRATION FEE |
||||||||||||
|
Ordinary Shares, par value 0.01 NIS per share
|
2,000,000
|
(2) |
$
|
0.95
|
$
|
1,900,000
|
$
|
207.29
|
||||||||
|
Total Registration Fee
|
2,000,000
|
$
|
207.29
|
|||||||||||||
|
(1)
|
Estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(o) under the Securities Act of 1933.
|
|
|
|
|
(2)
|
Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional ordinary shares as may be issued after the date hereof
as a result of share splits, share dividends or similar transactions.
|
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS
REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SECTION 8(a), MAY
DETERMINE.
The information in this
preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the United States Securities and Exchange Commission is declared effective. This preliminary prospectus is not an
offer to sell these securities and it is not soliciting any offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to
Completion, Dated April __, 2021
PROSPECTUS
HOLD ME LTD.
Up to 2,000,000 Ordinary Shares at $0.95 per Share
This is the initial public offering of Hold Me Ltd. We are selling up to a maximum of 2,000,000 of our ordinary shares at the fixed price of $0.95 per share. The shares are being offered on a “best efforts basis.” The
shares will be offered and sold by the sole officer and director of Hold Me Ltd., on its behalf, and no underwriters or broker-dealers will be involved in such offering. The offering will commence as soon as practicable after the effective date of
the registration statement relating to this prospectus. It will terminate 180 days after such effective date, but such termination date may be extended for up to an additional 90 days in our discretion. Hold Me Ltd. reserves the right to terminate
the offering at an earlier date, in its sole discretion, even if no or only some of the shares are sold.
There are no minimum purchase requirements, and there are no arrangements to place the funds in an escrow, trust, or similar account. Funds received by Hold Me Ltd. for the payment of shares subscribed for in the
offering will be deposited into a bank account maintained by us and under our control and be immediately available for our use. Such funds will not be placed into escrow, trust or any other similar arrangement. All funds received by Hold Me Ltd. will
be retained by it for its use and will not be refunded.
We are both an "emerging growth company" and a “foreign private issuer” under applicable U.S. Securities and Exchange Commission rules and are subject to reduced public company disclosure requirements. See
“Summary-Implications of Being an ‘Emerging Growth Company’ and a ‘Foreign Private Issuer’” on page 5 of this prospectus.
There has been no market for our securities and a public market may not develop, or, if any market does develop, it may not be sustained. We intend to seek quotation of the ordinary shares on The OTC Markets Group, Inc.
OTCQB Venture Markets or the OTCQB after effectiveness of the registration statement for this prospectus. Quotation of our common stock on the OTC Markets will require a market maker filing an application to quote our common stock and approval of
that application. We do not have a market maker willing to file the necessary application for quoting our common stock on the OTCQB as of the date of this prospectus. There is a risk that no public market will develop for our common stock.
Investing in our Company involves many risks. You should carefully read the “Risk Factors” beginning on page 8 of this prospectus before investing.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal offense.
PROSPECTUS DATED , 2021
Table of Contents
Page
| 2 |
|
| 8 | |
| 29 | |
| 32 | |
| 32 | |
| 33 | |
| 36 | |
| Capitalization | 36 |
| 36 |
|
| 37 |
|
| 48 |
|
| 55 | |
| 60 | |
| 65 | |
| 66 | |
| 67 | |
| 74 | |
| 75 | |
| 90 | |
| 91 | |
| 91 | |
| 91 | |
| 93 | |
|
Index to Consolidated Financial Statements
|
You should rely only on the information contained in this prospectus and any prospectus supplement or amendment. We have not authorized anyone to provide you with different information. This
prospectus may only be used where it is legal to sell these securities. The information in this prospectus is only accurate as of the date of this prospectus, regardless of the time of any sale of securities.
For investors outside the United States: We have not taken any action that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required,
other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.
About this prospectus
Except where the context otherwise requires or where otherwise indicated, references to “Hold Me Ltd.” the “Company,” “we,” “our” and “us” refer to Hold Me Ltd., a corporation established in the
State of Israel.
Basis of presentation
Our financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). We present our consolidated financial statements in U.S.
dollars.
Our fiscal year ends on December 31 of each year. References to fiscal 2020 are references to the fiscal year ended December 31, 2020 and references to fiscal 2019 are references to the fiscal year
ended December 31, 2019. Some amounts in this prospectus may not total due to rounding. All percentages have been calculated using unrounded amounts.
Throughout this prospectus, we provide a number of key performance indicators used by our management and often used by competitors in our industry. These and other key performance indicators are
discussed in more detail in the section entitled "Management's discussion and analysis of financial condition and results of operations—Key financial and operating metrics." We define certain terms used in this prospectus as follows:
| • |
“API” means Application Programming Interface, a computing interface that defines interactions between multiple software intermediaries.
|
| • |
“APP” means an Application, especially as downloaded by a user to a mobile device.
|
| • |
"Companies Law" means the Israeli Companies Law, 5759-1999.
|
| • |
“CAGR” means compound annual growth rate.
|
| • |
“NIS” means New Israeli Shekel, the currency of the State of Israel.
|
| • |
“VAT” means Value Added Tax.
|
Unless the context provides otherwise, “we,” “us,” “our company,” “our,” the “Company” and “Hold Me” is to Hold Me Ltd., an Israel company.
This disclosure contains translations of certain NIS amounts into U.S. dollar amounts at specified rates solely for the convenience of the reader. The relevant exchange rates are listed below:
|
|
For the
Year Ended December 31, 2020 |
For the
Year Ended December 31, 2019 |
||||||
|
Period Ended NIS: USD exchange rate
|
3.215
|
3.456
|
||||||
|
Period Average NIS: USD exchange rate
|
3.215
|
3.456
|
||||||
Numerical figures included in this disclosure have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables may not be arithmetic aggregations of the
figures that precede them.
1
Market and industry data
Unless otherwise indicated, information in this prospectus concerning economic conditions, our industry, our markets and our competitive position is based on a variety of sources, information from
independent industry analysts and publications, as well as our own estimates and research.
Our estimates are derived from publicly available information released by third-party sources, as well as data from our internal research, which we believe to be reasonable. None of the independent
industry publications used in this prospectus were prepared on our behalf.
The following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information and financial statements appearing elsewhere in this
prospectus. In addition to this summary, we urge you to read the entire prospectus carefully, especially the risks of investing in our Shares discussed under “Risk Factors,” before deciding whether to invest in our Shares.
Our Business
Hold Me Ltd. is a software company with a platform that enables its customers to enhance their brand and loyalty with digital payments and reward programs. Our prospect customers, including but not limited to restaurant
chains, media companies and financial organizations, can connect their unique brands with their customers through innovative yet completely intuitive digital payment mobile applications.
Our Market Opportunity
The mobile payments market was valued at $897.68 billion in 2018 and is expected to reach a value of $3695.46 billion by 2024, at a CAGR of 26.93% over the forecast period of 2019 – 2024. Stores and services across the
world are rapidly adopting and integrating mobile payment applications to accept mobile payments. Owing to changing lifestyle, daily commerce, and rapid growth in online retailing, this trend is expected to continue for many years.
With the rapidly increasing global economy, mobile phones (especially smartphones) have become an essential commodity for every individual. Similarly, the internet has also become part and parcel of life for many people.
This has increased the penetration of smartphones and internet users all over the world driving the growth of the mobile payment market.
Companies are rigorously investing in mobile payment technology due to significant growth in the industry. Many governments are also encouraging banks to build infrastructure to enable safe and secure mobile payments in
rural areas, which is a massive opportunity for vendors.
2
The financial services ecosystem is shifting rapidly towards consumer convenience, digitization, and granular product offerings. Brands and financial service providers are looking to merge payments with marketing and
brand awareness. Many are looking to offer branded wallets (mobile applications) coupled with their products and loyalty programs.
More and more consumers look to settle payments with speed, security, and most importantly, through their mobile device. In addition, during the COVID-19 pandemic, we see more and more merchants and consumers shifting
into the cashless society where payments are settled through digital tools – mainly using smartphones.
Impact of the Covid-19 Pandemic
The COVID-19 pandemic and resulting global disruptions have affected our businesses, as well as those of our customers and suppliers. There are material uncertainties related to events or conditions
due to the COVID-19 pandemic that may cast significant doubt upon our ability to achieve our commercial goals. Although lots of merchants and consumers witnessed shifts from traditional payments to the cashless society where payments are settled
through digital payments using smartphones which brings us market opportunities, the consequences of COVID-19 might combine with other events or conditions to create material uncertainty.
The currently known impacts of COVID-19 on the Company are:
| • |
A decline in the ability to generate new sales;
|
| • |
A significant delay in our expected investments in R&D and rollout of our products; and
|
| • |
Negative impact on ability to collect from our customer.
|
Corporate Information
Our principal executive offices are located at 30 Golomb Street, Nes Ziona, Israel, 7401337. Our telephone number at this address is ++972.50.2222755 and our email is info@holdme.co.il.
Investors should submit any inquiries to the address and telephone number of our principal executive offices. Our corporate website is www.holdme.co.il. The information contained on our websites is not a part of this
prospectus. Our agent for service of process in the United States is located at 500 Fifth Avenue, Suite 938, New York, N.Y. 10110, United States.
3
Summary Risk Factors
Our business is subject to numerous risks and uncertainties that you should be aware of before making a decision to invest in our ordinary shares. These risks are more fully described in the section
titled “Risk Factors” immediately following this prospectus summary. These risks include, among others, the following:
| • |
We are a startup company with limited resources and no significant revenue. Research shows that a significant high percentage of companies in similar situation fail to achieve their business
goals and end-up failing and losing the investments raised by them.
|
| • |
Our financial situation creates doubt whether we will continue as a going concern.
|
| • |
We are solely dependent on one customer. If we fail to acquire new customers or retain existing customer in a cost-effective manner, our business, financial condition and results of operations
may be materially and adversely affected.
|
| • |
Our business depends on the overall demand for information technology and loyalty and payment software spend and on the economic health of our current and prospective customers.
|
| • |
Since we are solely dependent on Amazon Cloud, our business, financial condition and results of operations may be materially and adversely affected if this agreement is terminated or if there
are service issues with the cloud that affects our application and operations.
|
| • |
Any security breaches, unauthorized access, unauthorized usage, virus or similar breach or disruption could result in loss of confidential information, damage to our reputation, early
termination of our contracts, litigation, regulatory investigations, indemnity obligations or other liabilities.
|
| • |
Many of our competitors and potential competitors are larger and have greater brand name recognition, longer operating histories, larger marketing budgets and significantly greater resources
than we do.
|
| • |
We do not have any patents or trademark or other form of registered IP.
|
| • |
Mr. Menachem Shalom, our sole director and officer, beneficially owns 100% of our outstanding shares and his interests may differ from the interests of other shareholders, which could cause
a material decline in the value of our shares.
|
| • |
Conditions in Israel could materially and adversely affect our business.
|
| • |
It may be difficult to enforce a U.S. judgment against us, our officer and director or to assert U.S. securities laws claims in Israel or serve process on our officer and director.
|
| • |
An active trading market for our ordinary shares may not develop and the trading price for our shares may fluctuate significantly.
|
| • |
The company is an Israeli company and as such it is subject to Israeli tax, accounting, corporate and securities regulations and practices.
|
| • |
Our registration with the SEC may make the Company subject to US tax, accounting, securities and other requirements and regulation. Such dual-regime is likely to increase the overall
operational effort by the company and may increase substantially the costs associated with compliance and regulation.
|
| • |
Your rights and responsibilities as our shareholder are governed by Israeli law, which may differ in some respects from the rights and responsibilities of shareholders of U.S. corporations.
|
Implications of Being an Emerging Growth Company
As a company with less than US$1.07 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act.
As long as we remain an emerging growth company, we may rely on exemptions from some of the reporting requirements applicable to public companies that are not emerging growth companies. These exemptions include: (1) being permitted to provide only
two years of selected financial data (rather than five years) and only two years of audited financial statements (rather than three years), in addition to any required unaudited interim financial statements, with correspondingly reduced “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” disclosure; (2) not being required to comply with the auditor attestation requirements of the Sarbanes-Oxley Act of 2002 in the assessment of our internal control over
financial reporting; and (3) not being required to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. We have taken, and
may continue to take, advantage of some of these exemptions until we are no longer an emerging growth company. The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards
until such date that a private company is otherwise required to comply with such new or revised accounting standards. However, we have elected to “opt out” of this provision and, as a result, we will comply with new or revised accounting standards as
required when they are adopted for public companies. This decision to opt out of the extended transition period under the JOBS Act is irrevocable.
4
We will remain an emerging growth company until the earliest of: (1) the last day of our fiscal year during which we have total annual gross revenues of at least US$1.07 billion; (2) the last day of our fiscal year
following the fifth anniversary of the completion of our initial public offering; (3) the date on which we have, during the previous three-year period, issued more than US$1.00 billion in non-convertible debt; or (4) the date on which we become a
“large accelerated filer” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which would occur if we have been a public company for at least 12 months and the market value of our ordinary shares held by non-affiliates exceeds
US$700 million as of the last business day of our most recently completed second fiscal quarter. We will not be entitled to the above exemptions if we cease to be an emerging growth company.
Implications of Our Foreign Private Issuers Status
Because we are a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic
issuers, including: (i) the rules under the Exchange Act requiring the filing of quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC; (ii) the sections of the Exchange Act regulating the solicitation of proxies, consents, or
authorizations in respect of a security registered under the Exchange Act; (iii) the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from
trades made in a short period of time; and (iv) the selective disclosure rules by issuers of material nonpublic information under Regulation FD.
We will be required to file an annual report on Form 20-F within four months of the end of each fiscal year. In addition, if we are successful at having our shares quoted on the OTCQB, we will
publish our results on a quarterly basis through press releases, distributed pursuant to the rules and regulations of the OTCQB. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However,
the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or
information, which would be made available to you, were you investing in a U.S. domestic issuer.
5
The Offering
|
Ordinary Shares Being Offered:
|
|
2,000,000 ordinary shares.
|
|
Offering Price:
|
|
$0.95 per share.
|
|
Ordinary Shares Issued and Outstanding:
|
|
|
| After this Offering: |
4,000,000 shares of ordinary stock if the maximum 2,000,000 shares being offered by this prospectus are sold by us.
|
|
|
Market for our Ordinary Shares:
|
There is no market for our securities. Our ordinary shares are not traded on any exchange or quoted on the OTC Markets. After the effective date of the registration statement relating to this
prospectus, we hope to have a market maker file an application for our shares to be eligible for quotation on the OTC Markets. We do not yet have a market maker who has agreed to file such application.
There is no assurance that a trading market will develop, or, if developed, that it will be sustained. Consequently, a purchaser of our ordinary shares may find it difficult to resell the
securities offered herein should the purchaser desire to do so when eligible for public resale.
|
|
|
|
|
|
|
Use of Proceeds:
|
|
If we are successful at selling all the shares being offered, we expect to receive net proceeds from this offering of approximately $1,840,000.
We intend to use the net proceeds from this offering for working capital, to fund growth and other general corporate purposes, pay existing liabilities including the repayment of approximately $184,000 to Mr. Shalom, our sole officer and director and shareholder. See “Use of Proceeds”. |
|
Risk Factors:
|
See “Risk Factors” and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in our ordinary shares.
|
|
|
|
|
|
|
Listing:
|
|
We intend to apply to quote our ordinary shares on the OTCQB. There is no assurance that we will be successful at having our shares quoted.
|
6
Summary Consolidated Financial Data
The following summary consolidated financial data for the years ended December 30, 2020 and 2019 has been derived from our audited consolidated financial statements included elsewhere in this
prospectus. Our consolidated financial statements are prepared and presented in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. Our historical results are not necessarily indicative of results
expected for future periods. You should read this Summary Consolidated Financial Data section together with our consolidated financial statements and the related notes and “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” included elsewhere in this prospectus.
|
|
|
Fiscal Year Ended
December 31, 2020
(audited)
|
|
|
Fiscal Year Ended
December 31, 2019
(audited)
|
|
||
|
Balance Sheet Data
|
|
|
|
|
|
|
||
|
Cash
|
NIS
|
149,791
|
|
NIS
|
5,313
|
|
||
|
Total Assets
|
NIS
|
736,478
|
|
NIS
|
1,096,265
|
|
||
|
Total Liabilities
|
NIS
|
1,958,213
|
|
NIS
|
1,940,167
|
|
||
|
Total Stockholder’s Equity
|
NIS
|
(1,221,735)
|
|
NIS
|
(843,902)
|
|
||
|
|
|
Fiscal Year Ended
December 31, 2020
(audited)
|
|
|
Fiscal Year Ended
December 31, 2019
(audited)
|
|
||
|
Statement of Operations
|
|
|
|
|
|
|
||
|
Revenue
|
NIS
|
486,360
|
|
134,377
|
|
|||
|
Net Income for Reporting Period
|
NIS
|
(1,521,738)
|
|
(1,143,905)
|
|
|||
7
You should consider carefully the risks described below making an investment decision. Additional risks not presently known to us or that we currently deem immaterial may also impair our business
operations. Our business, financial condition or results of operations could be materially and adversely affected by any of these risks. The trading price and value of our ordinary shares could decline due to any of these risks, and you may lose all
or part of your investment. This prospectus also contains forward-looking statements that involve risks and uncertain. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain
factors, including the risks faced by us described below and elsewhere in this prospectus.
Risks Relating to our business and industry
Our financial situation creates doubt whether we will continue as a going concern.
There can be no assurances that we will ever be able to achieve a level of revenues adequate to generate sufficient cash flow from operations or obtain additional financing through private
placements, public offerings and/or bank financing necessary to support our working capital requirements. To the extent that funds generated from any private placements, public offerings and/or bank financing are insufficient, we will have to raise
additional working capital and no assurance can be given that additional financing will be available, or if available, will be on acceptable terms. These conditions raise substantial doubt about our ability to continue as a going concern. If
adequate working capital is not available, we may be forced to discontinue operations, which would cause investors to lose their entire investment.
Our consolidated financial statements for the year ended December 31, 2020, were prepared assuming that we would continue as a going concern, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. The accompanying financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary
should the Company be unable to continue as a going concern.
The report of our independent registered public accounting firm on our audited consolidated financial statements as of December 31, 2020 and 2019 and for each of the two years then ended includes
an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern based upon our recurring losses, cash used in operations and accumulated deficit,
8
We are solely dependent on one customer. If we fail to acquire new customers or retain existing customers in a cost-effective manner, our business, financial
condition and results of operations may be materially and adversely affected.
As of the date of this prospectus, we only have one customer in Israel. For the year ended December 31, 2020, this customer accounted for all our revenues, an aggregate of NIS 149,791.
Our ability to cost-effectively attract new customers and retain our sole existing customer is crucial to driving net revenues growth and achieving profitability. We have invested significantly in
branding, sales and marketing to acquire and retain customers since our inception. For example, we attend domestic and international expos and exhibitions in marketing our products and attracting new customers. We also expect to continue to invest
significantly to acquire new customers and retain our sole customer. There can be no assurance that new customers will stay with us, or the net revenues from new customers we acquire will ultimately exceed the cost of acquiring those customers. In
addition, if our existing customer no longer finds our products appealing, or if our competitors offer more attractive products, prices, discounts or better customer services, our customers may lose interest in us, decrease their orders or even stop
ordering from us. If we are unable to retain our existing customer or acquire new customers in a cost-effective manner, our revenues may decrease, and our results of operations will be adversely affected.
If the market for digital payments does not continue to grow, our business will be adversely affected.
The market for digital payments may not continue to grow. Continued growth of this market will depend, in large part, upon:
| • |
the continued expansion of Internet usage and the number of organizations adopting or expanding intranets;
|
||
|
|
•
|
the continued adoption of “cloud” infrastructure by organizations;
|
|
|
|
•
|
the ability of the infrastructures implemented by organizations to support an increasing number of users and services;
|
|
|
|
•
|
the continued development of new and improved services for implementation across the Internet and between the Internet and intranets;
|
|
|
|
•
|
the adoption of data security measures as it pertains to data encryption and data loss prevention technologies;
|
|
|
|
•
|
continued access to mobile API’s, APPs and application stores with Apple, Google and Microsoft, etc.;
|
|
|
|
•
|
government regulation of the Internet and governmental and non-governmental requirements and standards with respect to data security and privacy; and
|
|
|
|
•
|
general economic conditions in the markets in which we, our customers and our suppliers operate.
|
|
9
In 2020, global and regional economies around the world and financial markets remained volatile as a result of a multitude of factors, including COVID-19 pandemic, economic and political
uncertainty, terrorism, governmental instability and other factors. During this period, many organizations limited their expenditures and a significant portion of such organizations have remained reluctant to increase expenditures. If challenging
conditions continue or worsen, it may cause our customers to reduce or postpone their technology spending significantly, which could result in reductions in sales of our products, longer sales cycles, slower adoption of new technologies and
increased price competition.
Further, if the necessary infrastructure or complementary products and services are not developed in a timely manner and, consequently, the enterprise security, data security, Internet or intranet
markets fail to grow or grow more slowly than we currently anticipate, our business, results of operations and financial condition may be materially adversely affected.
We may not be able to successfully compete, which could adversely affect our business and results of operations.
The digital payment market is profoundly shifting in the Covid-19 pandemic context. The crisis has affected the way people think about payments and financial services, with the use of cash
declining and the rise of contactless encouraged by many countries. All the actors are being impacted by this move towards a cashless society, including retailers, merchants, consumers, governments, financial institutions, and service providers.
The market for digital payment is intensely competitive and we expect that competition will continue to increase in the future. Our competitors include big tech companies, such as Google, Apple and
PayPal who are eagerly looking to grab an increasing share in the digital payment market. We also compete with several other companies, including wallet factory and dejamobile, with respect to digital wallets that we offer. In addition, there are
hundreds of small and large companies that offer digital payment products that we may compete with from time to time.
Some of our current and potential competitors have various advantages over us, including longer operating histories; access to larger customer bases; significantly greater financial, technical and
marketing resources; a broader portfolio of products, applications and services; and larger patent and intellectual property portfolios. As a result, they may be able to adapt better than we can to new or emerging technologies and changes in
customer requirements, or to devote greater resources to the promotion and sale of their products. Furthermore, some of our competitors with more diversified product portfolios and larger customer bases may be better able to withstand a reduction
in spending on digital payment solutions, as well as a general slowdown or recession in economic conditions in the markets in which they operate. In addition, some of our competitors have greater financial resources than we do, and they have
offered, and in the future may offer, their products at lower prices than we do, or may bundle digital payment products with their other offerings, which may cause us to lose sales or to reduce our prices in response to competition.
In addition, consolidation in the markets in which we compete may affect our competitive position. This is particularly true in circumstances where customers are seeking to obtain a broader set of
products and services than we are able to provide.
10
The markets in which we compete also include many niche competitors, generally smaller companies at a relatively early stage of operations, which are focused on specific digital payment needs.
These companies’ specialized focus may enable them to adapt better than we can to new or emerging technologies and changes in customer requirements in their specific areas of focus. In addition, some of these companies can invest relatively large
resources on very specific technologies or customer segments. The effect of these companies’ activities in the market may result in price reductions, reduced gross margins and loss of market share, any of which will materially adversely affect our
business, results of operations and financial condition.
We may not be able to continue competing successfully against our current and future competitors, and increased competition within the market may result in price reductions, reduced gross margins
and operating margins, reduced net income, and loss of market share, any or all of which may materially adversely affect our business, results of operations and financial condition.
We may not be able to maintain and improve the network effects of our digital economy, which could negatively affect our business and prospects.
Our ability to maintain a healthy and vibrant digital economy that creates strong network effects among financial institutions, consumers, merchants, brands, retailers and other participants is critical to our success.
The extent to which we are able to maintain and strengthen these network effects depends on our ability to:
|
●
|
offer secure and open platforms for all participants and balance the interests of these participants;
|
||
| ● |
provide a wide range of high-quality product, service and content offerings to consumers;
|
||
|
●
|
attract and retain consumers, merchants, brands and retailers of all sizes;
|
||
|
●
|
provide effective technologies, infrastructure and services that meet the evolving needs of financial institutions, consumers, merchants, brands, retailers and other businesses;
|
||
|
●
|
secure and trusted digital payment services;
|
||
|
●
|
address user concerns with respect to data security and privacy measures;
|
||
|
●
|
attract and retain third-party service providers that are able to provide quality services on commercially reasonable terms to our customers;
|
||
|
●
|
maintain the quality of our customer service; and
|
||
|
●
|
continue adapting to the changing demands of the digital payment market.
|
||
In addition, changes to current operations we may make to enhance and improve our digital economy or to comply with regulatory requirements may be viewed positively from one participant group’s perspective, such as our
customers, but may have negative effects from another group’s perspective, such as the clients of our customers. If we fail to balance the interests of all participants in our digital economy, our customers may spend less time, mind-share and
resources on our Platform and may conduct fewer transactions or use alternative platforms, any of which could result in a material decrease in our revenue and net income.
11
Raising additional capital would cause dilution to our existing shareholders and may affect the rights of existing shareholders.
We will have to seek additional capital through a combination of private and public equity offerings, debt financing and collaborations and strategic and licensing arrangements. To the extent that we
raise additional capital through the issuance of equity or convertible debt securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a holder of our shares.
We may not be able to introduce products acceptable to customers and we may not be able to improve the technology used in our current systems in response to
changing technology and end-user needs.
The markets in which we operate are subject to rapid and substantial innovation, regulation and technological change, mainly driven by technological advances and end-user requirements and
preferences, as well as the emergence of new standards and practices. Even if we are able to complete the development of our products, our ability to compete in the digital market will depend, in large part, on our future success in enhancing our
existing products and developing new systems that will address the varied needs of prospective end-users, and respond to technological advances and industry standards and practices on a cost-effective and timely basis to otherwise gain market
acceptance.
Even if we successfully introduce our existing products in development, it is likely that new systems and technologies that we develop will eventually supplant our existing systems or that our
competitors will create systems that will replace our systems. As a result, any of our products may be rendered obsolete or uneconomical by our or others’ technological advances.
We may need to change our pricing models to compete successfully.
The intense competition we face in the sales of our products and services and general economic and business conditions can put pressure on us to change our prices. If our competitors offer deep
discounts on certain products or services or develop products that the marketplace considers more valuable, we may need to lower prices or offer other favorable terms in order to compete successfully. Any such changes may reduce margins and could
adversely affect results of operations.
If our products fail to protect against attacks and our customers experience security breaches, our reputation and business could be harmed.
Hackers and other malevolent actors are increasingly sophisticated, often affiliated with organized crime and operate large scale and complex attacks. In addition, their techniques change
frequently and generally are not recognized until launched against a target. If we fail to identify and respond to new and increasingly complex methods of attack and to update our products to detect or prevent such threats in time to protect our
customers’ high-value business data, our business and reputation will suffer.
12
In addition, an actual or perceived security breach or theft of the sensitive data of one of our customers, regardless of whether the breach is attributable to the failure of our products, could
adversely affect the market’s perception of our products. Despite our best efforts, there is no guarantee that our products will be free of flaws or vulnerabilities, and even if we discover these weaknesses we may not be able to correct them
promptly, if at all. Our customers may also misuse our products, which could result in a breach or theft of business data.
Defects in products could give rise to product returns or product liability, warranty or other claims that could result in material expenses, diversion of
management time and attention, and damage to our reputation.
Even if we are successful in introducing our products to the market, our products may contain undetected defects or errors that, despite testing, are not discovered until after a product has been
used. This could result in delayed market acceptance of those products, claims from distributors, end-users or others, increased end-user service and support costs and warranty claims, damage to our reputation and business, or significant costs to
correct the defect or error. We may from time to time become subject to warranty or product liability claims that could lead to significant expenses as we need to compensate affected end-users for costs incurred related to product quality issues.
Any claim brought against us, regardless of its merit, could result in material expense, diversion of management time and attention, and damage to our reputation, which could cause us to fail to
retain or attract customers. Currently, we do not maintain product liability insurance, which will be necessary prior to the commercialization of our products. It is likely that any product liability insurance that we will have in the future will be
subject to significant deductibles and there is no guarantee that such insurance will be available or adequate to protect against all such claims, or we may elect to self-insure with respect to certain matters. Costs or payments made in connection
with warranty and product liability claims and product recalls or other claims could materially affect our financial condition and results of operations.
We expect that we will need to raise substantial additional capital before we can expect to become profitable from sales of our products. This additional
capital may not be available on acceptable terms, or at all. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate our product development efforts or other operations.
We expect that we will require substantial additional capital to commercialize our products. In addition, our operating plans may change as a result of many factors that may currently be unknown to
us, and we may need to seek additional funds sooner than planned. Our future capital requirements will depend on many factors, including but not limited to:
|
|
●
|
the scope, rate of progress, results and cost of product development, and other related activities;
|
13
|
|
●
|
the cost of establishing commercial supplies of our products;
|
|
|
●
|
the cost and timing of establishing sales, marketing, and distribution capabilities; and
|
|
|
●
|
the terms and timing of any collaborative, licensing, and other arrangements that we may establish.
|
Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our products. In addition, we cannot
guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional
securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The incurrence of indebtedness could result in increased fixed payment obligations, and we may be required to agree
to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our
ability to conduct our business. We could also be required to seek funds through arrangements with collaborative partners or otherwise at an earlier stage than otherwise would be desirable, and we may be required to relinquish rights to some of our
technologies or products or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospects. Even if we believe that we have sufficient funds for our current or future
operating plans, we may seek additional capital if market conditions are favorable or if we have specific strategic considerations.
If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of
our products or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations.
Since we are solely dependent on Amazon Cloud, our business, financial condition and results of operations may be materially and adversely affected if this
agreement is terminated or if there are service issues with the cloud that affects our application and operations.
As of the date of this prospectus, Amazon Cloud (also known as Amazon Web Services) is our sole cloud provider. Our entire technology was developed in Amazon’s cloud environment and is currently
deployed on it. Our reliance on a single vendor for our business involves high risks. If we our agreement with Amazon is terminated, our business may be severely interrupted, and our financial condition and results of operations may be materially and
adversely affected. In addition, all our software and code are held in Amazon cloud and could be subject to attacks, deletion or other bad affects.
14
If our relationships with other suppliers for our products and services were to terminate or our software development arrangements were to be disrupted, our
business could be interrupted.
Our products depend on certain third-party technology and we purchase component parts that are used in our products from third-party suppliers, some of whom may compete with us. For example, we
develop our products via a software company situated in India. Our reliance on a single or limited number of vendors involves several risks, including:
|
|
●
|
potential shortages of some key personnel or talented developers;
|
|
|
●
|
Developers performance shortfalls, if traceable to particular persons , since the developers of our software cannot readily be replaced;
|
|
|
●
|
discontinuation of service and talent-pool on which we rely;
|
|
|
●
|
potential insolvency of these vendors; and
|
|
|
●
|
reduced control over delivery schedules, quality and costs.
|
If certain suppliers were to decide to discontinue their service with us, the unanticipated change in the availability of supplies, or unanticipated supply limitations, could cause delays in, or loss
of, developments, integrations, sales, increased production or related costs and consequently reduced margins, and damage to our reputation. If we were unable to find a suitable supplier on time, we could be required to modify our existing
development and production settings or the end-solution that we offer to our customers.
A significant interruption in the operations of our third-party suppliers could potentially disrupt our operations.
We have limited control over the operations of our third-party suppliers and other business partners and any significant interruption in their operations may have an adverse impact on our operations.
For example, a significant interruption in the operations of the India software company, one of our suppliers, may cause interruption to our business. If we could not solve the impact of the interruptions of operations of our third-party suppliers,
our business operations and financial results may be materially and adversely affected.
Mr. Menachem Shalom, our sole director and officer, beneficially owns 100% of our outstanding shares and his interests may differ from the interests of other
shareholders, which could cause a material decline in the value of our shares.
Mr. Menachem Shalom, our sole director and officer, currently beneficially owns 100% of our outstanding ordinary shares. Assuming all the 2,000,000 shares offered in this offering are sold, Mr.
Shalom will have 50% of the outstanding ordinary shares. In addition, he owns, and is expected to own after the completion of the registration, 100% of the issued preferred shares of the company. Accordingly, he has a significant influence on
determining the outcome of any matters submitted to the shareholders for approval, including mergers, consolidations, the election of directors and other significant corporate actions. Without his consent, we may be prevented from entering into
transactions that could be beneficial to us or our minority shareholders. His interest may differ from the interests of our other shareholders. The concentration in the ownership of our shares may cause a material decline in the value of our shares.
15
We cannot assure you that Mr. Menachem Shalom will act in the best interests of all of our shareholders given Mr. Shalom’s ability to control the Company. See “Certain
Relationships and Related Transactions, and Director Independence”.
We are dependent upon our sole executive and we cannot assure his retention.
Our success depends, in part, upon the continued services of Mr. Shalom, whose knowledge of the market, our business and our Company represents a key strength of our business, which cannot be easily
replicated. The success of our business strategy and our future growth also depend on our ability to attract, train, retain and motivate skilled managerial, sales, administration, development and operating personnel. Even though we have a management
agreement with Mr. Shalom, there is no required time period in which he needs to be employed by us.
There can be no assurance that our existing personnel will be adequate or qualified to carry out our strategy, or that we will be able to hire or retain experienced, qualified employees to carry out
our strategy. The loss of Mr. Shalom or the failure to attract and retain additional key personnel, could have a material adverse effect on our business, financial condition and results of operations.
If we fail to adopt new technologies to evolving customer needs or emerging industry standards, our business may be materially and adversely affected.
To remain competitive, we must continue to stay abreast of the constantly evolving industry trends and to enhance and improve our technology accordingly. Our success will depend, in part, on our
ability to identify, develop, acquire or license leading technologies useful in our business. There can be no assurance that we will be able to use new technologies effectively or meet customer’s requirements. If we are unable to adapt in a
cost-effective and timely manner in response to changing market conditions or customer preferences, whether for technical, legal, financial or other reasons, our business may be materially and adversely affected.
We may experience significant liability claims or complaints from customers, or adverse publicity involving our products and our services.
We face an inherent risk of liability claims or complaints from our customers. We take our customers’ complaints seriously and endeavor to reduce such complaints by implementing various remedial
measures. Nevertheless, we cannot assure you that we can successfully prevent or address all customer complaints.
Any complaints or claims against us, even if meritless and unsuccessful, may divert management attention and other resources from our business and adversely affect our business and operations.
Customers may lose confidence in us and our brand, which may adversely affect our business and results of operations. Furthermore, negative publicity including but not limited to negative online reviews on social media and crowd-sourced review
platforms, industry findings or media reports related to safety and quality of our products, whether or not accurate, and whether or not concerning our products, can adversely affect our business, results of operations and reputation.
16
We may be subject to intellectual property infringement claims, which may be expensive to defend and may disrupt our business and operations.
We cannot be certain that our operations or any aspects of our business do not or will not infringe upon or otherwise violate intellectual property rights held by third parties. We have not but in
the future may be, subject to legal proceedings and claims relating to the intellectual property rights of others. There could also be existing intellectual property of which we are not aware that our products may inadvertently infringe. We cannot
assure you that holders of intellectual property purportedly relating to some aspect of our technology or business, if any such holders exist, would not seek to enforce such intellectual property against us in Israel, or any other jurisdictions. If
we are found to have violated the intellectual property rights of others, we may be subject to liability for our infringement activities or may be prohibited from using such intellectual property, and we may incur licensing fees or be forced to
develop alternatives of our own. In addition, we may incur significant expenses, and may be forced to divert management’s time and other resources from our business and operations to defend against these infringement claims, regardless of their
merits. Successful infringement or licensing claims made against us may result in significant monetary liabilities and may materially disrupt our business and operations by restricting or prohibiting our use of the intellectual property in question,
and our business, financial position and results of operations could be materially and adversely affected.
Further, the application and interpretation of Israel’s patent laws and the procedures and standards for granting patents in Israel are still evolving and are uncertain, and we cannot assure you that
the courts or regulatory authorities in Israel would agree with our analysis.
We may not be able to prevent others from unauthorized use of our intellectual property, which could harm our business and competitive position.
Although we regard our know-how, proprietary technologies, and similar intellectual property as critical to our success, we have no patents or trademarks protecting our intellectual property. We may
become an attractive target to intellectual property attacks in the future with the increasing recognition of our brand. Any of our intellectual property rights could be challenged, invalidated, circumvented or misappropriated, or such intellectual
property may not be sufficient to provide us with competitive advantages. In addition, there can be no assurance that (i) all of our intellectual property rights will be adequately protected, or (ii) our intellectual property rights will not be
challenged by third parties or found by a judicial authority to be invalid or unenforceable.
17
Because we are an “emerging growth company,” we may take advantage of certain exemptions from various reporting requirements that are applicable to other public
companies that are not “emerging growth companies.”
We are an “emerging growth company” as defined under the Jumpstart our Business Startups Act (“JOBS Act”). We will remain an “emerging growth company” for up to five years, or until the earliest of:
|
|
(i)
|
the last day of the first fiscal year in which our total annual gross revenues exceed $1.07 billion,
|
|
|
|
|
|
|
(ii)
|
the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our ordinary shares that is held by
non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter, or
|
|
|
|
|
|
|
(iii)
|
the date on which we have issued more than $1 billion in non-convertible debt during the preceding three-year period.
|
As an “emerging growth company”, we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies”
including, but not limited to:
|
|
●
|
not being required to comply with the auditor attestation requirements of section 404(b) of the Sarbanes-Oxley Act (“Sarbanes Oxley”) (we also will not be subject to the auditor attestation
requirements of section 404(b) as long as we are a “smaller reporting company”, which includes issuers that had a public float of less than $75 million as of the last business day of their most recently completed second fiscal quarter);
|
|
|
|
|
|
|
●
|
reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and
|
|
|
|
|
|
|
●
|
exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
|
In addition, section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in section 7(a)(2)(B) of the Securities Act of 1933
(the “Securities Act”) for complying with new or revised accounting standards. Under this provision, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
However, we are choosing to “opt out” of such extended transition period and, as a result, we will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth
companies. Section 107 of the JOBS Act provides that our decision to opt out of the extended transition period for complying with new or revised accounting standards is irrevocable.
18
The nature of our business requires the application of complex revenue recognition rules. Significant changes in U.S. generally accepted accounting
principles, or GAAP, including the adoption of the new revenue recognition rules, could materially affect our financial position and results of operations.
We prepare our financial statements in accordance with GAAP, which is subject to interpretation or changes by the Financial Accounting Standards Board, or FASB, the SEC, and other various bodies
formed to promulgate and interpret appropriate accounting principles. New accounting pronouncements and changes in accounting principles have occurred in the past and are expected to occur in the future, which may have a significant effect on our
financial results. For example, pursuant to the new revenue recognition rules, effective as of January 1, 2018, an entity recognizes sales and usage-based royalties as revenue only when the later of the following events occurs: (1) the subsequent
sale or usage occurs or (2) the performance obligation to which some or all of the sales-based or usage-based royalty allocated has been satisfied (or partially satisfied). Recognizing royalty revenue on a lag time basis is not permitted. As a
result, the royalties we generate from customers is based on royalty of units shipped during the quarter as estimated by our customers, not a quarter in arrears that we previously report. Adoption of this standard and any difficulties in
implementation of changes in accounting principles, including uncertainty associated with royalty revenues for the quarter based on estimates provided by our customer, could cause us to fail to meet our financial reporting obligations, which could
result in regulatory discipline and harm investors’ confidence in us.
Risks relating to legal uncertainty and doing business in Israel
Conditions in Israel could materially and adversely affect our business.
Our executive offices are located in Israel. In addition, our sole officer and director is a resident of Israel. Accordingly, political, economic and military conditions in Israel and the
surrounding region may directly affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries, as well as terrorist acts
committed within Israel, the Palestinian Authority areas and Lebanon by hostile elements.
Civil unrest and political turbulence has occurred in many other countries in the region, including those which share a common border with Israel, and is affecting the political stability of those
countries. This instability and any intervention may lead to deterioration of the political and economic relationships that exist between the State of Israel and some of these countries and may have the potential for additional conflicts in the
region. In addition, Iran has threatened to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, and Hezbollah in Lebanon.
Iran is known to support the government of Syria in its battles against various rebel militia groups in Syria.
Any future armed conflict, political instability, continued violence in the region or restrictions could have a material adverse effect on our business, operating results and financial condition.
While such hostilities did not in the past have a material adverse impact on our business, we cannot guarantee that hostilities will not be renewed and have such an effect in the future. The political and security situation in Israel may result in
parties with whom we have contracts claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions.
Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its present trading partners could adversely affect our operations and could make it more difficult for
us to raise capital or obtain components used in our products. Since many of our facilities are located in Israel, we could experience serious disruptions if acts associated with this conflict result in any serious damage to our facilities. Any
future armed conflict or political instability in the region could negatively affect business conditions and harm our results of operations.
19
Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of
direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a
material adverse effect on our business.
Furthermore, several countries still restrict trade with Israeli companies and additional countries may impose such restrictions as a result of changes in the military and/or political conditions
in Israel and/or the surrounding countries, which may limit our ability to make sales in, or purchase components from, those countries. In addition, such boycott, restrictive laws, policies, or practices may change over time in unpredictable ways,
and could, individually or in the aggregate, have a material adverse effect on our business in the future. Should the BDS Movement, the movement for boycotting, divesting and sanctioning Israel and Israeli institutions (including universities) and
products become increasingly influential in the United States, Europe and around the world, this may also adversely affect our business and financial condition.
In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists
who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military
reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely
affect our business, prospects, financial condition and results of operations.
The legislative power of the State of Israel resides in the Knesset, a unicameral parliament that consists of 120 members elected by nationwide voting under a system of proportional representation.
Israel's most recent general elections were held on April 9, 2019, September 17, 2019 and March 2, 2020, following which a process of composing and approving a new government has commenced. This uncertainty surrounding future elections and/or the
results of such elections in Israel may continue and the political situation in Israel may further deteriorate. Actual or perceived political instability in Israel or any negative changes in the political environment, may individually or in the
aggregate adversely affect the Israeli economy and, in turn, our business, financial condition, results of operations and prospects.
It may be difficult to enforce a U.S. judgment against us, our officer and director or to assert U.S. securities laws claims in Israel or serve process on our
officer and director.
Since our sole director and officer is not a resident of the United States and all of our assets are located outside the United States, service of process upon us or our non-U.S. resident director
and officers may be difficult to obtain within the United States. We have been informed by our legal counsel in Israel that it may be difficult to assert claims under U.S. securities laws in original actions instituted in Israel or obtain a
judgment based on the civil liability provisions of U.S. federal securities laws. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws against us or our non-U.S. officer and director because Israel may not be the
most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of
applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel addressing the matters described above.
Additionally, Israeli courts might not enforce judgments obtained in the United States against us or our non-U.S. director and executive officer, which may make it difficult to collect on judgments rendered against us or our non-U.S. officer and
director.
20
Moreover, an Israeli court will not enforce a non-Israeli judgment if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional
cases), if its enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence of due process, if it is at variance with another valid judgment that was given in the same matter
between the same parties, or if a suit in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought. For more information, see "Enforceability of civil liabilities."
Your rights and responsibilities as our shareholder are governed by Israeli law, which may differ in some respects from the rights and responsibilities of
shareholders of U.S. corporations.
We are incorporated under Israeli law. The rights and responsibilities of holders of our ordinary shares are governed by our articles of association and the Israeli Companies Law, 5759-1999 (the
"Companies Law"). These rights and responsibilities differ in some respects from the rights and responsibilities of shareholders in typical U.S. corporations. In particular, pursuant to the Companies Law each shareholder of an Israeli company has
to act in good faith and in a customary manner in exercising his or her rights and fulfilling his or her obligations toward the company and other shareholders and to refrain from abusing his or her power in the company, including, among other
things, in voting at the general meeting of shareholders on amendments to a company's articles of association, increases in a company's authorized share capital, mergers and certain transactions requiring shareholders' approval under the Companies
Law. In addition, a controlling shareholder of an Israeli company or a shareholder who knows that it possesses the power to determine the outcome of a shareholder vote or who has the power to appoint or prevent the appointment of a director or
officer in the company or has other powers toward the company has a duty of fairness toward the company. However, Israeli law does not define the substance of this duty of fairness. There is little case law available to assist in understanding the
implications of these provisions that govern shareholder behavior.
Provisions of Israeli law and our articles of association may delay, prevent or make undesirable an acquisition of all or a significant portion of our shares
or assets.
Provisions of Israeli law and our articles of association could have the effect of delaying or preventing a change in control and may make it more difficult for a third-party to acquire us or our
shareholders to elect different individuals to our board of directors, even if doing so would be considered to be beneficial by some of our shareholders, and may limit the price that investors may be willing to pay in the future for our ordinary
shares. Among other things:
| • |
Israeli corporate law regulates mergers and requires that a tender offer be effected when more than a specified percentage of shares in a company are purchased;
|
21
| • |
Israeli corporate law does not provide for shareholder action by written consent, thereby requiring all shareholder actions to be taken at a general meeting of shareholders;
|
| • |
our articles of association divide our directors into three classes, each of which is elected once every three years;
|
| • |
our articles of association generally require a vote of the holders of a majority of our outstanding ordinary shares entitled to vote present and voting on the matter at a general meeting of shareholders (referred to as simple majority),
and the amendment of a limited number of provisions, such as the provision dividing our directors into three classes, requires a vote of the holders of at least 65% of the total voting power of our shareholders;
|
| • |
our articles of association do not permit a director to be removed except by a vote of the holders of at least 65% of the total voting power of our shareholders and any amendment to such provision requires the approval of at least 65% of
the total voting power of our shareholders; and
|
| • |
our articles of association provide that director vacancies may be filled by our board of directors.
|
Further, Israeli tax considerations may make potential transactions undesirable to us or to some of our shareholders whose country of residence does not have a tax treaty with Israel granting tax
relief to such shareholders from Israeli tax.
We may be exposed to liabilities under the U.S. Foreign Corrupt Practices Act and other U.S. and foreign anti-corruption anti-money laundering, export
control, sanctions and other trade laws and regulations, and any determination that we violated these laws could have a material adverse effect on our business.
We are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations and various economic and trade sanctions regulations
administered by the U.S. Treasury Department's Office of Foreign Assets Control. We are also subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act,
the USA PATRIOT Act, the United Kingdom Bribery Act 2010, the Proceeds of Crime Act 2002, Chapter 9 (sub-chapter 5) of the Israeli Penal Law, 1977, the Israeli Prohibition on Money Laundering Law—2000 and possibly other anti-bribery and anti-money
laundering laws in countries outside of the United States in which we conduct our activities. Compliance with these laws has been the subject of increasing focus and activity by regulatory authorities, both in the United States and elsewhere, in
recent years. Anti-corruption laws are interpreted broadly and prohibit companies and their employees and third-party intermediaries from authorizing, promising, offering, providing, soliciting or accepting, directly or indirectly, improper
payments or benefits to or from any person whether in the public or private sector.
Noncompliance with anti-corruption, anti-money laundering, export control, sanctions and other trade laws could subject us to whistleblower complaints, investigations, sanctions, settlements,
prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from contracting with certain persons, the loss of export privileges,
reputational harm, adverse media coverage and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our
business, results of operations and financial condition could be materially harmed. Responding to any action will likely result in a materially significant diversion of management's attention and resources and significant defense and compliance
costs and other professional fees. In addition, regulatory authorities may seek to hold us liable for successor liability for violations committed by companies in which we invest or that we acquire. As a general matter, enforcement actions and
sanctions could harm our business, results of operations and financial condition.
22
Risks relating to our ordinary shares and the offering
An active trading market for our ordinary shares may not develop and the trading price for our shares may fluctuate significantly.
Although we intend to apply to have our shares of ordinary stock quoted on the OTCQB, there has been no public market for our ordinary shares, and we cannot assure you that a liquid public market for
our shares will develop. If an active public market for our shares does not develop, the market price and liquidity of our shares may be materially and adversely affected. The offering price for our shares was determined arbitrarily by us, and we can
provide no assurance that the trading price of our shares after this offering will not decline below the initial public offering price. As a result, investors in our securities may experience a significant decrease in the value of their shares.
The trading price of our shares is likely to be volatile, which could result in substantial losses to investors.
If we are successful at developing a market for our shares, the trading price of our shares is likely to be volatile and could fluctuate widely due to factors beyond our control. This may happen
because of broad market and industry factors, including the performance and fluctuation of the market prices of other companies with business operations located mainly in Israel that have listed their securities in the United States. In addition to
market and industry factors, the price and trading volume for our shares may be highly volatile for factors specific to our own operations, including the following:
|
|
●
|
variations in our revenues, earnings and cash flow;
|
|
|
|
|
|
|
●
|
announcements of new investments, acquisitions, strategic partnerships or joint ventures by us or our competitors;
|
|
|
|
|
|
|
●
|
announcements of new offerings, solutions and expansions by us or our competitors;
|
|
|
●
|
changes in financial estimates by securities analysts;
|
|
|
|
|
|
|
●
|
detrimental adverse publicity about us, our services or our industry;
|
|
|
|
|
|
|
●
|
additions or departures of key personnel;
|
|
|
|
|
|
|
●
|
sales of additional equity securities; and
|
|
|
|
|
|
|
●
|
potential litigation or regulatory investigations.
|
Any of these factors may result in large and sudden changes in the volume and price at which our shares will trade.
23
In the past, shareholders of public companies have often brought securities class action suits against those companies following periods of instability in the market price of their securities. If we
were involved in a class action suit, it could divert a significant amount of our management’s attention and other resources from our business and operations and require us to incur significant expenses to defend the suit, which could harm our
results of operations. Any such class action suit, whether or not successful, could harm our reputation and restrict our ability to raise capital in the future. In addition, if a claim is successfully made against us, we may be required to pay
significant damages, which could have a material adverse effect on our financial condition and results of operations.
Our sole officer and director has substantial influence over our company and his interests may not be aligned with the interests of our shareholders.
Menachem Shalom, our sole officer and director, currently owns all the total voting power of our outstanding ordinary shares. If we are successful at selling all the shares offered in this
prospectus, Mr. Shalom will own 50% of our issued and outstanding ordinary shares and 100% of our issued and outstanding preferred shares. As a result, he will maintain substantial influence over our business, including significant corporate actions
such as mergers, consolidations, sales of all or substantially all of our assets, election of directors and other significant corporate actions.
Mr. Shalom may take actions that are not in the best interest of our other shareholders. This concentration of ownership may discourage, delay or prevent a change in control of our company, which
could deprive our shareholders of an opportunity to receive a premium for their shares as part of a sale of our company and may reduce the price of the shares. These actions may be taken even if they are opposed by our other shareholders. In
addition, the significant concentration of share ownership may adversely affect the trading price of the shares due to investors’ perception that conflicts of interest may exist or arise. For more information regarding our principal shareholders and
their affiliated entities, see “Principal Shareholders.”
If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding our
shares, the market price for our shares and trading volume could decline.
The trading market for our shares will be influenced by research or reports that industry or securities analysts publish about our business. If one or more analysts who cover us downgrade our shares,
the market price for our shares would likely decline. If one or more of these analysts cease to cover us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause the market price or
trading volume for our shares to decline.
24
The sale or availability for sale of substantial amounts of our shares could adversely affect their market price.
Sales of substantial amounts of our shares in the public market after the completion of this offering, or the perception that these sales could occur, could adversely affect the market price of our
shares and could materially impair our ability to raise capital through equity offerings in the future. The Shares sold in this offering will be freely tradable without restriction or further registration under the Securities Act, and shares held by
our existing shareholders may also be sold in the public market in the future subject to the restrictions in Rule 144 and Rule 701 under the Securities Act. There will be 12,000,000 ordinary shares outstanding immediately after this offering,
assuming all 2,000,000 offered in this prospectus are sold. We cannot predict what effect, if any, market sales of securities held by our significant shareholder or any other shareholder or the availability of these securities for future sale will
have on the market price of our Shares.
Negative publicity may harm our brand and reputation and have a material adverse effect on our business.
Negative publicity about us, including our services, management, business model and practices, compliance with applicable rules, regulations and policies, or our network partners may materially and
adversely harm our brand and reputation and have a material adverse effect on our business. We cannot assure you that we will be able to defuse any such negative publicity within a reasonable period of time, or at all. Additionally, allegations,
directly or indirectly against us, may be posted on the internet by anyone on a named or anonymous basis, and can be quickly and widely disseminated. Information posted may be inaccurate, misleading and adverse to us, and it may harm our reputation,
business or prospects. The harm may be immediate without affording us an opportunity for redress or correction. Our reputation may be negatively affected as a result of the public dissemination of negative and potentially inaccurate or misleading
information about our business and operations, which in turn may materially adversely affect our relationships with our customers, employees or business partners, and adversely affect the price of our shares.
Because we do not expect to pay dividends in the foreseeable future after this offering, you must rely on price appreciation of our shares for return on your
investment.
We currently intend to retain most, if not all, of our available funds and any future earnings after this offering to fund the development and growth of our business. As a result, we do not expect to
pay any cash dividends in the foreseeable future. Therefore, you should not rely on an investment in our shares as a source for any future dividend income.
Our board of directors has complete discretion as to whether to distribute dividends. Even if our board of directors decides to declare and pay dividends, the timing, amount and form of future
dividends, if any, will depend on our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received by us from our subsidiaries, our financial condition, contractual restrictions and
other factors deemed relevant by our board of directors. Accordingly, the return on your investment will likely depend entirely upon any future price appreciation of our shares. There is no guarantee that our shares will appreciate in value after
this offering or even maintain the price at which you purchased the shares. You may not realize a return on your investment in our shares and you may even lose your entire investment in our shares.
25
We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to United
States domestic public companies.
Because we are a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic
issuers, including: (i) the rules under the Exchange Act requiring the filing of quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC; (ii) the sections of the Exchange Act regulating the solicitation of proxies, consents, or
authorizations in respect of a security registered under the Exchange Act; (iii) the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from
trades made in a short period of time; and (iv) the selective disclosure rules by issuers of material nonpublic information under Regulation FD.
We will be required to file an annual report on Form 20-F within four months of the end of each fiscal year. In addition, we intend to publish our results on a quarterly basis through press releases,
distributed pursuant to the rules and regulations of the Nasdaq Stock Exchange. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or
furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information, which would be made available to you,
were you investing in a U.S. domestic issuer.
We are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.
We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from requirements applicable to other public companies that are not emerging growth
companies including, most significantly, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 for so long as we are an emerging growth company until the earliest of (a) the last day
of the fiscal year during which we have total annual gross revenues of at least US$1.07 billion; (b) the last day of our fiscal year following the fifth anniversary of the completion of this offering; (c) the date on which we have, during the
preceding three-year period, issued more than US$1.0 billion in non-convertible debt; or (d) the date on which we are deemed to be a “large accelerated filer” under the Exchange Act, which would occur if the market value of our Shares that are held
by non-affiliates exceeds US$700 million as of the last business day of our most recently completed second fiscal quarter.
26
We will incur increased costs as a result of being a public company, particularly after we cease to qualify as an “emerging growth company.”
As a public company, we expect to incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act of 2002, as well as rules subsequently
implemented by the SEC and FINRA and OTC Markets, impose various requirements on the corporate governance practices of public companies. As a company with less than US$1.07 billion in revenues for our last fiscal year, we qualify as an “emerging
growth company” pursuant to the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. These provisions include exemption from the
auditor attestation requirement under Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, in the assessment of the emerging growth company’s internal control over financial reporting and permission to delay adopting new or revised
accounting standards until such time as those standards apply to private companies. However, we have elected to “opt out” of this provision and, as a result, we will comply with new or revised accounting standards as required when they are adopted
for public companies. This decision to opt out of the extended transition period under the JOBS Act is irrevocable.
We expect these rules and regulations to increase our legal and financial compliance costs and to make some corporate activities more time-consuming and costly. After we are no longer an “emerging
growth company,” we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the other rules and regulations of the SEC. For
example, as a result of becoming a public company, we will need to increase the number of independent directors and adopt policies regarding internal controls and disclosure controls and procedures. We also expect that operating as a public company
will make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage.
In addition, we will incur additional costs associated with our public company reporting requirements. It may also be more difficult for us to find qualified persons to serve on our board of directors or as executive officers. We are currently
evaluating and monitoring developments with respect to these rules and regulations, and we cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the timing of such costs.
We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.
As discussed above, we are a foreign private issuer, and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act. The
determination of foreign private issuer status is made annually on the last business day of an issuer's most recently completed second fiscal quarter, and, accordingly, the next determination will be made with respect to us on June 30, 2021. In the
future, we would lose our foreign private issuer status if (1) more than 50% of our outstanding voting securities are owned by U.S. residents and (2) a majority of our directors or executive officers are U.S. citizens or residents, or we fail to
meet additional requirements necessary to avoid loss of foreign private issuer status. If we lose our foreign private issuer status, we will be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer
forms, which are more detailed and extensive than the forms available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers, directors and principal shareholders will become
subject to the short-swing profit disclosure and recovery provisions of Section 16 of the Exchange Act. As a U.S. listed public company that is not a foreign private issuer, we will incur significant additional legal, accounting and other expenses
that we will not incur as a foreign private issuer.
27
If we fail to establish and maintain proper internal financial reporting controls, our ability to produce accurate financial statements or comply with
applicable regulations could be impaired.
Prior to this offering, we were a private company with limited accounting personnel and other resources with which to address our internal controls and procedures. Our management has not completed an
assessment of the effectiveness of our internal controls over financial reporting, and our independent registered public accounting firm has not conducted an audit of our internal control over financial reporting. In the course of auditing our
consolidated financial statements for the years ended December 31, 2020 and 2019, we identified several material weaknesses in our internal control over financial reporting and other control deficiencies as of December 31, 2020. A “material weakness”
is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or
detected on a timely basis.
The material weaknesses identified to date relate to (i) a lack of accounting staff and resources with appropriate knowledge of generally accepted accounting principles in the United States (“U.S.
GAAP”) and SEC reporting and compliance requirements; (ii) a lack of sufficient documented financial closing policies and procedures; (iii) a lack of independent directors and an audit committee; (iv) lack of risk assessment in accordance with the
requirement of COSO 2013 framework and (v) a lack of an effective review process by the accounting manager which led to material audit adjustments to the financial statements.
Following the identification of the material weaknesses and control deficiencies, we plan to continue to take remedial measures including (i) hiring more qualified accounting personnel with relevant
U.S. GAAP and SEC reporting experience and qualifications to strengthen the financial reporting function and to set up a financial and system control framework; (ii) implementing regular and continuous U.S. GAAP accounting and financial reporting
training programs for our accounting and financial reporting personnel; (iii) setting up an internal audit function as well as engaging an external consulting firm to assist us with assessment of Sarbanes-Oxley compliance requirements and improvement
of overall internal control; and (iv) appointing independent directors, establishing an audit committee, and strengthening corporate governance.
We plan to take measures to remedy these material weaknesses. The implementation of these measures may not fully address the material weaknesses in our internal control over financial reporting, and
we cannot conclude that they have been fully remedied. Our failure to correct theses material weaknesses or our failure to discover and address any other material weaknesses could result in inaccuracies in our financial statements and could also
impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis. As a result, our business, financial condition, results of operations and prospects, as well as the trading price of our
Ordinary shares, may be materially and adversely affected. Moreover, ineffective internal control over financial reporting significantly hinders our ability to prevent fraud. Upon the completion of this offering, we will become a public company in
the United States subject to the Sarbanes-Oxley Act of 2002. Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, will require that we include a report from management on our internal control over financial reporting in our annual report on
Form 20-F beginning with our annual report for the fiscal year ending December 30, 2020. In addition, once we cease to be an “emerging growth company” as such term is defined in the JOBS Act, our independent registered public accounting firm must
attest to and report on the effectiveness of our internal control over financial reporting. Our management may conclude that our internal control over financial reporting is not effective. Moreover, even if our management concludes that our internal
control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue a report that is qualified if it is not satisfied with our internal controls or the level at
which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we become a public company, our reporting obligations may place a significant strain on our
management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation.
28
We have broad discretion over the use of proceeds we receive in this offering and may not apply the proceeds in ways that increase the value of your
investment.
Our management will have broad discretion in the application of the net proceeds from this offering and, as a result, you will have to rely upon the judgment of our management with respect to the
use of these proceeds. Our management may spend a portion or all of the net proceeds in ways that not all shareholders approve of or that may not yield a favorable return. The failure by our management to apply these funds effectively could harm
our business.
We do not expect to pay any dividends in the foreseeable future.
We have never declared or paid any dividends on our ordinary shares. We do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to
finance operations and expand our business. Our board of directors has sole discretion whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings,
capital requirements and surplus, general financial condition, contractual restrictions and other factors that our directors may deem relevant. The Companies Law imposes restrictions on our ability to declare and pay dividends. Payment of dividends
may also be subject to Israeli withholding taxes. See "Taxation and government programs" for more information.
This prospectus contains forward-looking statements about our current expectations and views of future events, which are contained principally in the sections entitled “Prospectus Summary”, “Risk
Factors,” “Use of Proceeds,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Business.” These forward-looking statements relate to events that involve known and unknown risks, uncertainties and other
factors which may cause our actual results, performance or achievements to be materially different from those expressed or implied by these statements.
29
You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely
to,” “propose,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial
condition, results of operations, business strategy and financial needs. The forward-looking statements included in this prospectus relate to, among other things:
|
|
●
|
our goals and strategies;
|
|
|
●
|
our business and operating strategies and plans for the development of existing and new businesses, ability to implement such strategies and plans and expected time;
|
|
|
|
|
|
|
●
|
our future business development, financial condition and results of operations;
|
|
|
|
|
|
|
●
|
expected changes in our revenues, costs or expenditures;
|
|
|
|
|
|
|
●
|
our dividend policy;
|
|
|
|
|
|
|
●
|
our expectations regarding demand for and market acceptance of our products and services;
|
|
|
|
|
|
|
●
|
our expectations regarding our relationships with customers and business partners;
|
|
|
|
|
|
|
●
|
the trends in, expected growth in and market size of the global digital wallet industry;
|
|
|
|
|
|
|
●
|
our ability to maintain and enhance our market position;
|
|
|
|
|
|
|
●
|
our ability to continue to develop new technologies and/or upgrade our existing technologies;
|
|
|
|
|
|
|
●
|
developments in, or changes to, laws, regulations, governmental policies, incentives and taxation affecting our operations, in particular in the digital wallet industry;
|
30
|
|
●
|
relevant governmental policies and regulations relating to our businesses and industry;
|
|
|
|
|
|
|
●
|
competitive environment, competitive landscape and potential competitor behavior in our industry and the overall outlook in our industry;
|
|
|
|
|
|
|
●
|
our ability to attract, train and retain executives and other employees;
|
|
|
|
|
|
|
●
|
the development of the global financial and capital markets;
|
|
|
|
|
|
|
●
|
fluctuations in inflation, interest rates and exchange rates;
|
|
|
|
|
|
|
●
|
general business, political, social and economic conditions in Israel and the overseas markets we have business;
|
|
|
|
|
|
|
●
|
the length and severity of the recent COVID-19 outbreak and its impact on our business and industry; and
|
|
|
|
|
|
|
●
|
assumptions underlying or related to any of the foregoing.
|
These forward-looking statements involve various risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations and
our actual results could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in “Prospectus Summary—Our Challenges,”
“Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Business,” “Regulation” and other sections in this prospectus. Moreover, we operate in an evolving environment. New risk factors and
uncertainties emerge from time to time and it is not possible for our management to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors,
may cause actual results to differ materially from those contained in any forward-looking statements. You should read thoroughly this prospectus and the documents that we refer to with the understanding that our actual future results may be
materially different from and worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements.
31
This prospectus contains information derived from government and private publications. These publications include forward-looking statements, which are subject to risks, uncertainties and
assumptions. Although we believe the data and information to be reliable, we have not independently verified the accuracy or completeness of the data and information contained in these publications. Statistical data in these publications also include
projections based on a number of assumptions. The digital wallet industry may not grow at the rate projected by market data, or at all. Failure of these markets to grow at the projected rate may have a material and adverse effect on our business and
the market price of our ordinary shares. In addition, the rapidly evolving nature of the industry results in significant uncertainties for any projections or estimates relating to the growth prospects or future condition of our market. Furthermore,
if any one or more of the assumptions underlying the market data are later found to be incorrect, actual results may differ from the projections based on these assumptions. See “Risk Factors—Risks Relating to Our Shares and General Risk Factors.”
Therefore, you should not place undue reliance on these statements.
You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements in this prospectus are made based on events and information as of the date of this
prospectus. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to
reflect the occurrence of unanticipated events. You should read this prospectus and the documents that we refer to in this prospectus and have filed as exhibits to the registration statement, of which this prospectus is a part, completely and with
the understanding that our actual future results or performance may materially differ from what we expect.
This prospectus relates to the offering and sale by our Company of up to an aggregate of 2,000,000 ordinary shares of our stock, par value NIS 0.01 per share. The purchase price per share is $0.95. If we are successful
at selling all the shares in the offering, we would receive gross proceeds of $1,900,000.
The shares to be offered and sold by us will be offered on a “best efforts basis.” The shares will be sold by our sole director and officer on our behalf, and no underwriters or broker-dealers will be involved in such
offering. The offering will commence as soon as practicable after the effective date of the registration statement relating to this prospectus. It will terminate 180 days after such effective date, but such termination date may be extended for up
to an additional 90 days in our discretion. We reserve the right to terminate the offering at an earlier date, in our sole discretion, even if no shares are sold.
USE OF PROCEEDS
We expect to receive net proceeds from this offering, after deducting offering expenses payable by us, of approximately $1,840,000.
We intend to use the net proceeds from this offering for working capital, to fund growth and for other general corporate purposes.
32
We intend to use the net proceeds of this offering as follows:
|
|
●
|
approximately $1,288,000 as working capital of the company – used for our ongoing operations; specifically, for research and software development, sales and marketing efforts and for
management and overhead;
|
|
|
●
|
approximately $184,000 to Mr. Shalom, our sole officer and director for repayment of some of the amounts the Company owes him; and
|
|
|
●
|
approximately $368,000 for business development purposes – mainly to license and/or to buy additional technology and software that may complement the Company's technology; and
|
|
|
●
|
the balance for general corporate purposes.
|
As of December 31, 2020, we are indebted to Mr. Shalom in the aggregate amount of NIS 1,474,171 (approximately $446,718), consisting of NIS900,900 of management fees pursuant to the terms of the
Management Services Agreement dated December 30, 2017 and NIS573,271 borrowed by the Company from Mr. Shalom pursuant to the terms of the Shareholders’ Loan Agreement dated February 1, 2018. See “Certain Relationships and Related Party Transactions”.
As indicated above, we intend to reduce the amount of our obligation to Mr. Shalom by utilizing $184,000 from the net proceeds of this offering.
We will retain broad discretion over the use of the net proceeds of this offering which may result in an allocation of net proceeds in differing amounts than those listed above, or in entirely new
areas. Our use of the net proceeds from this offering will depend on a number of factors, including our future revenue and cash generated by operations and the other factors described in "Risk Factors." As a result, you will be relying on the
judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. It is possible that the proceeds will
be used in a way that does not yield a favorable, or any, return for us. Pending application of the net proceeds as described above, we intend to invest the proceeds in investment grade interest bearing instruments or will hold the proceeds in
interest bearing or non-interest-bearing bank accounts.
We are offering up to a maximum of 2,000,000 ordinary shares by direct public offering on a "best efforts basis." The offering price is $0.95 per share. The shares will be sold on our behalf by our sole officer and
director. Mr. Shalom will not receive any commissions or proceeds from the offering for selling shares on our behalf. No brokers, dealers or finders or agent for commission are involved in this offering.
33
The offering will commence as soon as practicable after the effective date of the registration statement relating to this prospectus. It will terminate 180 days after such effective date, but such termination date may be
extended for up to an additional 90 days in our discretion. We reserve the right to terminate the offering at an earlier date, in our sole discretion, even if no shares are sold.
There are no other minimum purchase requirements, and there are no arrangements to place the funds in an escrow, trust, or similar account. Funds received by us for the payment of shares subscribed for in the offering
will be deposited into a bank account maintained by us and under our control and be immediately available for our use. All funds received by us will be retained by us for our use and will not be refunded.
There has been no market for our securities. Our ordinary shares are not traded on any exchange or quoted on the OTC Markets. After the effective date of the registration statement relating to this prospectus, we hope to
have a market maker file an application with the National Association of Securities Dealers, Inc. for our ordinary shares to eligible for trading on the OTCQB. We do not yet have a market maker who has agreed to file such application.
As noted above, we will sell the shares in this offering through Mr. Shalom, our sole officer and director. Such person will receive no commission from the sale of any shares. He will not register as a broker-dealer
under section 15 of the Exchange Act in reliance upon Rule 3a4-1. Rule 3a4-1 sets forth those conditions under which a person associated with an issuer may participate in the offering of the issuer's securities and not be deemed to be a
broker/dealer. The conditions are namely: (1) The person is not statutorily disqualified, as that term is defined in Section 3(a)(39) of the Act, at the time of his participation; (2) The person is not compensated in connection with his participation
by the payment of commissions or other remuneration based either directly or indirectly on transactions in securities; (3) The person is not at the time of their participation, an associated person of a broker/dealer; and (4) The person meets the
conditions of paragraph (a)(4)(ii) of Rule 3a4-1 of the Exchange Act, in that he (A) primarily performs, or is intended primarily to perform at the end of the offering, substantial duties for or on behalf of the issuer otherwise than in connection
with transactions in securities; and (B) is not a broker or dealer, or an associated person of a broker or dealer, within the preceding twelve (12) months; and (C) does not participate in selling and offering of securities for any issuer more than
once every twelve (12) months other than in reliance on Paragraphs (a)(4)(i) or (a)(4)(iii).
Our officer and director is not statutorily disqualified, is not being compensated, and is not associated with a broker/dealer. He is and will continue to be our officer and director at the end of the offering and has
not been during the last twelve months and is currently not a broker/dealer or associated with a broker/dealer. He will not participate in selling and offering securities for any issuer more than once every twelve months.
Only after our registration statement relating to this prospectus is declared effective by the SEC, do we intend to hold investment meetings in various states where the offering will be registered. We will not utilize
the Internet or any form of paid media to advertise our offering, but rather through meetings arranged by our officer and director and his business associates and his friends or relatives who may also distribute the prospectus to potential investors,
to see who are interested in us and in making a possible investment in the offering. No shares purchased in this offering will be subject to any kind of lock-up or trust agreement, implicit or explicit.
34
Procedures for Subscribing
We will not accept any money until this registration statement is declared effective by the SEC. Once the registration statement is declared effective by the SEC, if you decide to subscribe for any shares in this
offering, you must
1. execute and deliver a subscription agreement, a copy of which is included with the prospectus; and
2. deliver payment to us for acceptance or rejection.
All checks for subscriptions must be made payable to "Hold Me Ltd." All wire transfer fees, currency exchange differences and credit card processing fees must be paid by the subscriber.
Right to Reject Subscriptions
We have the right to accept or reject subscriptions in whole or in part, for any reason or for no reason. All monies from rejected subscriptions will be returned immediately by us to the subscriber, without interest or
deductions. Subscriptions for securities will be accepted or rejected within 48 hours after we receive them.
Underwriters
We have no underwriter and do not intend to have one. In the event that we sell or intend to sell by means of any arrangement with an underwriter, then we will file a post-effective amendment to accurately reflect the
changes to us and our financial affairs and any new risk factors, and in particular to disclose such material relevant to this Plan of Distribution.
Regulation M
We are subject to Regulation M of the Securities Exchange Act of 1934. Regulation M governs activities of underwriters, issuers, selling security holders, and others in connection with offerings of securities. Regulation
M prohibits distribution participants and their affiliated purchasers from bidding for purchasing or attempting to induce any person to bid for or purchase the securities being distribute.
Penny Stock Regulations
You should note that our stock is a penny stock. The Securities and Exchange Commission has adopted Rule 15g-9 which generally defines "penny stock" to be any equity security that has a market price (as defined) less
than $5.00 per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Our securities are covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons
other than established customers and "accredited investors". The term "accredited investor" refers generally to institutions with assets in excess of $5,000,000 or individuals with a net worth in excess of $1,000,000 or annual income exceeding
$200,000 or $300,000 jointly with their spouse. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the
SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the
broker-dealer and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the customer's account. The bid and offer quotations, and the broker-dealer and salesperson compensation
information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer's confirmation. In addition, the penny stock rules require that prior to a
transaction in a penny stock not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the
transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of
broker-dealers to trade our securities. We believe that the penny stock rules discourage investor interest in and limit the marketability of our common stock.
35
We have never declared or paid any dividends on our ordinary shares. We do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to
finance operations and expand our business. Our board of directors has sole discretion whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings,
capital requirements and surplus, general financial condition, contractual restrictions and other factors that our directors may deem relevant.
The Companies Law imposes restrictions on our ability to declare and pay dividends. See "Description of share capital and articles of association—Dividend and liquidation rights" for additional
information. Payment of dividends may be subject to Israel withholding taxes. See “Taxation and government programs-Israeli tax considerations and government programs” for additional information.
The following table sets forth our capitalization as of December 31, 2020 presented on:
|
•
|
An actual basis (assuming the addback of 1,997,000 common shares that were issued on April 12, 2021); and
|
|
•
|
a pro forma as adjusted basis to give effect to the issuance and sale of the 2,000,000 Shares by us in this offering at an assumed initial public offering price of US$0.95 per share, after
deducting the estimated offering expenses.
|
The pro forma and pro forma as adjusted information below is illustrative only and our capitalization following the completion of this offering is subject to adjustment based on the initial public offering price of
our ordinary shares. You should read this table in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes included elsewhere in this
prospectus.
|
As of December 31, 2020
|
||||||||||||||||
|
(Presented in NIS)
(b)(c)
|
(Presented in US$)
|
|||||||||||||||
|
|
Actual
|
Pro forma
|
Actual
|
Pro forma
|
||||||||||||
|
Long term debt
|
90,053
|
90,053
|
28,010
|
28,010
|
||||||||||||
|
Par Value Amount of Ordinary Shares
|
0.01
|
0.01
|
0.003
|
0.003
|
||||||||||||
|
Ordinary Shares, 2,000,000 issued and outstanding as of December 31, 2020; pro forma 4,000,000 shares issued and outstanding (a)
|
20,000
|
40,000
|
6,221
|
12,442
|
||||||||||||
|
Additional paid in capital
|
300,000
|
6,195,600
|
93,313
|
1,927,092
|
||||||||||||
|
Accumulated deficit
|
(1,521,738
|
)
|
(1,521,738
|
)
|
(473,324
|
)
|
(473,324
|
)
|
||||||||
|
Total capitalization
|
(1,201,738
|
)
|
4,713,862
|
(373,791
|
)
|
1,466,209
|
||||||||||
(a) Assumes the addback of 1,997,000 ordinary shares that were issued on April 12, 2021
(b) Assumes the sale of 2,000,000 shares at $0.95 USD, less $60,000 in $USD offering expenses resulting in net proceeds of $1,840,000 USD
(c) Conversion rate used 3.215 shekels to the $USD as of December 31, 2020
Purchasers of our securities in this offering will experience immediate and substantial dilution in the net tangible book value of their ordinary shares from the initial public offering price.
The historical net tangible book value as of December 31, 2020 was (NIS1,221,735), or approximately (NIS4,072.45) per share calculated with the number of shares as of December 31, 2020 (300 ordinary
shares) or approximately (NIS0.61) per share calculated with the adjusted number of shares prior to this registration (2,000,000 ordinary shares). Historical net tangible book value per share of ordinary shares is equal to our total tangible assets
less total liabilities, divided by the number of shares of ordinary shares outstanding as of December 31, 2020. Adjusted to give effect to the receipt of net proceeds, after deducting the estimated offering expenses payable by us, from the sale of
2,000,000 ordinary shares for $1,900,000, net tangible book value will be approximately NIS1.21 per share. This will represent an immediate increase of approximately NIS1.82 per share to the existing stockholder and an immediate and substantial
dilution of approximately $(0.26) per share, or approximately (27.37%), to new investors purchasing our securities in this offering. Dilution in pro forma net tangible book value per share represents the difference between the amount per share paid
by purchasers of shares of our ordinary shares in this offering and the pro forma net tangible book value per share of our ordinary shares immediately following this offering.
The following table sets forth as of December 31, 2020 the number of shares of ordinary shares purchased from us and the total consideration paid by our existing stockholders and by new investors in this offering if
new investors purchase the maximum offering, assuming a purchase price in this offering of $0.95 per share of ordinary shares.
|
Number
|
Percent
|
|||||||
|
Existing Stockholder
|
2,000,000
|
50.00
|
||||||
|
New Investors
|
2,000,000
|
50.00
|
||||||
|
Total
|
4,000,000
|
100
|
||||||
36
Report of Independent Registered Public Accounting Firm
To the shareholders and the board of directors of Hold Me Ltd.
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Hold Me Ltd. as of December 31, 2020 and 2019, the related statements of operations, stockholders' equity (deficit), and cash flows for the years
then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and
the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States.
Substantial Doubt about the Company’s Ability to Continue as a Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has suffered
recurring losses from operations and has a significant accumulated deficit. In addition, the Company continues to experience negative cash flows from operations. These factors raise substantial doubt about the Company's ability to continue as a going
concern. Management's plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an
understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
37
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1)
relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the
financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Revenue recognition — identification of contractual terms in certain customer arrangements
As described in Note 2 to the financial statements, management assesses relevant contractual terms in its customer arrangements to determine the transaction price and recognizes revenue upon transfer of control of the
promised goods or services in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. Management applies judgment in determining the transaction price which is dependent on the
contractual terms. In order to determine the transaction price, management may be required to estimate variable consideration when determining the amount and timing of revenue recognition.
The principal considerations for our determination that performing procedures relating to the identification of contractual terms in customer arrangements to determine the transaction price is a critical audit matter
are there was significant judgment by management in identifying contractual terms due to the volume and customized nature of the Company’s customer arrangements. This in turn led to significant effort in performing our audit procedures which were
designed to evaluate whether the contractual terms used in the determination of the transaction price and the timing of revenue recognition were appropriately identified and determined by management and to evaluate the reasonableness of
management’s estimates.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. These procedures included testing the effectiveness of
controls relating to the revenue recognition process, including those related to the identification of contractual terms in customer arrangements that impact the determination of the transaction price and revenue recognition. These procedures also
included, among others, (i) testing the completeness and accuracy of management’s identification of the contractual terms by examining customer arrangements on a test basis, and (ii) testing management’s process for determining the appropriate
amount and timing of revenue recognition based on the contractual terms identified in the customer arrangements.
/S/ BF Borgers CPA PC
We have served as the Company's auditor since 2021
Lakewood, CO
April 22, 2021
You should read the following selected financial data together with our financial statements and the related notes appearing at the end of this prospectus and the “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” section of this prospectus. We have derived the statements of operations data for the years ended December 31, 2020 and December 31, 2019 and the balance sheet data as of December 31, 2020
and 2019 from our audited financial statements appearing at the end of this prospectus. Our historical results are not necessarily indicative of the results that should be expected in any future periods.
38
Balance Sheets
|
As at December 31
|
||||||||||||
|
2020
|
2019
|
|||||||||||
|
Notes
|
New Israeli Shekels
|
|||||||||||
|
Current Assets
|
||||||||||||
|
Cash and Cash Equivalents
|
3
|
149,791
|
5,313
|
|||||||||
|
Customers
|
1,832
|
|||||||||||
|
Receivables and Debit Balances
|
4
|
3,466
|
110,000
|
|||||||||
|
155,089
|
115,313
|
|||||||||||
|
Fixed Assets
|
5
|
581,389
|
980,952
|
|||||||||
|
Intangible Assets
|
-
|
-
|
||||||||||
|
736,478
|
1,096,265
|
|||||||||||
|
Current Liabilities
|
||||||||||||
|
Credit from Banking Corporations
|
6
|
45,502
|
70,359
|
|||||||||
|
Suppliers and Service Providers
|
423
|
-
|
||||||||||
|
Payables and Credit Balances
|
7
|
1,822,235
|
1,733,190
|
|||||||||
|
1,868,160
|
1,803,549
|
|||||||||||
|
Long-Term Liabilities
|
||||||||||||
|
Loans from Banking Corporations and other Credit Providers
|
8
|
90,053
|
136,618
|
|||||||||
|
Capital Deficit
|
||||||||||||
|
Share Capital
|
9
|
3
|
3
|
|||||||||
|
Premium on Shares
|
300,000
|
300,000
|
||||||||||
|
Deficit Balance
|
(1,521,738
|
)
|
(1,143,905
|
)
|
||||||||
|
(1,221,735
|
)
|
(843,902
|
)
|
|||||||||
|
736,478
|
1,096,265
|
|||||||||||
The Notes Attached to the Financial Statements Form an Integral Part Hereof.
39
Statements of Profit and Loss
|
For the Year Ended December 31,
|
||||||||||||
|
2020
|
2019
|
|||||||||||
|
Notes
|
New Israeli Shekels
|
|||||||||||
|
Income
|
486,360
|
134,377
|
||||||||||
|
Cost of projects
|
455,035
|
289,692
|
||||||||||
|
Gross deficit
|
31,325
|
(155,315
|
)
|
|||||||||
|
Selling, administrative and general expenses
|
10
|
(397,481
|
)
|
(769,543
|
)
|
|||||||
|
Operating deficit
|
(366,156
|
)
|
(924,858
|
)
|
||||||||
|
Financing expenses, net
|
(11,677
|
)
|
(14,898
|
)
|
||||||||
|
Loss for the year after financing
|
(377,833
|
)
|
(939,756
|
)
|
||||||||
|
Other expenses
|
-
|
(10,000
|
)
|
|||||||||
|
Loss for the period
|
(377,833
|
)
|
(949,756
|
)
|
||||||||
|
Loss from previous years
|
(1,143,905
|
)
|
(194,149
|
)
|
||||||||
|
Deficit balance
|
(1,521,738
|
)
|
(1,143,905
|
)
|
||||||||
The Notes Attached to the Financial Statements Form an Integral Part Hereof.
40
Statements of Changes in Shareholders' Equity
|
Number of Issued shared
|
Ordinary shares
|
Additional Paid-in Capital
|
Accumulated Deficit
|
Total Shareholders' Equity
|
||||||||||||||||
|
Balance at January 1, 2019
|
300
|
3
|
-
|
(194,149
|
)
|
(194,146
|
)
|
|||||||||||||
|
Issuance of Shares and Premium
|
-
|
-
|
300,000
|
-
|
300,000
|
|||||||||||||||
|
Total comprehensive loss
|
-
|
-
|
-
|
(949,756
|
)
|
(949,756
|
)
|
|||||||||||||
|
Balance at December 31, 2019
|
300
|
3
|
300,000
|
(1,143,905
|
)
|
(843,902
|
)
|
|||||||||||||
|
Balance at January 1, 2020
|
300
|
3
|
300,000
|
(1,143,905
|
)
|
(843,902
|
)
|
|||||||||||||
|
Total comprehensive loss
|
-
|
-
|
-
|
(377,833
|
)
|
(377,833
|
)
|
|||||||||||||
|
Balance at December 31, 2020
|
300
|
3
|
300,000
|
(1,521,738
|
)
|
(1,221,735
|
)
|
|||||||||||||
The Notes Attached to the Financial Statements Form an Integral Part Hereof.
41
Statements of Cash Flows
|
For the Year Ended
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
(377,833
|
)
|
(949,756
|
)
|
||||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Depreciation
|
433,044
|
297,017
|
||||||
|
Increase (Decrease) in Customers
|
(1,832
|
)
|
||||||
|
Decrease (Increase) in other accounts receivable and prepaid expenses
|
106,534
|
(87,624
|
)
|
|||||
|
Increase in Creditors
|
423
|
|||||||
|
Increase in accrued expenses and other accounts payable
|
89,045
|
806,381
|
||||||
|
Net cash provided by (used in) operating activities
|
249,381
|
66,018
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchase of property and equipment
|
(33,481
|
)
|
(341,685
|
)
|
||||
|
Net cash provided by (used in) investing activities
|
(33,481
|
)
|
(341,685
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Cash for issuance of shares
|
-
|
300,000
|
||||||
|
Short Term Credit from Bank, net
|
(24,857
|
)
|
6,747
|
|||||
|
Repayment of Long-Term Loans and Liabilities
|
(46,565
|
)
|
(30,752
|
)
|
||||
|
Net cash provided by (used in) financing activities
|
(71,422
|
)
|
275,995
|
|||||
|
Increase (Decrease) in cash and cash equivalents
|
144,478
|
328
|
||||||
|
Cash and cash equivalents at the beginning of the period
|
5,313
|
4,985
|
||||||
|
Cash and cash equivalents at the end of the period
|
149,791
|
5,313
|
||||||
42
Note 1 - General
| A. |
The Company was incorporated under the laws of the state of Israel and commenced operations as a private company in January 2007, under Companies Registrar number 513933218.
|
| B. |
The Company develops a software-based platform that enables its customers to enhance their brand and loyalty plans with digital payments and reward programs through the creation and offering of branded mobile applications.
|
| C. |
Since inception, the Company incurred an accumulated deficit of NIS 1,521,738. The Company will need funds to continue its operations until profitability is achieved or until additional funding is raised.
|
Note 2 - Summary of Significant Accounting Policies
The principal accounting policies, consistently applied in the preparation of the financial statements, are as follows:
| A. |
Financial Statements Reporting Basis
|
The financial statements are drawn up on the basis of generally accepted accounting principles ("GAAP"), and are expressed in New Israeli Shekel ("NIS") based
on historical values, and provide no information on changes in the general purchasing power of the Israeli currency on the business results.
Those reports are filed as part of form F-1 (Registration Statement Under the Securities Act of 1933). Since the Company was incorporated in Israel and is
considered a Foreign Issuer and as such is allowed to file the statement and the financial reports in its home country currency, New Israeli Shekel (NIS).
| B. |
Cash and Cash Equivalents
|
The Company considers high-liquidity investments, including short-term cash deposits in banks (up to three months), as cash equivalents.
| C. |
Fixed Assets
|
Property and equipment are stated at cost. Major improvements and betterments are capitalized. Maintenance and repairs are expensed as incurred. Depreciation
is computed using the straight-line method over the estimated useful life. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is
reflected in the statements of operations as other gain or loss, net.
Annual depreciation rates are as follows:
|
%
|
| Office furniture and equipment |
6 - 15
|
| Vehicles |
15
|
| Computers |
33
|
| D. |
Use of Estimates in Preparing the Financial Statements
|
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results may differ from those estimates.
43
| E. |
Income Tax
|
The Company accounts for income taxes in accordance with ASC 740, "Income Taxes" ("ASC 740"). ASC 740 prescribes the use of the liability method whereby
deferred tax assets and liability account balances are determined based on differences between the financial reporting and the tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the
differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value, and if it is more likely than not that a portion or all of the deferred tax assets will
not be realized.
| F. |
Revenue Recognition
|
Significant management judgments and estimates must be made and used in connection with the recognition of revenue in any accounting period. Material differences in the amount
of revenue in any given period may result if these judgments or estimates prove to be incorrect or if management’s estimates change on the basis of development of business or market conditions.
We have decided to follow the provisions of Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”). The guidance provides a
unified model to determine how revenue is recognized.
Revenues are recognized when control of the promised goods or services are transferred to the customers in an amount that reflects the consideration that we expect to receive in
exchange for those goods or services.
We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the
contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.
We enter into contracts that can include various combinations of products and services, as detailed below, which are generally capable of being distinct and accounted for as
separate performance obligations.
We generate our revenues from (1) licensing intellectual properties, which in certain circumstances are modified for customer-specific requirements, (2) royalty revenues and (3)
other revenues, which include revenues from support, training and sale of development systems and chips. We license our assets IP to other companies who can then resell, develop or market otherwise in variety of business models.
We account for license revenues and related services, which provide our customers with rights to use our platform, in accordance with ASC 606. A license may be perpetual or time
limited in its application. In accordance with ASC 606, we recognize revenue from platform license at the time of delivery when the customer accepts control of the platform, as the platform is functional without professional services, updates and
technical support. We have concluded that our platform license is distinct as the customer can benefit from the software on its own.
44
Revenues that are derived from the sale of a licensee’s products that incorporate our platform are classified as royalty revenues. Royalty revenues are recognized during the
quarter in which the sale of the product incorporating our platform occurs. Royalties are calculated either as a percentage of the revenues received by our licensees on sales of products incorporating our platform or on a per unit basis, as specified
in the agreements with the licensees. We receive the actual sales data from our customers after the quarter ends and accounts for it as unbilled receivables. When we do not receive actual sales data from the customer prior to the finalization of its
financial statements, royalty revenues are recognized based on our estimation of the customer’s sales during the quarter. We may engage a third party to perform royalty audits of our licensees, and if these audits indicate any over- or under-reported
royalties, we account for the results when the audits are resolved.
| G. |
Going Concern
|
The accompanying financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern.
The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a
going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.
The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources
of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Note 3 - Cash and Cash Equivalents
|
As at December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
`
|
Israel Shekels
|
|||||||
|
Bank Mizrahi Current Account No. 684795
|
-
|
5,313
|
||||||
|
Bank Mizrahi Current Account No. 073959
|
149,791
|
-
|
||||||
|
149,791
|
5,313
|
|||||||
Note 4 - Receivables and Debit Balances
|
As at December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Israel Shekels
|
||||||||
|
Prepaid expenses
|
-
|
110,000
|
||||||
|
Institutions
|
-
|
-
|
||||||
|
Other receivables
|
3,466
|
-
|
||||||
|
3,466
|
110,000
|
|||||||
45
Note 5 - Fixed Assets
|
As at December 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
|
Cost
|
Accumulated Depreciation
|
Depreciated Cost
|
Depreciated Cost
|
|||||||||||||
|
Israel Shekels
|
||||||||||||||||
|
R&D expenses
|
1,290,062
|
1,290,062
|
1,290,062
|
1,290,062
|
||||||||||||
|
Computers
|
22,196
|
22,196
|
22,196
|
22,196
|
||||||||||||
|
1,312,258
|
1,312,258
|
1,312,258
|
1,312,258
|
|||||||||||||
Note 6 - Credit from Banking Institutions
|
As at December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Israel Shekels
|
||||||||
|
Bank Mizrahi Current Account 684728
|
7,639
|
9,789
|
||||||
|
Bank Mizrahi Current Account 73959
|
-
|
29,978
|
||||||
|
Current maturities of long-term loans
|
37,863
|
30,592
|
||||||
|
45,502
|
70,359
|
|||||||
Note 7 - Payables and Credit Balances
|
As at December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Israel Shekels
|
||||||||
|
Payable Expenses
|
216,000
|
-
|
||||||
|
Down payments from clients
|
1,453
|
2,179
|
||||||
|
Government institutions
|
81,867
|
9,710
|
||||||
|
Employees and institutions - salaries
|
-
|
-
|
||||||
|
Related parties
|
48,744
|
121,144
|
||||||
|
Shareholders
|
1,474,171
|
1,583,338
|
||||||
|
Others
|
-
|
16,819
|
||||||
|
1,822,235
|
1,733,190
|
|||||||
Note 8 - Loans from Banking Corporations and other Credit Providers
|
As at December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Israel Shekels
|
||||||||
|
Loan from Mizrahi Bank A/c 73959
|
125,669
|
151,772
|
||||||
|
Loan from Mizrahi Bank A/c 684728
|
2,247
|
15,438
|
||||||
|
Less - current maturities
|
(37,863
|
)
|
(30,592
|
)
|
||||
|
90,053
|
136,618
|
|||||||
46
Note 9 - Share Capital
|
December 31, 2019 and 2020
|
||||||||
|
Registered
|
Issued and Paid Up
|
|||||||
|
Number of Shares
|
||||||||
|
Ordinary shares of ILS 1 each p.v.
|
100,000
|
300
|
||||||
Note 10 - Selling, Administrative and General Expenses
|
For the Year Ended on December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Israel Shekels
|
||||||||
|
Salary
|
-
|
20,484
|
||||||
|
Advertising
|
10,945
|
13,324
|
||||||
|
Rent (*)
|
820
|
12,009
|
||||||
|
Management fees (*) (**) (***)
|
320,000
|
660,001
|
||||||
|
Communication
|
2,235
|
3,519
|
||||||
|
Professional services
|
51,524
|
21,793
|
||||||
|
Travel abroad
|
1,552
|
19,621
|
||||||
|
Maintenance and Electricity
|
307
|
-
|
||||||
|
Office expenses
|
-
|
8,490
|
||||||
|
Refreshments
|
405
|
-
|
||||||
|
Taxes and fees
|
1,511
|
1,133
|
||||||
|
Travel and parking
|
857
|
1,844
|
||||||
|
Depreciation expenses
|
7,325
|
7,325
|
||||||
|
397,481
|
769,543
|
|||||||
(*) Re-classified
(**) 2019 Includes differences for 2018
(***) Management fee for the period starting May 2020 onwards, and until the date of this report, was not charged yet and is expected to be charged during 2021
Note 11 – Subsequent Events
| • |
On April 12, 2021 the Company changed its articles of association and its capital structure. As a result, the new authorized capital of the company is:
|
990,000,000 Ordinary shares of nominal value NIS 0.01 per share
10,000,000 Preferred shares of nominal value NIS 0.01 per share
|
•
|
On April 12, 2021, the Company issued 1,999,700 Ordinary shares and 10,000,000 Preferred shares for an aggregate purchase price of NIS 119,997 to Menachem Shalom. The purchase amount was not paid in cash but by deducting the amount from the Company's debt owed to Menachem Shalom.
|
47
RESULTS OF OPERATIONS
Key Financial Performance Indicators
In assessing our financial performance, we consider a variety of financial performance measures, including principal growth in net revenue and gross profit, our ability to control costs and operating
expenses to improve our operating efficiency and net income. Our review of these indicators facilitates timely evaluation of the performance of our business and effective communication of results and key decisions, allowing our business to respond
promptly to competitive market conditions and different demands and preferences from our customers. The key measures that we use to evaluate the performance of our business are set forth below and are discussed in greater details under “Results of
Operations”:
Net Revenue
Our revenues are generated primarily (approximately 96%) from licensing fees received from our sole customer, Galileo Tech Ltd.
Gross Profit
Gross profit is equal to net revenue minus cost of goods sold. Cost of goods sold primarily includes all direct and indirect software development expenses paid to service providers, contractors and freelancers.
Selling, administrative and general expenses
Our SA&G expenses consist of all other expenses of the business including management, rent and maintenance, professional services, and depreciation.
Results of Operations for the Years Ended December 31, 2020 and 2019
Comparison of Results of Operations for the Years Ended December 31, 2020 and 2019
Revenues
Revenues were NIS 486,360 for the year ended December 31, 2020, an increase of NIS 351,983, or approximately 262%, as compared to NIS 134,377 for the year ended December 31, 2019.
The increase in revenues was attributed primarily to revenues from our licensing agreement with Galileo.
Cost of Revenues
Our cost of revenues primarily consists of all direct and indirect software development expenses paid to service providers, contractors and freelancers. Our cost of revenues increased by NIS 165,343
from NIS 289,692 in fiscal year 2019 to NIS 455,035 in fiscal year 2020. The increase in our cost of revenue was a result of increased software development costs.
48
Gross Profit
Our gross profit in fiscal year 2020 of NIS 1,521,738 increased by NIS377,833, or approximately 33%, from our gross profit in fiscal year 2019 of NIS1,143,905. The increase was due to an increase in
the amount generated from our licensing agreement with Galileo.
General and administrative expenses
General and administrative expenses decreased by NIS372,062, or approximately 48%, from NIS769,543 in fiscal year end 2019 to NIS397,481 of expenses in fiscal year end 202020. The change was
primarily due to (i) a decrease in management fees payable from NIS320,000 in 2020 to NIS660,001 in 2019; (ii) no salary paid in 2020 compared to NIS20,484 paid in 2019; (iii) professional services increased in 2020 to NIS51,524 from NIS21,793 in
2019; (iv) travel abroad in 2019 was NIS19,621 to NIS1,552 in 2020; and (v) no office expenses in 2020 compared to NIS8,490 in 2019.
Research and development expenses
We do not have research and developments expenses itemized as specific line items as they are included in the cost of revenues.
Net income
As a result of the foregoing, our net income increased from NIS1,143,905 in fiscal year 2019 to NIS1,521,738 in fiscal year 2020.
Liquidity and Capital Resources
As reflected in the Company’s financial statements, the Company had a cash balance of NIS149,791, liabilities of NIS1,958,213 and a net total stockholders’ equity of NIS1,221,735 as of December 31,
2020.
As of December 31, 2020, we borrowed a total of NIS135,555 from a bank in Israel. The outstanding principal amount, plus accrued and unpaid interest, is due May 24, 2024. We are currently paying
NIS3,204 a month to the bank.
We currently have no material commitments for capital expenditures. Even if we are successful at selling all the shares offered in this prospectus, we may be required to raise additional funds,
particularly if we are unable to continue generating positive cash flow as a result of our operations. We estimate that based on current plans and assumptions, that our available cash will not be sufficient to satisfy our cash requirements under our
present operating expectations, without further financing, for up to 12 months. In addition, our company may, from time to time, receive continued funding and capital resources from related parties. However, as of the date of this annual report, such
related parties do not have any existing obligation to advance funds or working capital to support our business, nor can our company rely on any advance funds from such related parties. We may not have sufficient working capital to fund the expansion
of our operations and to provide working capital necessary for our ongoing operations and obligations. We may need to raise significant additional capital to fund our operating expenses, pay our obligations, and grow our company. We do not anticipate
we will be profitable in 2021. Therefore our future operations may be dependent on our ability to secure additional financing. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other
financing mechanisms. However, we have no current arrangements to issue any securities. Also, a downturn in the U.S. equity and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if
we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore,
if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. The inability to obtain
additional capital will restrict our ability to grow and may reduce our ability to continue to conduct business operations. If we are unable to obtain additional financing, we will likely be required to curtail our marketing and development plans and
possibly cease our operations.
49
We anticipate that depending on market conditions and our plan of operations, we may incur operating losses in the foreseeable future. Therefore, our auditors have raised substantial doubt about our
ability to continue as a going concern.
Our liquidity may be negatively impacted by the significant costs associated with our public company reporting requirements, costs associated with newly applicable corporate governance requirements,
including requirements under the Sarbanes-Oxley Act of 2002 and other rules implemented by the Securities and Exchange Commission. We expect all of these applicable rules and regulations to significantly increase our legal and financial compliance
costs and to make some activities more time consuming and costly
Cash flows from operating activities
The operating activity has provided a net cash amount of NIS249,381.
Cash flows from investing activities
NIS33,481 was used in the Company investing activity.
Cash flows from financing activities
NIS71,422 was used in the Company financing activity.
Off Balance Sheet Arrangements
We have no off balance sheet arrangements.
50
Tabular Disclosure of Contractual Obligations
As of December 31, 2020, we had the following contractual obligations:
|
|
|
Payments Due by Period
|
|
|||||||||||||||||
|
Contractual Obligations
|
|
|
Total
|
|
|
|
Less than 1 year
|
|
|
|
1-3 years
|
|
|
|
3-5 years
|
|
|
|
More than 5 years
|
|
|
Debt Obligations(1)
|
|
NIS125,606
|
|
NIS35,616
|
|
|
NIS89,990
|
|
|
|
|
—
|
|
|||||||
|
Debt to Shareholder(2)
|
1,474,171
|
1,474,171
|
||||||||||||||||||
|
Total
|
|
NIS1,599,777
|
|
NIS1,509787
|
|
NIS89,990
|
|
|
|
|
|
|||||||||
(1) Amount specified represents payments due to Bank Mizrachi, which is due and payable on _____.
(2) Amounts specified exclude the NIS245,000 management fee owed to Menachem Shalom for the period of May 2020 until December 31, 2020.
Legal proceedings
We are currently not a party to any material legal or administrative proceedings. We may from time to time be subject to various legal or administrative claims and proceedings arising in the ordinary
course of business. Litigation or any other legal or administrative proceeding, regardless of the outcome, may result in substantial cost and diversion of our resources, including our management’s time and attention.
Quantitative and Qualitative Analysis about Market Risk
Foreign Exchange Risk
Foreign Currency Exchange Rates
Currently, our revenues from Israeli customers are collected in NIS. Some of our expenses are paid in NIS and some are paid in USD. We face foreign currency rate translation risks when our results
are translated to U.S. dollars.
The NIS was relatively stable against the U.S. dollar at approximately NIS3.215 to the US$1.00. There can be no assurance that such exchange rate will continue to remain stable in the future amongst
the volatility of currencies, globalization and the unstable economies in recent years. Since our revenues and net income are denominated in NIS, any decrease in the value of NIS against U.S. dollars would adversely affect our revenues.
51
Interest Rate Risk
We are not currently exposed to interest rate risk. We do not own any interest-bearing instruments and our interest-bearing debt carries a fixed rate.
Market Price Risk
We are not currently exposed to commodity price risk or market price risk.
Inflation
Inflation does not materially affect our business or the results of our operations.
Seasonality
Seasonality does not materially affect our business or the results of our operations.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements. These financial statements are prepared in accordance with U.S.
GAAP, which requires us to make estimates and assumptions that affect the reported amounts of our assets and liabilities and revenues and expenses, to disclose contingent assets and liabilities on the date of the consolidated financial statements,
and to disclose the reported amounts of revenues and expenses incurred during the financial reporting period. The most significant estimates and assumptions include the valuation of accounts receivable and inventories, useful lives of property, plant
and equipment and intangible assets, the recoverability of long-lived assets, provision necessary for contingent liabilities, and revenue recognition. We continue to evaluate these estimates and assumptions that we believe to be reasonable under the
circumstances. We rely on these evaluations as the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Since the use of estimates is an integral component of the financial
reporting process, actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application. We believe critical accounting policies as disclosed in this prospectus reflect
the more significant judgments and estimates used in preparation of our consolidated financial statements.
Risks and Uncertainties
Our operation is located in the State of Israel. Accordingly, our business, financial condition, and results of operations may be influenced by political, economic, and legal environments in Israel,
as well as by the general state of the Israeli economy. Our results may be adversely affected by changes in the political, regulatory and social conditions in Israel. Although we have not experienced losses from these situations and believes that we
are in compliance with existing laws and regulations including our organization and structure, this may not be indicative of future results.
52
Our business, financial condition and results of operations may also be negatively impacted by risks related to natural disasters, extreme weather conditions, health epidemics and other catastrophic
incidents, such as the recent outbreak and spread of the COVID-19, which could significantly disrupt our operations.
An accounting policy is considered critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time such estimate is made, and if
different accounting estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur, could materially impact the consolidated financial statements. We believe that the following accounting
policies involve a higher degree of judgment and complexity in their application and require us to make significant accounting estimates. The following description of critical accounting policies, judgments and estimates should be read in conjunction
with our consolidated financial statements and other disclosures included in this prospectus.
The following critical accounting policies rely upon assumptions and estimates and were used in the preparation of our consolidated financial statements:
Uses of estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. Significant items subject to such estimates and
assumptions include, but are not limited to, the allocation of transaction price among various performance obligations, the estimated customer life on deferred contract acquisition costs, the allowance for doubtful accounts, the fair value of
financial assets and liabilities; including accounting and fair value of derivatives, the fair value of acquired intangible assets and goodwill, the useful lives of acquired intangible assets and property and equipment, share-based compensation
including the determination of the fair value of the Company’s ordinary shares, and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends, and various other
assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Accounts receivable, net
Accounts receivable are recorded at the invoiced amount and amounts for which revenue has been recognized but not invoiced, net of allowance for doubtful accounts. The allowance for doubtful accounts
is based on the Company’s assessment of the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts based on a combination of factors, including an assessment of the current customer’s aging
balance, the nature and size of the customer, the financial condition of the customer, and the amount of any receivables in dispute. Accounts receivable deemed uncollectable are charged against the allowance for doubtful accounts when identified. The
allowance of doubtful accounts was not material for the periods presented.
53
Inventories, net
Not relevant
Capitalized Software Costs
Costs related to software acquired, developed, or modified solely to meet the Company’s internal requirements, with no substantive plans to market such software at the time of development are capitalized. Costs
incurred during the preliminary planning and evaluation stage of the project and during the post implementation operational stage are expensed as incurred. Costs incurred during the application development stage of the project are capitalized.
Maintenance costs are expensed as incurred.
Revenue recognition
The Company elected to adopt Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), effective as of January 1, 2018, utilizing the full retrospective method of adoption.
In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to
receive in exchange for these goods or services.
Contract Assets and Liabilities
Income Tax
Income tax income or expense reflects our current income tax, as well as our deferred tax income (expense).
Shareholder Taxation
Investors should consult their own tax advisor regarding the specific tax consequences of owning and disposing of our common stock, including eligibility for the benefits of any treaty for the
avoidance of double taxation, the applicability or effect of any special rules to which they may be subject, and the effect of any state, local, or other tax laws.
Recently Issued Accounting Pronouncements
We have reviewed other recent accounting pronouncements issued to the date of the issuance of these consolidated financial statements, and we do not believe any of these pronouncements will have a
material impact on the Company.
54
Overview
We were originally incorporated under the name of P.M.E SAL Technologies Ltd. under the laws of the State of Israel on January 29, 2007. In September 2008, we changed our name to Hold Me Ltd. by filing a Certificate of
Amendment with the Registrar of Companies in Israel to effect a name change. Initially we were engaged in providing website design and development services. We ceased conducting such business activity in 2011 and have not had any significant business
activity until 2018.
At the beginning of 2018, we started to develop a mobile-wallet-as-a-service platform for organizations interested in launching mobile wallet applications for their brand.
Today, we are a software company offering a well-rounded platform that supports a wide range of digital payment services integrating into mobile apps (“Platform”). Our Platform enables the creation of applications and
digital wallets for our customers, including but not limited to financial institutions, brands, retailers, credit card companies, insurance companies and other organizations, in a quick and cost-saving manner.
Innovation has always been at the core of our fundamental philosophy, as it continuously pursues various new initiatives, including the commercial applications of our Platform.
We are committed to democratizing financial services to improve the financial health of individuals and to increase economic opportunity for entrepreneurs and businesses of all sizes around the world. Our goal is to
enable our customers and their clients to manage and move their money anywhere in the world, anytime, on any platform, and using any device when sending payments or getting paid. By achieving our goal, we will continue to expand our product offerings
by adding additional services, functions and capabilities with our innovative and evolving technologies, combined with our marketing efforts.
Our Platform
We started the research and development for the Platform in 2018 and offered its first commercial application at 2019. Our Platform provides the technical infrastructure through Amazon cloud to our customers, using
Application Programming Interface, or API. API is a computing interface that defines interactions between multiple software intermediaries, which could be utilized and integrated by our customers into their own mobile apps. It connects brands,
merchants, retailers, financial institutions, insurance companies and other organizations with their clients through our innovative digital payment solutions.
Our Revenue Model
We generate revenues primarily through license fees from our customers. In general, the amount of the license fee is determined by the range and type of API services offered and consumed on our platform and by the usage
volume of our customer on our API software – meaning number of end-users and transactions (API-calls) triggered on our platform.
For the year ended December 31, 2020 and 2019, our revenues were NIS486,360 and NIS134,377, respectively.
Our products
Our current product portfolio consists of a digital wallet platform (used for commercial engagement of brands with their end-customers) and a digital banking service that can be used for innovation and development
purposes by financial institutions. For the year ended December 31, 2020, the digital payment services generated NIS486,360, or 100% of our total revenues, and digital banking services generated no revenues. For the year ended December 31, 2019, we
generated NIS134,377 in sales.
55
Digital Payment Services
Through our Platform, we provide a digital platform that can support creation and operation of mobile wallets applications that allow our business customers to stay engaged with their end clients through the application
that include payments and loyalty functionalities.
Similar to peer-to-peer money transfer applications we developed a platform that enables the transfer of payments between end users and between end users and businesses.
We will continue to be the active software provider of the digital payment market, while expanding the functionality offered through our platform to include marketing and marketing automation tasks and capabilities,
additional loyalty schemes and more.
Digital Financial Services
In today’s hyper-connected world, sustainable digital innovation has become a survival strategy for banks and financial institutions. As technologies evolve, consumers constantly continue to raise the bar for their
expectations of better service, new products, and ongoing connectivity. Digital creativity and trust must always be reflected to customers as the competitors are using a new wealth of information to satisfy customers and attempt to attract new ones.
Incumbent banks' core banking systems are legacy systems built over decades using multiple hardware and software providers. These various parts have been "patched" one on top of one another raising significant
difficulties for connectivity and compatibility, intensifying the already-substantial security challenges and operational risks. Such patches cannot foster the market-presence of an innovation-minded bank.
Our Platform may serve as the basis for innovation programs for our potential customers, which simulates a banking core system, so as to create a digital environment that enables collaboration between their development
teams and external software providers, such as start-ups and development-stage companies, developers, and other financial institutions, without exposing the technological manufacturing environments of our customers to outsiders.
Since it saves the effort and time needed to develop an innovation platform, our Platform provides cost-effective and time-saving solutions to our customers as it enables them to integrate our digital financial services
into their mobile apps. This significantly minimizes the financial and business exposure of our customers to external security threats
Our Platform serves as a core-banking-as-a-service solution for legacy banks to build their own banking and financial innovation programs, to connect with developers’ communities, and to meet market and regulatory
demands while saving on IT investments across hardware, software, and support staff.
The solution delivers three key capabilities:
| ◾ |
API gateway for external and internal systems including a ready-to-use set of PCI-DSS certified banking APIs for user and account management, transactions and payments, credit cards, loans, and more, through a single integration point
|
| ◾ |
Business logic layer for banking products
|
| ◾ |
Hosted and managed database
|
56
The Platform is an exceptionally market-responsive Core-Banking-as-a-Service solution. It’s the bank's innovation mock-up platform that revs up innovation engines with agile, customer-centric BaaS powers. The bank can
have in-house developers, thought leaders, and intrapreneurs join forces with software providers and fintech firms to innovate easily around a ready-to-use set of banking APIs. Launch POCs with providers securely, purposefully, and effortlessly with
no need to allocate valuable IT resources or risk your existing operational systems. Platform includes APIs for user and account management, transactions and payments, credit cards, loans, and more – all that is needed is one integration point to
connect the bank with the future.
Use Cases
The Platform is a secure, cloud-native, and highly scalable digital innovation platform for innovation-driven legacy banks. Use cases may include:
| ◾ |
Building a fully-customizable white-label developer portal to invite, manage, and service developers
|
| ◾ |
Running fintech programs, competitions, and hackathons
|
| ◾ |
Launching secure and purposeful POCs with the fintech industry
|
| ◾ |
Possessing a production environment built for the new serverless era
|
| ◾ |
Shortening time-to-market: from inception to the launch of new digital products and services
|
| ◾ |
Migrating existing bank products and services to the Innovatn.io micro-services-based architecture
|
The market-responsive of the Platform is designed to allow banks to foster digital creativity in-house and reflect it to the outside world. The Platform is integrable and interoperable with existing systems.
Our customer
We anticipate that our future customers may include businesses of all sizes and from various industries in Israel, such as financial institutions, credit card companies, insurance companies, and retailers, etc. We
currently do not have international customers and our sole customer is located in Israel. We plan to extend our business internationally and develop customers outside of Israel in future.
For the year ended December 31, 2020, we served 1 customer in Israel. During the same period, our main customer, Galileo Tech Ltd., a company located in Israel, accounted for 96% of our revenues. Approximately 4% of the
revenues derived from other non-substantial sales.
On December 5, 2019, we entered into an Agreement for Operation and Sale of Digital Wallets, which was amended by an Addendum to Sales Agreement on December 5, 2020, with our sole customer Galileo Tech Ltd.
We granted Galileo an exclusive license to commercialize our technology in Israel. However, we are not bound to make any development, consultation, management and/or other service of our technology to Galileo or its
customers.
In accordance with the terms of our agreement with Galileo, the licensing fee included an one-time establishment fee of approximately NIS800,000 (including the annual licensing fee for the first year of the agreement)
and an annual licensing fee of NIS 100,000 for the second and third years (2021 and 2022), and NIS 150,000 per additional year commencing December 5, 2020. In addition, Hold Me is also entitled to 12% of all income generated by Galileo from using or
sub-licensing the Company's products licensed to Galileo.
57
Galileo was also given the right to use our technology for clearing payments between various digital wallets and the businesses registers in Israel. For such right we are to receive 10% of all gross profits generated by
Galileo from their customers.
Galileo is entitled to market and commercialize in Israel the applications developed by Hold Me and to make changes and/or additions as it deems fit. For this right we were paid NIS100,000 and are entitled to 10% of all
gross profits.
Pursuant to the terms of the agreement, we are obligated to fix or repair the failures and/or inadequacies, but not those developed or changed by Galileo.
The agreement does not provide for a term. Each party has the right to terminate the agreement if the other party in breach fails to cure a breach within 30 days or conducts illegal activities or violates the laws.
As a result of not making payment to us for the year ended December 31, 2020, Galileo issued us shares of Galileo; we are entitled to additional shares of Galileo if the stock price of Galileo is less than NIS1.4 in June
2021. In addition, the payment of the 100,000 NIS annual registration fee was postponed until June 2021; however, if Galileo does not enter into one contract for a significant payment transaction before such date, then the fee shall be paid upon the
execution of such sub-licensing agreement but in any event no later than December 5, 2021.
The shares we received in Galileo were assigned to Mr. Shalom, our sole officer and director, in consideration for the reduction in the debt owed to him. It is anticipated that if Galileo issues the Company additional
shares, such shares will also be assigned to Mr. Shalom in order to reduce the amount we owe Mr. Shalom. See “Certain Relationships and Related Party Transactions”.
Our Suppliers
Our only relationship with vendors are with a software company in India which assisted us in developing our software and Amazon. Amazon provides us networking and hosting services through which additional
software-as-a-service products and services are offered.
Intellectual Property
We do not have any intellectual property protection on our source code or any other aspect of the Platform.
Marketing and Competition
The company does not currently have the resources to market its Platform, but when and if it does, it will attempt to generate customers by:
| • |
Direct sales to business customers;
|
| • |
Establishment of subsidiaries to do sales and marketing in different geographies;
|
| • |
Engaging with distributors and partners to engage in distributors, reseller or other forms of marketing; and
|
| • |
Joint ventures
|
In addition we may launch paid digital campaign(s) on different relevant social media networks (mainly LinkedIn) to approach relevant organizations and decision makers in those organizations.
58
Leading Competitors
There are many companies, both large and small, which are our competitors. Companies to which we hope to offer the Platform can choose to develop their own mobile wallet. Software development
companies can be engaged by our potential customers to develop a mobile wallet. Software or payment companies such as Stripe, Paypal and GooglePay, can offer services and solutions which can easily enable customers to have their own mobile wallets.
Competitive Challenges and Advantages
Given the extremely fast changes that occur in the overall technology world, including in the payment and software sectors, management does not believe that the Platform has any competitive
advantage.
Development and Expansion Strategy
The key components of our development and expansion strategy over the next two-to-five years are as follows:
| • |
ongoing continues development of the company's products.
|
| • |
marketing and sales efforts of the company's products to potential customers.
|
| • |
licensing or buying of additional technology, software or products that may increase the attractiveness or the price of the company's products.
|
| • |
the Company will be looking to form commercial partnerships with software distributors and integrators – to expand its market reach and sales.
|
| • |
once substantial sales are achieved, the company is looking to expand its product offering by developing, acquiring or licensing additional products relevant for its customer-base.
|
Property, Plant, and Equipment
We currently have an office in the house of Menachem Shalom, our sole officer and director.
Employees
Other than our sole officer and director, we have no employees.
59
Board of Directors, Executive Officers and Significant Employees
|
Name
|
Age
|
Position
|
|
|
|
|
|
Menachem Shalom
|
46
|
Chief Executive Officer, Chief Financial Officer and Director
|
Set forth below is a brief description of the background and business experience of our executive officers and directors:
Menachem Shalom, age 46, has been our Chief Executive Officer, Chief Financial Officer and member of our Board of Directors since 2008. Mr. Shalom founded and
served as the chief executive officer for Wayerz Solutions Ltd. from January 2015 to August 2017. From August 2013 to April 2014, Mr. Shalom served as vice president development, sales and marketing, of Dsnr Media Group Ltd. Mr. Shalom obtained a LLM
with honors from Columbia University School of Law in 2000, a MBA from Hebrew University in 2003 and a LLB, magna cum laude, from Hebrew University of Jerusalem in 1998.
Menachem Shalom is currently our sole officer and director. Prior to the effectiveness of this registration statement we intend to elect additional officers and directors in accordance with the
applicable provisions of the Companies Law. Currently we do not have any agreement or arrangement with any person to become an officer or director.
See “Management Services Agreement” for terms of Mr. Shalom’s Management Services Agreement with the Company.
Corporate governance practices
As an Israeli company, we are subject to various corporate governance requirements under the Companies Law. Our directors have a duty to act honestly, in good faith and with a view to our best
interests. Our directors also have a duty to exercise the care, diligence and skills that a reasonably prudent person would exercise in comparable circumstances. In fulfilling their duty of care to us, our directors must ensure compliance with our
memorandum and articles of association and the class rights vested thereunder in the holders of the shares. A shareholder may in certain circumstances have rights to damages if a duty owed by the directors is breached.
Our board of directors has all the powers necessary for managing, and for directing and supervising, our business affairs. The functions and powers of our board of directors include, among others:
|
|
●
|
convening shareholders’ annual general meetings and reporting its work to shareholders at such meetings;
|
|
|
|
|
|
|
●
|
declaring dividends and distributions;
|
|
|
|
|
|
|
●
|
appointing officers and determining the term of office of the officers; and
|
|
|
|
|
|
|
●
|
exercising the borrowing powers of our company and mortgaging the property of our company;
|
60
Approval of related party transactions under Israeli law
Fiduciary duties of directors and officers
The Companies Law codifies the fiduciary duties that office holders owe to a company. An office holder is defined in the Companies Law as a general manager, chief business manager, deputy general
manager, vice general manager, executive Vice President, vice President, any other person assuming the responsibilities of any of these positions regardless of such person's title, a director and any other manager directly subordinate to the
general manager. Each person listed in the table under "Management—Executive officers and directors" is an office holder under the Companies Law.
An office holder's fiduciary duties consist of a duty of care and a duty of loyalty. The duty of care requires an office holder to act with the level of care with which a reasonable office holder
in the same position would have acted under the same circumstances. The duty of loyalty requires that an office holder act in good faith and in the best interests of the company.
Disclosure of personal interests of an office holder and approval of certain transactions
The Companies Law requires that an office holder promptly disclose no later than the first Board Meeting in which such transaction is discussed, to the board of directors any personal interest that
he or she may have and all related material information known to him or her concerning any existing or proposed transaction with the company. A personal interest includes an interest of any person in an act or transaction of a company, including a
personal interest of one's relative or of a corporate body in which such person or a relative of such person is a 5% or greater shareholder, director or general manager or in which he or she has the right to appoint at least one director or the
general manager, but excluding a personal interest stemming solely from one's ownership of shares in the company. A personal interest includes the personal interest of a person for whom the office holder holds a voting proxy or the personal
interest of the office holder with respect to his or her vote on behalf of a person for whom he or she holds a proxy even if such shareholder has no personal interest in the matter.
If it is determined that an office holder has a personal interest in a non-extraordinary transaction, meaning any transaction that is in the ordinary course of business, on market terms or that is
not likely to have a material impact on the company's profitability, assets or liabilities, approval by the board of directors is required for the transaction, unless the company's articles of association provide for a different method of approval.
Any such transaction that is not for the benefit of the company may not be approved by the board of directors.
61
In addition to any approval required by the articles of association, approval first by the company's audit committee and subsequently by the board of
directors, and, under specified circumstances, by a meeting of the shareholders, as well, is required for an extraordinary transaction (meaning, any transaction that is not in the ordinary course of business, not on market terms or that is likely
to have a material impact on the company's profitability, assets or liabilities) in which an office holder has a personal interest.
A director and any other office holder who has a personal interest in a transaction which is considered at a meeting of the board of directors or the audit committee may generally (unless it is
with respect to a transaction which is not an extraordinary transaction) not be present at such a meeting or vote on that matter however, with respect to an office holder, he/she may be present at the meeting discussions if the chairman determines
that the presence of the office holder is necessary in order to present the matter. However, if a majority of the members of the audit committee or the board of directors has a personal interest in the approval of such a transaction then all of the
directors may participate in the meeting with respect to such transaction and vote on the approval thereof and, in such case, shareholder approval is also required.
Certain disclosure and approval requirements apply under Israeli law to certain transactions with controlling shareholders, certain transactions in which a controlling shareholder has a personal
interest and certain arrangements regarding the terms of service or employment of a controlling shareholder.
For a description of the approvals required under Israeli law for compensation arrangements of officers and directors, see above under "—Compensation of directors and executive officers."
Shareholder duties
Pursuant to the Companies Law, a shareholder has a duty to act in good faith and in a customary manner toward the company and other shareholders and to refrain from abusing his or her power with
respect to the company, including, among other things, in voting at a general meeting and at shareholder class meetings with respect to the following matters:
| • |
an amendment to the company's articles of association;
|
| • |
an increase of the company's authorized share capital;
|
| • |
a merger; or
|
| • |
interested party transactions that require shareholder approval.
|
In addition, a shareholder has a general duty to refrain from discriminating against other shareholders.
Certain shareholders also have a duty of fairness toward the company. These shareholders include any controlling shareholder, any shareholder who knows that it has the power pursuant to the
provisions of a company's articles of association, to determine the outcome of a shareholder vote and any shareholder who has the power to appoint or to prevent the appointment of an office holder of the company. The Companies Law does not define
the substance of this duty of fairness, except to state that the remedies generally available upon a breach of contract adjusted according to the circumstances, and taking into account the status within the company of such shareholder, will also
apply in the event of a breach of the duty of fairness.
62
Exculpation, insurance and indemnification of office holders
We entered into an indemnification agreement with Menachem Shalom to indemnify Mr. Shalom to the fullest extent permitted under Israeli law. We are not
contractually obligated to indemnify Mr. Shalom for, among others, (i) a breach of duty of loyalty, unless such breach was done in good faith and having reasonable cause to assume that such act would not prejudice the interests of the Company and
(ii) a willful or reckless breach of his duty of care, unless such breach was done solely in negligence.
Under the Companies Law, a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability
to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our articles of association include such
a provision. An Israeli company may not exculpate a director from liability arising out of a prohibited dividend or distribution to shareholders.
An Israeli company may indemnify an office holder in respect of the following liabilities and expenses incurred for acts performed as an office holder, either in advance of an event or following an
event, provided a provision authorizing such indemnification is contained in its articles of association:
| • |
financial liability imposed on him or her in favor of another person pursuant to a judgment, settlement or arbitrator's award approved by a court. However, if an undertaking to indemnify an office holder with respect to such liability is
provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company's activities when the undertaking to indemnify is given, and to an amount or
according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned events and amount or criteria;
|
| • |
reasonable litigation expenses, including attorneys' fees, incurred by the office holder (1) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or
proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability, such as a criminal penalty, was imposed upon him or her as a substitute for
the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent and (2) in connection with a
monetary sanction;
|
| • |
reasonable litigation expenses, including attorneys' fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf or by a third-party or in connection with criminal
proceedings in which the office holder was acquitted or as a result of a conviction for an offense that does not require proof of criminal intent; and
|
| • |
expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation to an administrative proceeding instituted against such office holder, or certain compensation payments made to an injured party
imposed on an office holder by an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law, 1968 (the "Israeli Securities Law").
|
63
An Israeli company may insure an office holder against the following liabilities incurred for acts performed as an office holder if and to the extent provided in the company's articles of
association:
| • |
a breach of the duty of loyalty to the company, to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
| • |
a breach of the duty of care to the company or to a third-party, including a breach arising out of the negligent conduct of the office holder;
|
| • |
a financial liability imposed on the office holder in favor of a third-party;
|
| • |
a financial liability imposed on the office holder in favor of a third-party harmed by a breach in an administrative proceeding; and
|
| • |
expenses, including reasonable litigation expenses and legal fees, incurred by the office holder as a result of an administrative proceeding instituted against him or her pursuant to certain provisions of the Israeli Securities Law.
|
An Israeli company may not indemnify or insure an office holder against any of the following:
| • |
a breach of the duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
| • |
a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;
|
| • |
an act or omission committed with intent to derive illegal personal benefit; or
|
| • |
a fine, monetary sanction or forfeit levied against the office holder.
|
Under the Companies Law, exculpation, indemnification and insurance of office holders must be approved by the compensation committee and the board of directors (and, with respect to directors and
the Chief Executive Officer, by shareholders).
Our articles of association allow us to indemnify and insure our office holders for any liability imposed on them as a consequence of an act (including any omission) which was performed by virtue
of being an office holder. (Our office holders are currently covered by a directors and officers' liability insurance policy).
We have entered into agreements with (each of) our director(s) and executive officer(s) exculpating them, to the fullest extent permitted by law, from liability to us for damages caused to us as a
result of a breach of duty of care, and undertaking to indemnify them to the fullest extent permitted by law. This indemnification is limited to events determined as foreseeable by the board of directors based on our activities, and to an amount or
according to criteria determined by the board of directors as reasonable under the circumstances.
In the opinion of the SEC, indemnification of directors and office holders for liabilities arising under the Securities Act, however, is against public policy and therefore unenforceable.
64
Management Services Agreement
We entered into a written management services agreement with our sole executive officer and director as of December 30, 2017 to provide us services full time. Mr. Shalom shall be entitled to
receive a monthly management fee of NIS35,000 (USD10,606) plus VAT, which shall increase to NIS45,000 (USD13,636) plus VAT upon completion of the development of the system and the commencement of the sales stage. Upon completion of fundraising in
the sum of NIS5,000,000 (USD1,515,152) or more, Mr. Shalom shall be entitled to payment of monthly fee of NIS60,000 (USD18,181) plus VAT. Mr. Shalom is also entitled to reimbursement for travel expenses as well as all his expenses related to the
execution of the agreement. The Company has the right to terminate the agreement upon 6-months notice.
Committees of the Board
We currently do not have any committees under the board of directors.
Share Incentive Plan
We currently do not have any stock incentive plans.
The following table sets forth, as of the date of this prospectus, the beneficial ownership of our ordinary shares by each executive officer and director, by each person known by us to beneficially
own more than 5% of our ordinary shares and by the executive officers and directors as a group. As used in this table, “beneficial ownership” means the sole or shared power to vote, or to direct the voting of, a security, or the sole or shared
investment power with respect to a security (i.e., the power to dispose of, or to direct the disposition of, a security). In addition, for purposes of this table, a person is deemed, as of any date, to have “beneficial ownership” of any security that
such person has the right to acquire within 60 days after such date.
The persons named above have full voting and investment power with respect to the shares indicated. Under the rules of the Securities and Exchange Commission, a person (or group of persons) is deemed
to be a “beneficial owner” of a security if he or she, directly or indirectly, has or shares the power to vote or to direct the voting of such security, or the power to dispose of or to direct the disposition of such security. Accordingly, more than
one person may be deemed to be a beneficial owner of the same security. A person is also deemed to be a beneficial owner of any security, which that person has the right to acquire within 60 days, such as options or warrants to purchase our ordinary
shares.
All of our shareholders, including the shareholders listed below, have the same voting rights attached to their ordinary shares. See “Description of share capital and articles of association”. None
of our principal shareholders or our directors and executive officers have different or special voting rights with respect to their ordinary shares. Unless otherwise noted below, each shareholder’s address is 30 Golomb Street, Nes Ziona, Israel.
65
Except as otherwise indicated, all shares are owned directly and the percentage shown is based on 2,000,000 ordinary shares issued and outstanding, and 4,000,000 ordinary shares outstanding after the
close of this offering.
|
Title of class
|
|
Name of beneficial owner
|
|
Amount of
beneficial ownership
|
|
Percent
of class
|
|
Percent of class after close of offering
|
||||||
|
Current Executive
Officers and Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Ordinary Shares
|
|
Menachem Shalom
|
2,000,000(1)
|
100
|
50.00
|
%
|
||||||||
|
Total of All Current
Officers and Directors
(1 person):
|
Menachem Shalom
|
|
|
2,000,000(1)
|
|
|
100
|
|
|
50.00
|
%
|
|||
| (1) |
Does not include 10,000,000 shares of Preferred Shares owned by Mr. Shalom. Each Preferred Share is convertible at any time by the holder thereof to 100 shares of ordinary shares.
|
The following is a description of transactions during our preceding three fiscal years up to the date of this prospectus, to which we were a party or will be party, in which the amount involved
exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years, and any of our directors, executive officers or holders of more than 5% of our outstanding capital stock, or
any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.
As of December 31, 2020, we are indebted to Mr. Shalom in the aggregate amount of NIS 1,474,171 (approximately $446,718), consisting of NIS900,900 of management fees pursuant to the terms of the
Management Services Agreement and NIS573,271 borrowed by the Company from Mr. Shalom pursuant to the terms of the Shareholders’ Loan Agreement. Those amounts do not include a management fee owed to Mr. Shalom in an amount of NIS 420,000, which have
not been invoiced since May 2020 until April 2021.
Upon receipt of the 128,571 shares received from Galileo pursuant to the terms of our agreement, we transferred the shares to Mr. Shalom to reduce the outstanding balance owed by us to Mr. Shalom to reduce the amount of
accrued NIS180,000 pursuant to the management agreement.
66
In addition, as indicated in our financial reports, we owe Tamarindi Ltd, an Israeli company owned by Menachem Shalom, NIS48,744. Billio Ltd, another Israeli company owned by Menachem Shalom, owes us
NIS3,466.
See “Employment Agreement” for terms of Mr. Shalom’s management services agreement with the Company.
Our board of directors has not adopted a written related party transaction policy to set forth the policies and procedures for the review and approval or ratification of related person
transactions.
The following is a description of the material terms of our articles of association. The following description may not contain all of the information that is important to you, and we therefore
refer you to our articles of association, a copy of which is filed with the SEC as an exhibit to the registration statement of which this prospectus is a part.
Share capital
Our authorized share capital consists of 990,000,000 ordinary shares, par value NIS 0.01 per share, and 10,000,000 shares of Preferred Shares, par value NIS 0.01 per share. Currently there are
2,000,000 ordinary shares and 10,000,000 shares of Preferred Shares issued and outstanding, all of which are owned by Menachem Shalom. Assuming all the shares will be sold in this offering, 4,000,000 ordinary shares will be issued and outstanding.
All of our outstanding ordinary shares are validly issued, fully paid and non-assessable. Our ordinary shares are not redeemable and do not have any preemptive rights.
Our board of directors may determine the issue prices and terms for such shares or other securities and may further determine any other provision relating to such issue of shares or securities. We
may also issue and redeem redeemable securities on such terms and in such manner as our board of directors shall determine.
The following descriptions of share capital and provisions of our articles of association are summaries and are qualified by reference to our articles of association. A copy of our articles of
association is filed with the SEC as an exhibit to our registration statement, of which this prospectus forms a part.
Registration number and purposes of the company
We are registered with the Israeli Registrar of Companies. Our registration number is 51-3933218. Our purpose as set forth in our articles of association is to engage in any lawful act or activity.
Voting rights
All ordinary shares will have identical voting and other rights in all respects.
67
Transfer of shares
Our fully paid ordinary shares are issued in registered form and may be freely transferred under our articles of association, unless the transfer is restricted or prohibited by another instrument,
applicable law or the rules of a stock exchange on which the ordinary shares are listed for trade. The ownership or voting of our ordinary shares by non-residents of Israel is not restricted in any way by our articles of association or the laws of
the State of Israel, except for ownership by nationals of some countries that are, or have been, in a state of war with Israel.
Election of directors
Under our articles of association, our board of directors shall have up to 11 directors. Pursuant to our articles of association, each of our directors will be appointed by a simple majority vote
of holders of our ordinary shares, participating and voting at an annual general meeting of our shareholders, In addition, other than in certain circumstances our articles of association allow our board of directors only to appoint new directors to
fill vacancies on the board of directors temporarily up to the maximum number of directors permitted under articles of association. Any director so appointed serves for a term of office equal to the remaining period of the term of office of the
director whose office has been vacated (or in the case of any new director, for a term of office according to the class to which such director was assigned upon appointment).
Dividend and liquidation rights
We may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective shareholdings. Under the Companies Law, dividend distributions are determined by the
board of directors and do not require the approval of the shareholders of a company unless the company's articles of association provide otherwise. Our articles of association do not require shareholder approval of a dividend distribution and
provide that dividend distributions may be determined by our board of directors.
Pursuant to the Companies Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two years, according to our then last reviewed or
audited financial statements (less the amount of previously distributed dividends, if not reduced from the earnings), provided that the end of the period to which the financial statements relate is not more than six months prior to the date of the
distribution. If we do not meet such criteria, then we may distribute dividends only with court approval. In each case, we are only permitted to distribute a dividend if our board of directors and, if applicable, the court determines that there is
no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they become due.
In the event of our liquidation, after satisfaction of liabilities to creditors, our assets will be distributed to the holders of our ordinary shares in proportion to their shareholdings. This
right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with preferential rights that may be authorized in the future.
68
Exchange controls
There are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the ordinary shares or interest or other payments to
non-residents of Israel, except for shareholders who are subjects of countries that are, or have been, in a state of war with Israel.
Shareholder meetings
Under Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year that must be held no later than 15 months after the date of the previous annual
general meeting. All meetings other than the annual general meeting of shareholders are referred to in our articles of association as special general meetings. Our board of directors may call special general meetings whenever it sees fit, at such
time and place, within or outside of Israel, as it may determine. In addition, the Companies Law provides that our board of directors is required to convene a special general meeting upon the written request of (i) any two or more of our directors
or one-quarter or more of the serving members of our board of directors or (ii) one or more shareholders holding, in the aggregate, either (a) 5% or more of our outstanding issued shares and 1% or more of our outstanding voting power or (b) 5% or
more of our outstanding voting power.
Subject to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of record on a date
to be decided by the board of directors, which, as a company listed on an exchange outside Israel, may be between four and 40 days prior to the date of the meeting. Furthermore, the Companies Law requires that resolutions regarding the following
matters must be passed at a general meeting of our shareholders:
| • |
amendments to our articles of association;
|
| • |
appointment, termination or the terms of service of our auditors;
|
| • |
appointment of external directors (if applicable);
|
| • |
approval of certain related party transactions;
|
| • |
increases or reductions of our authorized share capital;
|
| • |
a merger; and
|
| • |
the exercise of our board of director's powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management.
|
The Companies Law requires that a notice of any annual general meeting or special general meeting be provided to shareholders at least 21 days prior to the meeting and if the agenda of the meeting
includes, among other things, the appointment or removal of directors, the approval of transactions with office holders or interested or related parties or the approval of a merger, notice must be provided at least 35 days prior to the meeting.
69
Voting rights
Quorum
Pursuant to our articles of association, holders of our ordinary shares have one vote for each ordinary share held on all matters submitted to a vote before the shareholders at a general meeting.
The quorum required for our general meetings of shareholders consists of at least two shareholders present in person, by proxy or written ballot who hold or represent between them at least 33.3% of the total outstanding voting rights, within half
an hour of the time fixed for the commencement of the meeting. A meeting adjourned for lack of a quorum shall be adjourned to the same day in the next week, at the same time and place, to such day and at such time and place as indicated in the
notice to such meeting, or to such day and at such time and place as the Board may determine in a notice to the Shareholders. If within half an hour from the time scheduled for the adjourned meeting a legal quorum is not present, then any two
Shareholders entitled to vote, present in person or by proxy, shall constitute a legal quorum for such adjourned meeting and shall be entitled to resolve any matters on the agenda of the meeting. unless a meeting was called pursuant to a request by
our shareholders, in which case the quorum required is one or more shareholders present in person or by proxy and holding the number of shares required to call the meeting as described under "—Shareholder meetings."
Vote requirements
Our articles of association provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required by the Companies Law or by our articles of association. Under
the Companies Law, certain actions require a special majority, including: (i) the approval of an extraordinary transaction with a controlling shareholder or in which the controlling shareholder has a personal interest, (ii) the terms of employment
or other engagement of a controlling shareholder of the company or a controlling shareholder's relative (even if such terms are not extraordinary) and (iii) approval of certain compensation-related matters require the approval described above under
"—Board of directors and officers—Compensation committee." Under our articles of association, the alteration of the rights, privileges, preferences or obligations of any class of our shares (to the extent there are classes other than ordinary
shares) may require a simple majority of the class so affected (or such other percentage of the relevant class that may be set forth in the governing documents relevant to such class), in addition to the ordinary majority vote of all classes of
shares voting together as a single class at a shareholder meeting.
Access to corporate records
Under the Companies Law, all shareholders generally have the right to review minutes of our general meetings, our shareholder register, including with respect to material shareholders, our articles
of association, our financial statements, other documents as provided in the Companies Law, and any document we are required by law to file publicly with the Israeli Companies Registrar or the Israeli Securities Authority. Any shareholder who
specifies the purpose of its request may request to review any document in our possession that relates to any action or transaction with a related party which requires shareholder approval under the Companies Law. We may deny a request to review a
document if we determine that the request was not made in good faith, that the document contains a commercial secret or a patent or that the document's disclosure may otherwise impair our interests.
70
Preferred Shares
On April 11, 2021, our shareholders approved the amendment to our amended and restated articles of association, as well as to our memorandum of association, for the addition to Hold Me Ltd.’s
registered share capital of 10,000,000 Preferred Shares, par value NIS 0.01 per share (the “Preferred Shares”). Each Preferred Share is convertible at the option of the holder to 100 ordinary shares.
The rules and procedures for calling and conducting any meeting of the holders of Preferred Shares (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other procedural aspect or matter with regard to such a meeting or such consents shall be governed by any rules the Board of Directors, in its discretion,
may adopt from time to time, which rules and procedures shall conform to the requirements of our amended and restated articles of association (including the provisions set forth above), applicable law and, if applicable, the rules of any national
securities exchange or other trading facility on which the Preferred Shares are listed or traded at the time.
Acquisitions under Israeli law
Full tender offer. A person wishing to acquire shares of a public Israeli company and who would as a result hold over 90% of the target company's voting
rights or the target company's issued and outstanding share capital (or of a class thereof), is required by the Companies Law to make a tender offer to all of the company's shareholders for the purchase of all of the issued and outstanding shares
of the company (or the applicable class). If (a) the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company (or the applicable class) and the shareholders who accept the offer
constitute a majority of the offerees that do not have a personal interest in the acceptance of the tender offer or (b) the shareholders who did not accept the tender offer hold less than two percent (2%) of the issued and outstanding share capital
of the company (or of the applicable class), all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. A shareholder who had its shares so transferred may petition the court within six months
from the date of acceptance of the full tender offer, regardless of whether such shareholder agreed to the offer, to determine whether the tender offer was for less than fair value and whether the fair value should be paid as determined by the
court. However, an offeror may provide in the offer that a shareholder who accepted the offer will not be entitled to appraisal rights as described in the preceding sentence, as long as the offeror and the company disclosed the information required
by law in connection with the full tender offer. If the full tender offer was not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares of the company that will increase its holdings to more than 90% of the
voting rights or the issued and outstanding share capital of the company (or the applicable class) from shareholders who accepted the tender offer.
Special tender offer. The Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender
offer if as a result of the acquisition the purchaser would become a holder of 25% or more of the voting rights in the company. This rule does not apply if there is already another holder of 25% or more of the voting rights in the company.
Similarly, the Companies Law provides that an acquisition of shares in a public company must be made by means of a tender offer if as a result of the acquisition the purchaser would become a holder of more than 45% of the voting rights in the
company, if there is no other shareholder of the company who holds more than 45% of the voting rights in the company. These requirements do not apply if the acquisition (i) occurs in the context of a private placement by the company that received
shareholder approval as a private placement whose purpose is to give the acquirer at least 25% of the voting rights in the company if there is no person who holds 25% or more of the voting rights in the company, or as a private placement whose
purpose is to give the acquirer 45% of the voting rights in the company, if there is no person who holds 45% of the voting rights in the company, (ii) was from a shareholder holding 25% or more of the voting rights in the company and resulted in
the acquirer becoming a holder of 25% or more of the voting rights in the company, or (iii) was from a holder of more than 45% of the voting rights in the company and resulted in the acquirer becoming a holder of more than 45% of the voting rights
in the company. A special tender offer must be extended to all shareholders of a company. A special tender offer may be consummated only if (i) at least 5% of the voting power attached to the company's outstanding shares will be acquired by the
offeror and (ii) the special tender offer is accepted by a majority of the votes of those offerees who gave notice of their position in respect of the offer; (excluding the purchaser, its controlling shareholders, holders of 25% or more of the
voting rights in the company and any person having a personal interest in the acceptance of the tender offer, or anyone on their behalf, including any such person's relatives and entities under their control).
71
In the event that a special tender offer is made, a company's board of directors is required to express its opinion on the advisability of the offer, or shall abstain from expressing any opinion if
it is unable to do so, provided that it gives the reasons for its abstention. The board of directors shall also disclose any personal interest that any of the directors has with respect to the special tender offer or in connection therewith. An
office holder in a target company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause the failure of an existing or foreseeable special tender offer or is to impair the chances of its acceptance, is
liable to the potential purchaser and shareholders for damages, unless such office holder acted in good faith and had reasonable grounds to believe he or she was acting for the benefit of the company. However, office holders of the target company
may negotiate with the potential purchaser in order to improve the terms of the special tender offer, and may further negotiate with third parties in order to obtain a competing offer.
If a special tender offer is accepted, then shareholders who did not respond to or that had objected the offer may accept the offer within four days of the last day set for the acceptance of the
offer and they will be considered to have accepted the offer.
In the event that a special tender offer is accepted, then the purchaser or any person or entity controlling it, at the time of the offer, or under common control with the purchaser or such
controlling person or entity may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser
or such person or entity undertook to effect such an offer or merger in the initial special tender offer.
Merger. The Companies Law permits merger transactions if approved by each party's board of directors and, unless certain conditions described under the
Companies Law are met, a majority of each party's shares voted on the proposed merger at a shareholders’ meeting called with at least 35 days’ prior notice. The board of directors of a merging company is required pursuant to the Companies Law to
discuss and determine whether in its opinion there exists a reasonable concern that as a result of a proposed merger, the surviving company will not be able to satisfy its obligations towards its creditors, such determination taking into account
the financial status of the merging companies. If the board of directors determines that such a concern exists, it may not approve a proposed merger. Following the approval of the board of directors of each of the merging companies, the boards of
directors must jointly prepare a merger proposal for submission to the Israeli Registrar of Companies.
72
For purposes of the shareholder vote of a merging company whose shares are held by the other merging company or a person or entity holding 25% or more of the voting rights at the general meeting or
the right to appoint 25% or more of the directors of the other merging company, unless a court rules otherwise, the merger will not be deemed approved if a majority of the shares voted on the matter at the shareholders meeting (excluding
abstentions) that are held by shareholders other than the other party to the merger, or by any person or entity who holds 25% or more of the voting rights or the right to appoint 25% or more of the directors of the other party, or any one on their
behalf including their relatives or corporations controlled by any of them, vote against the merger. In addition, if the non-surviving entity of the merger has more than one class of shares, the merger must be approved by each class of
shareholders. If the transaction would have been approved but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the request of holders of at
least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable, taking into account the valuation of the merging companies and the consideration offered to the shareholders. If a merger is with a company's
controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions with controlling shareholders.
Under the Companies Law, each merging company must deliver to its secured creditors the merger proposal and inform its unsecured creditors of the merger proposal and its content. Upon the request
of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations
of any of the parties to the merger, and may further give instructions to secure the rights of creditors.
In addition, a merger may not be completed unless at least 50 days have passed from the date that a proposal for approval of the merger is filed with the Israeli Registrar of Companies and 30 days
from the date that shareholder approval of both merging companies is obtained.
Anti-takeover measures
The Companies Law allows us to create and issue shares having rights different from those attached to our ordinary shares, including shares providing certain preferred rights with respect to
voting, distributions or other matters and shares having preemptive rights. We recently authorized the Company to issue 10,000,000 Preferred Shares, with each Preferred Share being convertible at the option of the holder to 100 ordinary shares. We
issued 10,000,000 Preferred Shares to Mr. Shalom.
In the future, if we authorize additional shares of preferred stock, we will have the ability to create and issue a specific class of preferred shares, such class of shares, depending on the
specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the market value of their ordinary shares. The authorization and
designation of a class of preferred shares will require an amendment to our articles of association, which requires the prior approval of the holders of a majority of the voting power attaching to our issued and outstanding shares at a general
meeting. The convening of the meeting, the shareholders entitled to participate and the majority vote required to be obtained at such a meeting will be subject to the requirements set forth in the Companies Law and our amended articles of
association as described above in "—Voting Rights."
73
Borrowing powers
Pursuant to the Companies Law and our articles of association, our board of directors may exercise all powers and take all actions that are not required under law or under our articles of
association to be exercised or taken by our shareholders, including the power to borrow money for company purposes.
Changes in capital
Our articles of association enable us to increase or reduce our share capital. Any such changes are subject to Israeli law and must be approved by a resolution duly passed by our shareholders at a
general meeting by voting on such change in the capital. In addition, transactions that have the effect of reducing capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits, require the
approval of both our board of directors and an Israeli court.
Transfer agent and registrar
We have not yet appointed a transfer agent and registrar for our ordinary shares.
Future sales of substantial amounts of our ordinary shares in the public market could adversely affect market prices prevailing from time to time. Furthermore, because a significant number of our
ordinary shares will not be available for sale shortly after this offering due to existing contractual and legal restrictions on resale as described below, there may be sales of substantial amounts of our ordinary shares in the public market after
such restrictions lapse. This may adversely affect the prevailing market price of our ordinary shares and our ability to raise equity capital in the future.
Upon consummation of the sale of all the shares in this offering, we will have an aggregate of 4,000,000 ordinary shares outstanding. Our ordinary shares are available for sale in the public
market, subject to the expiration or waiver of the lock-up agreements described below, and in certain cases subject to limitations imposed by U.S. securities laws on resale by our "affiliates" as that term is defined in Rule 144 under the
Securities Act ("Rule 144").
All of the ordinary shares sold in this offering will be freely tradable without restriction or further registration under the Securities Act, unless purchased by "affiliates" as that term is
defined under Rule 144. In addition, following the expiration or waiver of the lock-up agreements described below, all of our ordinary shares, including ordinary shares issuable pursuant to awards granted under certain of our share option plans
will be freely tradable without restriction or further registration under the Securities Act unless held by "affiliates" as that term is defined under Rule 144.
74
Eligibility of restricted shares for sale in the public market
Any ordinary shares held by "affiliates" as that term is defined under Rule 144 will be "restricted securities" as that phrase is defined in Rule 144. Subject to certain contractual restrictions,
holders of restricted shares will be entitled to sell those shares in the public market only if the sale is registered or pursuant to an exemption from registration, such as the safe harbor discussed below under "—Rule 144."
Rule 144
In general, under Rule 144, a person (or persons whose shares are aggregated) who is not deemed to have been an affiliate of ours at any time during the three months preceding a sale, and who has
beneficially owned restricted securities within the meaning of Rule 144 for at least six months (including any period of consecutive ownership of preceding non-affiliated holders) would be entitled to sell those shares, subject only to the
availability of current public information about us. A non-affiliated person who has beneficially owned restricted securities within the meaning of Rule 144 for at least one year would be entitled to sell those shares without regard to the
provisions of Rule 144.
A person (or persons whose shares are aggregated) who is deemed to be an affiliate of ours and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six
months would be entitled to sell within any three-month period a number of shares that does not exceed the greater of one percent of the then outstanding shares of our ordinary shares or the average weekly trading volume of our ordinary shares on
the NYSE during the four calendar weeks preceding such sale. Such sales are also subject to certain manner of sale provisions, notice requirements and the availability of current public information about us.
The following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition of our ordinary shares. You should consult
your own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.
Israeli tax considerations and government programs
The following is a brief summary of the material Israeli tax laws applicable to us, and certain Israeli Government programs that benefit us. This section also contains a discussion of material
Israeli tax consequences concerning the ownership and disposition of our ordinary shares purchased by investors in this offering. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in
light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are subject to special tax
regimes not covered in this discussion. To the extent that the discussion is based on new tax legislation that has not yet been subject to judicial or administrative interpretation, we cannot assure you that the appropriate tax authorities or the
courts will accept the views expressed in this discussion. The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change
could affect the tax consequences described below.
75
General corporate tax structure in Israel
Israeli companies are generally subject to corporate tax. The corporate tax rate for 2017 was 24%, and in 2018 and thereafter the corporate tax rate is 23% of their taxable income. However, the
effective tax rate payable by a company that derives income from an Approved Enterprise, a Preferred Enterprise, a Benefited Enterprise or a Technology Enterprise (as discussed below) may be considerably less. Capital gains derived by an Israeli
company are generally subject to the prevailing corporate tax rate.
Law for the Encouragement of Industry (Taxes), 5729-1969
The Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax benefits for "Industrial Companies." We believe that we
currently qualify as an Industrial Company within the meaning of the Industry Encouragement Law.
The Industry Encouragement Law defines an "Industrial Company" as an Israeli resident-company, of which 90% or more of its income in any tax year, other than income from certain government loans,
is derived from an "Industrial Enterprise" owned by it and located in Israel or in the "Area", in accordance with the definition under section 3A of the Israeli Income Tax Ordinance (New Version) 1961, or the Ordinance. An "Industrial Enterprise"
is defined as an enterprise whose principal activity in a given tax year is industrial production.
The following corporate tax benefits, among others, are available to Industrial Companies:
• amortization of the cost of purchased patent, rights to use a patent, and know-how, which are used for the development or advancement of the Industrial Enterprise, over an eight-year period, commencing on the year in
which such rights were first exercised;
• under limited conditions, an election to file consolidated tax returns with controlled Israeli Industrial Companies; and
• expenses related to a public offering are deductible in equal amounts over three years commencing on the year of the offering.
Eligibility for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority.
76
Tax benefits and grants for research and development
Israeli tax law allows, under certain conditions, a tax deduction for expenditures, including capital expenditures, for the year in which they are incurred. Expenditures are deemed related to
scientific research and development projects, if:
• The expenditures are approved by the relevant Israeli government ministry, determined by the field of research;
• The research and development must be for the promotion of the company; and
• The research and development is carried out by or on behalf of the company seeking such tax deduction.
The amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific research and development projects. No deduction under
these research and development deduction rules is allowed if such deduction is related to an expense invested in an asset depreciable under the general depreciation rules of the Ordinance. Expenditures that are unqualified under the conditions
above are deductible in equal amounts over three years.
From time to time we may apply to the Israel Innovation Authority for approval to allow a tax deduction for all or most of research and development expenses during the year incurred. There can be
no assurance that such application will be accepted.
Law for the Encouragement of Capital Investments, 5719-1959
The Law for the Encouragement of Capital Investments, 5719 1959, generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other
eligible assets).
The Investment Law was significantly amended effective as of April 1, 2005 (the "2005 Amendment"), as of January 1, 2011 (the "2011 Amendment") and as of January 1, 2017 (the "2017 Amendment").
Pursuant to the 2005 Amendment, tax benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force but any benefits granted subsequently are subject to the provisions of the
amended Investment Law. Similarly, the 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment. However, companies entitled to benefits under the
Investment Law as in effect prior to January 1, 2011 were entitled to choose to continue to enjoy such benefits, provided that certain conditions are met, or elect instead, irrevocably, to forego such benefits and have the benefits of the 2011
Amendment apply. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.
Tax benefits subsequent to the 2005 amendment
The 2005 Amendment applies to new investment programs and investment programs commencing after 2004, but does not apply to investment programs approved prior to April 1, 2005. The 2005 Amendment
provides that terms and benefits included in any certificate of approval that was granted before the 2005 Amendment became effective (April 1, 2005) will remain subject to the provisions of the Investment Law as in effect on the date of such
approval. Pursuant to the 2005 Amendment, the Investment Center will continue to grant Approved Enterprise status to qualifying investments. The 2005 Amendment, however, limits the scope of enterprises that may be approved by the Investment Center
by setting criteria for the approval of a facility as an Approved Enterprise, such as provisions generally requiring that at least 25% of the Approved Enterprise's income be derived from exports.
77
In order to receive the tax benefits, a company must make an investment which meets all of the conditions, including exceeding a minimum entitling investment amount, set forth in the Investment
Law. Such investment allows a company to receive "Benefited Enterprise" status, and may be made over a period of no more than three years ending at the end of the year in which the company chose to have the tax benefits apply to its Benefited
Enterprise, referred to as the "Year of Election."
The extent of the tax benefits available under the 2005 Amendment to qualifying income of a Benefited Enterprise depend on, among other things, the geographic location in Israel of the Benefited
Enterprise. The location will also determine the period for which tax benefits are available. In the event that the Company is profitable for tax purposes, such tax benefits include an exemption from corporate tax on undistributed income for a
period of between two to ten years, depending on the geographic location of the Benefited Enterprise in Israel, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the level of foreign
investment in the company in each year. A company qualifying for tax benefits under the 2005 Amendment which pays a dividend out of income derived by its Benefited Enterprise during the tax exemption period will be subject to corporate tax in
respect of the gross amount of the dividend (to reflect the pre-tax income that it would have had to earn in order to distribute the dividend) which would have otherwise been applicable, or a lower rate in the case of a qualified foreign investment
company which is at least 49% owned by non-Israeli residents. In addition dividends paid out of income attributed to a Benefited Enterprise are generally subject to withholding tax at source at the rate of 15% or such lower rate as may be provided
under any applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate).
The benefits available to a Benefited Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations. If a company does not meet these conditions, it
may be required to refund the amount of tax benefits, as adjusted by the Israeli consumer price index, and interest, or other monetary penalties.
The Company has not applied for "Benefited Enterprise" status.
Tax benefits under the 2011 amendment
The 2011 Amendment canceled the availability of the benefits granted to Industrial Companies under the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a
"Preferred Company" through its "Preferred Enterprise" (as such terms are defined in the Investment Law) as of January 1, 2011. The definition of a Preferred Company includes a company incorporated in Israel that is not fully owned by a
governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its
income derived by its Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise is located in a specified development zone, in which case the rate will be 10%. Under the 2011 Amendment, such corporate tax rate was reduced from 15% and
10%, respectively, to 12.5% and 7%, respectively, in 2013, 16% and 9% respectively, in 2014, 2015 and 2016, and 16% and 7.5%, respectively, in 2017 and thereafter. Income derived by a Preferred Company from a "Special Preferred Enterprise" (as such
term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or 5% if the Special Preferred Enterprise is located in a certain development zone.
78
Dividends distributed from income which is attributed to a "Preferred Enterprise" will be subject to withholding tax at source at the following rates: (i) Israeli resident corporations–0%,
(although, if such dividends are subsequently distributed to individuals or a non-Israeli company the below rates detailed in sub sections (ii) and (iii) shall apply) (ii) Israeli resident individuals–20% (iii) non-Israeli residents (individuals
and corporations)–20%, subject to a reduced tax rate under the provisions of any applicable double tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate).
The 2011 Amendment also provided transitional provisions to address companies already enjoying existing tax benefits under the Investment Law. These transitional provisions provide, among other
things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income to be derived as of January 1, 2011, a Benefited Enterprise can elect to continue to benefit from the
benefits provided to it before the 2011 Amendment came into effect, provided that certain conditions are met.
We currently do not intend to implement the 2011 Amendment.
New tax benefits under the 2017 amendment that became effective on January 1, 2017
The 2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and is effective as of January 1, 2017. The 2017 Amendment provides new tax benefits
for two types of "Technology Enterprises," as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.
The 2017 Amendment provides that a technology company satisfying certain conditions will qualify as a "Preferred Technology Enterprise" and will thereby enjoy a reduced corporate tax rate of 12% on
income that qualifies as "Preferred Technology Income", as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technology Enterprise located in development zone "A". In addition, a Preferred Technology Company
will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain "Benefitted Intangible Assets" (as defined in the Investment Law) to a related foreign company if the Benefitted Intangible Assets were acquired from a
foreign company on or after January 1, 2017 for at least NIS 200 million, and the sale receives prior approval from the National Authority for Technological Innovation ("NATI").
79
The 2017 Amendment further provides that a technology company satisfying certain conditions (group turnover of at least NIS 10 billion) will qualify as a "Special Preferred Technology Enterprise"
and will thereby enjoy a reduced corporate tax rate of 6% on "Preferred Technology Income" regardless of the company's geographic location within Israel. In addition, a Special Preferred Technology Enterprise will enjoy a reduced corporate tax rate
of 6% on capital gain derived from the sale of certain "Benefitted Intangible Assets" to a related foreign company if the Benefitted Intangible Assets were either developed by the Special Preferred Enterprise or acquired from a foreign company on
or after January 1, 2017, and the sale received prior approval from NATI. A Special Preferred Technology Enterprise that acquires Benefitted Intangible Assets from a foreign company for more than NIS 500 million will be eligible for these benefits
for at least ten years, subject to certain approvals as specified in the Investment Law.
Dividends distributed by a Preferred Technology Enterprise or a Special Preferred Technology Enterprise, paid out of Preferred Technology Income, are generally subject to withholding tax at source
at the rate of 20% or such lower rate as may be provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). However, if such dividends are paid to an
Israeli company, no tax is required to be withheld. If such dividends are distributed to a foreign company that holds solely or together with other foreign companies 90% or more in the Israeli company and other conditions are met, the withholding
tax rate will be 4%.
We are examining the impact of the 2017 Amendment and the degree to which we will qualify as a Preferred Technology Enterprise, the amount of Preferred Technology Income that we may have and other
benefits that we may receive from the 2017 Amendment.
Taxation of our shareholders
Capital gains taxes applicable to non-Israeli resident shareholders. A non-Israeli resident who derives capital gains from the sale of shares in an Israeli
resident company that were purchased after the company was listed for trading on a stock exchange outside of Israel, will be exempt from Israeli tax so long as the shares were not held through a permanent establishment that the non-resident
maintains in Israel. However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli residents: (i) have a controlling interest more than 25% in such non-Israeli corporation or (ii) are the beneficiaries of, or are
entitled to, 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly. In addition, such exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed
to be business income.
Additionally, a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, under Convention Between the
Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended (the "United States Israel Tax Treaty"), the sale, exchange or other disposition of shares by a shareholder who is a
United States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to claim the benefits afforded to such a resident by the U.S. Israel Tax Treaty (a "Treaty U.S. Resident") is generally exempt from Israeli
capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed to real estate located in Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties;
(iii) the capital gain arising from the such sale, exchange or disposition is attributed to a permanent establishment in Israel, under certain terms; (iv) such Treaty U.S. Resident holds, directly or indirectly, shares representing 10% or more of
the voting capital during any part of the 12 month period preceding the disposition, subject to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel for 183 days or more during the relevant taxable year.
In some instances where our shareholders may be liable for Israeli tax on the sale of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at
source. Shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale (i.e., resident certificate or other documentation).
80
Taxation of non-Israeli shareholders on receipt of dividends. Non-Israeli residents (either individuals or corporations) are generally subject to Israeli
income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%, which tax will be withheld at source, unless relief is provided in a treaty between Israel and the shareholder's country of residence. With respect to a person
who is a "substantial shareholder" at the time of receiving the dividend or on any time during the preceding twelve months, the applicable tax rate is 30%. A "substantial shareholder" is generally a person who alone or together with such person's
relative or another person who collaborates with such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the "means of control" of the corporation. "Means of control" generally include the right to vote, receive
profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, regardless of the source of such right. Such dividends are generally subject to Israeli
withholding tax at a rate of 25% so long as the shares are registered with a nominee company (whether the recipient is a substantial shareholder or not) and 20% if the dividend is distributed from income attributed to an Approved Enterprise, a
Benefited Enterprise or a Preferred Enterprise , unless a reduced rate is provided under an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). For example,
under the United States-Israel Tax Treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a Treaty U.S. Resident is 25%. However, generally, the maximum rate of withholding tax on
dividends, not generated by a Preferred Enterprise or Benefited Enterprise, that are paid to a United States corporation holding 10% or more of the outstanding voting capital throughout the tax year in which the dividend is distributed as well as
during the previous tax year, is 12.5%, provided that not more than 25% of the gross income for such preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from income attributed to
an Approved Enterprise, Benefited Enterprise or Preferred Enterprise are not entitled to such reduction under the tax treaty but are subject to a withholding tax rate of 15% for a shareholder that is a U.S. corporation, provided that the conditions
related to holding 10% or more from the outstanding voting capital and our gross income for the previous year (as set forth in the previous sentence) are met. If the dividend is attributable partly to income derived from an Approved Enterprise,
Benefited Enterprise or Preferred Enterprise, and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income. We cannot assure you that we will designate the profits
that we may distribute in a way that will reduce shareholders' tax liability.
Surtax. Subject to the provisions of an applicable tax treaty, individuals who are subject to tax in Israel are also subject to an additional tax at a
rate of 3% on annual income (including, but not limited to, dividends, interest and capital gain) exceeding NIS 647,640 for 2021, which amount is linked to the annual change in the Israeli consumer price index.
Estate and Gift Tax. Israeli law presently does not impose estate or gift taxes.
United States federal income taxation
United States federal income taxation
The following is a description of the material U.S. federal income tax consequences of the acquisition, ownership and disposition of our ordinary shares. This description addresses only the U.S.
federal income tax consequences to U.S. Holders (as defined below) that are initial purchasers of our ordinary shares pursuant to the offering and that will hold such ordinary shares as capital assets within the meaning of Section 1221 of the
Internal Revenue Code of 1986, as amended (the "Code"), and that have the U.S. dollar as their functional currency. This discussion is based upon the Code, applicable U.S. Treasury regulations, administrative pronouncements and judicial decisions,
in each case as in effect on the date hereof, all of which are subject to change (possibly with retroactive effect). No ruling will be requested from the Internal Revenue Service (the "IRS") regarding the tax consequences of the acquisition,
ownership or disposition of the ordinary shares, and there can be no assurance that the IRS will agree with the discussion set out below. This summary does not address any U.S. tax consequences other than U.S. federal income tax consequences
(e.g., the estate and gift tax or the Medicare tax on net investment income) and does not address any state, local or non-U.S. tax consequences.
81
This description does not address tax considerations applicable to holders that may be subject to special tax rules, including, without limitation:
• banks, financial institutions or insurance companies;
• real estate investment trusts or regulated investment companies;
• dealers or brokers;
• traders that elect to mark-to-market;
• tax exempt entities or organizations;
• "individual retirement accounts" and other tax deferred accounts;
• certain former citizens or long-term residents of the United States;
• persons that are resident or ordinarily resident in or have a permanent establishment in a jurisdiction outside the United States;
• persons that acquired our ordinary shares pursuant to the exercise of any employee share option or otherwise as compensation for the performance of services;
• persons holding our ordinary shares as part of a "hedging," "integrated" or "conversion" transaction or as a position in a "straddle" for U.S. federal income tax purposes;
• persons subject to special tax accounting as a result of any item of gross income with respect to the ordinary shares being taken into account in an applicable financial statement;
• partnerships or other pass through entities and persons holding the ordinary shares through partnerships or other pass through entities; or
• holders that own directly, indirectly or through attribution 10% or more of the total voting power or value of all of our outstanding shares.
For purposes of this description, a "U.S. Holder" is a beneficial owner of our ordinary shares that, for U.S. federal income tax purposes, is:
• an individual who is a citizen or resident of the United States;
• a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or any state thereof, including the District of Columbia;
• an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
• a trust if such trust has validly elected to be treated as a United States person for U.S. federal income tax purposes or if (1) a court within the United States is able to exercise primary supervision over its
administration and (2) one or more United States persons have the authority to control all of the substantial decisions of such trust.
82
If a partnership (or any other entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds our ordinary shares, the tax treatment of a partner in such partnership
will generally depend on the status of the partner and the activities of the partnership. Such a partner or partnership should consult its tax advisor as to the particular U.S. federal income tax consequences of acquiring, owning and disposing of
our ordinary shares in its particular circumstance.
You should consult your tax advisor with respect to the U.S. federal, state, local and foreign tax consequences of acquiring, owning and disposing of our ordinary shares.
Distributions
Subject to the discussion under "—Passive Foreign Investment Company considerations" below, the gross amount of any distribution made to you with respect to our ordinary shares, before reduction
for any Israeli taxes withheld therefrom, generally will be includible in your income as dividend income on the date on which the dividends are actually or constructively received, to the extent such distribution is paid out of our current or
accumulated earnings and profits as determined under U.S. federal income tax principles. To the extent that the amount of any distribution by us exceeds our current and accumulated earnings and profits as determined under U.S. federal income tax
principles, it will be treated first as a tax-free return of your adjusted tax basis in our ordinary shares and thereafter as capital gain. However, we do not expect to maintain calculations of our earnings and profits under U.S. federal income tax
principles and, therefore, you should expect that the entire amount of any distribution generally will be reported as dividend income to you. If you are a non-corporate U.S. Holder you may qualify for the lower rates of taxation with respect to
dividends on ordinary shares applicable to long-term capital gains (i.e., gains from the sale of capital assets held for more than one year), provided that we are not a PFIC (as discussed below under "—Passive Foreign Investment Company
considerations") with respect to you in our taxable year in which the dividend was paid or in the prior taxable year and certain other conditions are met, including certain holding period requirements and the absence of certain risk reduction
transactions. However, such dividends will not be eligible for the dividends received deduction generally allowed to corporate U.S. Holders.
Dividends paid to you with respect to our ordinary shares generally will be treated as foreign source income, which may be relevant in calculating your foreign tax credit limitation. Subject to
certain conditions and limitations, Israeli tax withheld on dividends may be credited against your U.S. federal income tax liability or, at your election, be deducted from your U.S. federal taxable income. Dividends that we distribute generally
should constitute "passive category income" for purposes of the foreign tax credit. A foreign tax credit for foreign taxes imposed on distributions may be denied if you do not satisfy certain minimum holding period requirements. The rules relating
to the determination of the foreign tax credit are complex, and you should consult your tax advisor to determine whether and to what extent you will be entitled to this credit.
Sale, exchange or other disposition of ordinary shares
Subject to the discussion under "Passive Foreign Investment Company considerations" below, you generally will recognize gain or loss on the sale, exchange or other disposition of our ordinary
shares equal to the difference between the amount realized on such sale, exchange or other disposition and your adjusted tax basis in our ordinary shares, and such gain or loss will be capital gain or loss. If you are a non-corporate U.S. Holder,
capital gain from the sale, exchange or other disposition of ordinary shares is generally eligible for a preferential rate of taxation applicable to capital gains, if your holding period for such ordinary shares exceeds one year (i.e., such gain is
long-term capital gain). The deductibility of capital losses for U.S. federal income tax purposes is subject to limitations under the Code. Any such gain or loss that a U.S. Holder recognizes generally will be treated as U.S. source income or loss
for foreign tax credit limitation purposes.
83
Passive foreign investment company considerations
If a non-U.S. company is classified as a PFIC in any taxable year, a U.S. Holder of such passive foreign investment company ("PFIC")'s shares will be subject to special rules generally intended to
reduce or eliminate any benefits from the deferral of U.S. federal income tax that such U.S. Holder could derive from investing in a non-U.S. company that does not distribute all of its earnings on a current basis.
In general, a non-U.S. corporation will be classified as a PFIC for any taxable year if at least (i) 75% of its gross income is classified as "passive income" or (ii) 50% of its gross assets
(generally determined on the basis of a quarterly average) produce or are held for the production of passive income (the "asset test"). Passive income for this purpose generally includes dividends, interest, royalties, rents, gains from commodities
and securities transactions and the excess of gains over losses from the disposition of assets which produce passive income. For these purposes, cash and other assets readily convertible into cash are considered passive assets, and goodwill and
other unbooked intangibles are generally taken into account. In making this determination, the non-U.S. corporation is treated as earning its proportionate share of any income and owning its proportionate share of any assets of any corporation in
which it directly or indirectly holds 25% or more (by value) of the stock.
We will not be classified as a controlled foreign corporation (“CFC”) for our 2020 taxable year. In general, we will be classified as a CFC for a taxable year if more than 50% of the total combined
voting power or the total value of our ordinary shares is owned by "United States shareholders" (generally, United States persons who are treated as owning (directly, indirectly, or constructively, using certain attribution rules) at least 10% of
the total combined voting power or the total value of our ordinary shares). The PFIC asset test for a CFC is applied based on the adjusted tax bases of its assets as determined for the purposes of computing earnings and profits under U.S. federal
income tax principles, unless it is a "publicly traded corporation" for the taxable year, in which case the PFIC asset test is based on the fair market value of its assets. The determination is generally made on the basis of a quarterly average.
Recently proposed U.S. Treasury regulations provide relief from the application of the aforementioned attribution rules enacted in December 2017 for the purpose of determining a foreign corporation's PFIC status, and clarify the application of the
asset test to CFCs in the year in which such CFC becomes publicly traded. Under the rules set forth in these proposed Treasury regulations, we believe that we would not be classified as a PFIC in respect of our 2020 taxable year. However, it is not
clear to what extent we or our shareholders can rely on these proposed Treasury regulations. U.S. Holders should consult their own tax advisors regarding the application of these rules and the potential applicability of these proposed Treasury
regulations.
84
Based on the current and anticipated composition of our income and assets, operations and the value of our assets (including the value of our goodwill, going-concern value or any other unbooked
intangibles which may be determined based on the price of the ordinary shares), we do not expect to be treated as a PFIC for the current taxable year or in the foreseeable future. Because PFIC status is based on our income, assets and activities
for the entire taxable year, it is not possible to determine whether we will be characterized as a PFIC for our current taxable year or future taxable years until after the close of the applicable taxable year. Moreover, we must determine our
PFIC status annually based on tests that are factual in nature, and our status in the current year and future years will depend on our income, assets and activities in each of those years and, as a result, cannot be predicted with certainty as of
the date hereof. Furthermore, fluctuations in the market price of our ordinary shares may cause our classification as a PFIC for the current or future taxable years to change because the value of our assets for purposes of the asset test,
including the value of our goodwill and unbooked intangibles, generally will be determined by reference to the market price of our shares from time to time (which may be volatile). Accordingly, if our market capitalization declines significantly,
it may make our classification as a PFIC more likely for the current or future taxable years. The composition of our income and assets may also be affected by how, and how quickly, we use our liquid assets and the cash raised in any equity
offering. The IRS or a court may disagree with our determinations, including the manner in which we determine the value of our assets and the percentage of our assets that are passive assets under the PFIC rules. Therefore there can be no
assurance that we will not be a PFIC for the current taxable year or for any future taxable year.
Under the PFIC rules, if we were considered a PFIC at any time that you hold our ordinary shares, we would continue to be treated as a PFIC with respect to your investment in all succeeding years
during which you own our ordinary shares (regardless of whether we continue to meet the tests described above) unless (i) we have ceased to be a PFIC and (ii) you have made a "deemed sale" election under the PFIC rules. If such election is made,
you will be deemed to have sold your ordinary shares at their fair market value on the last day of the last taxable year in which we were a PFIC, and any gain from the deemed sale would be subject to the rules described in the following paragraph.
After the deemed sale election, so long as we do not become a PFIC in a subsequent taxable year, the ordinary shares with respect to which such election was made will not be treated as shares in a PFIC. You should consult your own tax advisor as to
the possibility and consequences of making a deemed sale election.
If we are considered a PFIC at any time that you hold ordinary shares, unless (i) we have ceased to be a PFIC and you have previously made the deemed sale election described above or (ii) you make
one of the elections described below, any gain recognized by you on a sale or other disposition of the ordinary shares, as well as the amount of any "excess distribution" (defined below) received by you, would be allocated ratably over your holding
period for the ordinary shares. The amounts allocated to the taxable year of the sale or other disposition (or the taxable year of receipt, in the case of an excess distribution) and to any year before we became a PFIC would be taxed as ordinary
income. The amount allocated to each other taxable year would be subject to tax at the highest rate in effect for individuals or corporations, as appropriate, for that taxable year, and an interest charge would be imposed. For purposes of these
rules, an excess distribution is the amount by which any distribution received by you on your ordinary shares in a taxable year exceeds 125% of the average of the annual distributions on the ordinary shares during the preceding three taxable years
or your holding period, whichever is shorter. Distributions below the 125% threshold are treated as dividends taxable in the year of receipt and are not subject to prior highest tax rates or the interest charge.
85
If we are treated as a PFIC with respect to you for any taxable year, you will be deemed to own shares in any of our subsidiaries that are also PFICs, and you may be subject to the tax consequences
described above with respect to the shares of such lower-tier PFIC you would be deemed to own.
Mark-to-market elections
If we are a PFIC for any taxable year during which you hold ordinary shares, then in lieu of being subject to the tax and interest charge rules discussed above, you may make an election to include
gain on the ordinary shares as ordinary income under a mark-to-market method, provided that such ordinary shares are "marketable." The ordinary shares will be marketable if they are "regularly traded" on a qualified exchange or other market, as
defined in applicable U.S. Treasury regulations, such as the New York Stock Exchange (or on a foreign stock exchange that meets certain conditions). For these purposes, the ordinary shares will be considered regularly traded during any calendar
year during which they are traded, other than in de minimis quantities, on at least 15 days during each calendar quarter. Any trades that have as their principal purpose meeting this requirement will be disregarded. However, because a
mark-to-market election cannot be made for any lower-tier PFICs that we may own, you will generally continue to be subject to the PFIC rules discussed above with respect to your indirect interest in any investments we hold that are treated as an
equity interest in a PFIC for U.S. federal income tax purposes. As a result, it is possible that any mark-to-market election will be of limited benefit.
If you make an effective mark-to-market election, in each year that we are a PFIC, you will include in ordinary income the excess of the fair market value of your ordinary shares at the end of the
year over your adjusted tax basis in the ordinary shares. You will be entitled to deduct as an ordinary loss in each such year the excess of your adjusted tax basis in the ordinary shares over their fair market value at the end of the year, but
only to the extent of the net amount previously included in income as a result of the mark-to-market election. If you make an effective mark-to-market election, in each year that we are a PFIC, any gain that you recognize upon the sale or other
disposition of your ordinary shares will be treated as ordinary income and any loss will be treated as ordinary loss, but only to the extent of the net amount of previously included income as a result of the mark-to-market election.
Your adjusted tax basis in the ordinary shares will be increased by the amount of any income inclusion and decreased by the amount of any deductions under the mark-to-market rules discussed above.
If you make an effective mark-to-market election, it will be effective for the taxable year for which the election is made and all subsequent taxable years unless the ordinary shares are no longer regularly traded on a qualified exchange or the IRS
consents to the revocation of the election. You should consult your tax advisor about the availability of the mark-to-market election, and whether making the election would be advisable in your particular circumstances.
Qualified electing fund elections
In certain circumstances, a U.S. equity holder in a PFIC may avoid the adverse tax and interest-charge regime described above by making a "qualified electing fund" election to include in income its
share of the corporation's income on a current basis. However, you may make a qualified electing fund election with respect to the ordinary shares only if we agree to furnish you annually with a PFIC annual information statement as specified in the
applicable U.S. Treasury regulations. We do not intend to provide the information necessary for you to make a qualified electing fund election if we are classified as a PFIC. Therefore, you should assume that you will not receive such information
from us and would therefore be unable to make a qualified electing fund election with respect to any of our ordinary shares were we to be or become a PFIC.
86
Tax reporting
If you own ordinary shares during any year in which we are a PFIC and you recognize gain on a disposition of such ordinary shares or receive distributions with respect to such ordinary shares, you
generally will be required to file an IRS Form 8621 with respect to us, generally with your federal income tax return for that year. If we are a PFIC for a given taxable year, then you should consult your tax advisor concerning your annual filing
requirements.
You should consult your tax advisor regarding whether we are a PFIC as well as the potential U.S. federal income tax consequences of holding and disposing of our ordinary shares if we are or become
classified as a PFIC, including the possibility of making a mark-to-market election in your particular circumstances.
Backup withholding tax and information reporting requirements
Dividend payments on and proceeds paid from the sale or other taxable disposition of the ordinary shares may be subject to information reporting to the IRS. In addition, a U.S. Holder may be
subject to backup withholding on cash payments received in connection with dividend payments and proceeds from the sale or other taxable disposition of ordinary shares made within the United States or through certain U.S. related financial
intermediaries.
Backup withholding will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number, provides other required certification and otherwise complies with the applicable
requirements of the backup withholding rules or who is otherwise exempt from backup withholding (and, when required, demonstrates such exemption). Backup withholding is not an additional tax. Rather, any amount withheld under the backup withholding
rules will be creditable or refundable against the U.S. Holder's U.S. federal income tax liability, provided the required information is timely furnished to the IRS.
Foreign asset reporting
Certain U.S. Holders are required to report their holdings of certain foreign financial assets, including equity of foreign entities, if the aggregate value of all of these assets exceeds certain
threshold amounts, by filing IRS Form 8938 with their federal income tax return. Our ordinary shares are expected to constitute foreign financial assets subject to these requirements unless the ordinary shares are held in an account at certain
financial institutions. U.S. Holders are urged to consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of our ordinary shares and the significant penalties for
non-compliance.
The above description is not intended to constitute a complete analysis of all tax consequences relating to acquisition, ownership and disposition of our ordinary shares. You should consult your
tax advisor concerning the tax consequences of your particular situation.
Government legislation and regulation
Actions of our users
In many jurisdictions, including the United States and countries in Europe, laws relating to the liability of providers of online services for activities of their users and other third parties are
currently being tested by a number of claims, including actions based on defamation, breach of data protection and privacy rights and other torts, unfair competition, copyright and trademark infringement and other theories based on the nature and
content of the materials searched, the ads posted, or the content uploaded by users. Any court ruling or other governmental action that imposes liability on providers of online services for the activities of their users and other third parties
could harm our business. In addition, rising concern about the use of the Internet for illegal conduct, such as the unauthorized dissemination of national security information, money laundering or supporting terrorist activities may in the future
produce legislation or other governmental action that could require changes to our products or services, restrict or impose additional costs upon the conduct of our business or cause users to abandon material aspects of our service.
87
Data protection
We hold certain personal data of our users, including their username, email address, IP address, device identifiers, address, telephone number, photo, transactional data, consumption habits (such
as purchase history), profession and education, location, social media account log in details and username and additional information regarding the use of our Marketplace (such as published portfolio, Gig information, purchases, ratings and
additional information the user decides to upload and share with us or other users of our marketplace), and may hold certain personal data of the visitors to our users' websites. In addition, we hold certain personal data of our employees and
contractors. We operate in accordance with the terms of our privacy policies, which describe our practices concerning the collection, use, transmission and disclosure of personal data. As a "database owner" pursuant to the Privacy Law, we are
subject to certain obligations and restrictions, such as the obligation to register databases containing personal data, the requirement to properly notify the data subjects regarding the nature of the collection and use of their personal data prior
to their collection, the requirement to obtain valid informed consents from the data subjects prior to using their personal data, conditions with respect to transfer of personal data outside Israeli borders, conditions and restrictions regarding
the use of any personal data for direct mailing, obligations to meet certain data subject rights (such as access, rectification and deletion rights) as well as data security obligations. In this respect, the new Israeli Privacy Protection
Regulations (Data Security) 2017 ("Data Security Regulations"), which entered into effect in Israel in May 2018, impose obligations with respect to the manner personal data is processed, maintained, transferred, disclosed, accessed and secured. The
Data Security Regulations may require us to adjust our data protection and data security practices, information security measures, certain organizational procedures, applicable positions (such as an information security manager) and other technical
and organizational security measures. The Israeli Privacy Protection Authority may initiate administrative inspection proceedings, from time to time, without any suspicion of any particular breach of the Privacy Law, as the Authority has done in
the past with respect to dozens of Israeli companies in various business sectors. In addition, to the extent that any administrative supervision procedure is initiated by the Israeli Privacy Protection Authority that reveals certain irregularities
with respect to our compliance with the Privacy Law, in addition to our exposure to administrative fines, civil claims (including class actions) and in certain cases criminal liability, we may also need to take certain remedial actions to rectify
such irregularities, which may increase our costs.
While it is generally the laws of the jurisdiction in which a business is located that apply, there is a risk that data protection regulators of other countries may seek jurisdiction over our
activities in locations in which we process data or have users but do not have an operating entity. Where the local data protection and privacy laws of a jurisdiction apply, we may be required to register our operations in that jurisdiction or make
changes to our business so that user data is only collected and processed in accordance with applicable local law. In addition, because our services are accessible worldwide, certain foreign jurisdictions may claim that we are required to comply
with their privacy and data protection laws, including in jurisdictions where we have no local entity, employees, or infrastructure. In such cases, we may require additional legal review and resources to ensure compliance with any applicable
privacy or data protections laws and regulations. In addition, in many jurisdictions there is new legislation that may affect our business and require additional legal review.
88
United States
A number of legislative proposals pending before the U.S. Congress, various state legislative bodies and foreign governments concerning data protection could affect us. For example, in June 2018,
California passed the California Consumer Privacy Act ("CCPA"), which entered into effect on January 1, 2020 and provides new data privacy rights for consumers and new operational requirements for companies. Additionally, some other states have
passed proactive, rather than reactive, information security legislation. These state laws require that certain minimum protections and security measures be taken to protect personal data. The costs of compliance with these laws may increase in the
future as a result of changes in interpretation.
Europe
European legislators adopted the GDPR, repealing the 1995 European Data Protection Directive (Directive 95/46/EC). We are defined as a "Data Controller" with respect to the personal data of our
users that we collect and are therefore subject to a number of key legal obligations under the GDPR. In addition to reflecting existing requirements that already existed under the old data protection regime, such as, among other things,
requirements to provide users with a "fair processing notice" if we process their data, ensure that inaccurate data is corrected, only retain data for so long as is necessary and not transfer data outside the European Economic Area to jurisdictions
which do not ensure an adequate level of protection of personal data without taking certain safeguards, the GDPR also implemented new, more stringent operational and procedural requirements for our use of personal data. These include expanded prior
information requirements in light of the transparency principle to tell our users how we may use their personal data, increased controls on profiling users, increased rights for users to access, control and delete their personal data and mandatory
data breach notification requirements. In addition, there are significantly increased administrative fines of the greater of €20 million and 4% of global turnover (as well as the right to compensation for financial or non-financial damages claimed
by any individuals under Article 82 of the GDPR).
The European ePrivacy Directive (Directive 2002/58/EC as amended by Directive 2009/136/EC) obliges the EU member states to introduce certain national laws regulating privacy or data protection in
the electronic communications sector. Pursuant to the requirements of the ePrivacy Directive, companies must, among other things, obtain consent to store information or access information already stored, on a user's terminal equipment
(e.g., computer or mobile device). These requirements predominantly regulate the use by companies of cookies and similar technologies. Prior to providing such consent, users must receive clear and comprehensive information, both in accordance with
the more stringent requirements under the GDPR. Certain exemptions to these requirements on which we rely are available for technical storage or access for the sole purpose of carrying out the transmission of a communication over an electronic
communications network or as strictly necessary to provide a service explicitly requested by the user.
89
In recent years, U.S. and European lawmakers and regulators have expressed concern over the use of third-party cookies and similar technologies for online behavioral advertising, and laws in this
area are also under reform. In the European Union, current national laws that implement the ePrivacy Directive will soon be replaced by an EU regulation known as the ePrivacy Regulation. In the European Union, informed consent is required for the
placement of a cookie on a user's device and for direct electronic marketing, and the GDPR also imposes additional conditions in order to satisfy such consent, such as a prohibition on pre-checked consents and on bundled consents thereby requiring
users to affirmatively consent for a given purpose through separate tick boxes. The draft ePrivacy Regulation retains these additional consent conditions and also imposes the strict opt-in marketing rules on direct marketing that is "presented" on
a web page rather than sent by email, alters rules on third-party cookies and similar technology and significantly increases penalties for breach of the rules. Regulation of cookies and similar technologies may lead to broader restrictions on our
marketing and personalization activities and may negatively impact our efforts to understand users' internet usage, as well as the effectiveness of our marketing and our business generally. Such regulations may have a negative effect on businesses,
including ours, that collect and use online usage information for consumer acquisition and marketing, it may increase the cost of operating a business that collects or uses such information and undertakes online marketing, it may also increase
regulatory scrutiny and increase potential civil liability under data protection or consumer protection laws. In response to marketplace concerns about the usage of third-party cookies and web beacons to track user behaviors, providers of major
browsers have included features that allow users to limit the collection of certain data generally or from specified websites, and the ePrivacy Regulation draft also advocates the development of browsers that block cookies by default. These
developments could impair our ability to collect user information, including personal data and usage information, that helps us provide more targeted advertising to our current and prospective consumers, which could adversely affect our business,
given our use of cookies and similar technologies to target our marketing and personalize the consumer experience.
As the text of the ePrivacy Regulation is still under development and currently in draft form, and as further guidance is issued and interpretation of both the ePrivacy Regulation and the GDPR
develop, it is difficult to assess the impact of the ePrivacy Regulation on our business or operations, but it may require us to modify our data practices and policies and we could incur substantial costs as a result.
The estimated costs of this offering are as follows:
|
Selling Commissions
|
$
|
0
|
||
|
Securities and Exchange Commission registration fee
|
$
|
207.29
|
||
|
Edgar Fees (estimate)
|
2,000
|
|||
|
Translation Fees
|
$
|
3,000
|
||
|
Transfer Agent Fees
|
$
|
2,500
|
||
|
Accounting fees and expenses
|
$
|
16,200
|
||
|
Legal fees and expenses
|
$
|
36,093
|
||
|
Total
|
$
|
60,000.29
|
All amounts are estimates, other than the Commission's registration fee.
90
Crone Law Group, P.C., our legal counsel in the United States, is our lead counsel with regard to this Registration Statement. The validity of the ordinary shares offered in this
offering will be passed upon for us by Yigal Arnon & Co., our independent legal counsel in the State of Israel.
EXPERTS
The consolidated financial statements as of December 31, 2020 and 2019 included in this prospectus have been audited by BF Borgers CPA PC, an independent registered public
accounting firm. BF Borgers has presented their report with respect to our audited financial statements. The report of BF Borgers is included in reliance upon their authority as experts in accounting and auditing. The offices of BF Borgers are
located at Lakewood, Colorado.
ENFORCEABILITY OF CIVIL LIABILITIES
We are incorporated under the laws of the State of Israel. Service of process upon us and upon our director and officer who resides outside the United States, may be difficult to obtain within the
United States. Furthermore, because all of our assets and our director and officer is located outside the United States, any judgment obtained in the United States against us or our director and officer may not be collectible within the United
States.
We have irrevocably appointed The Crone Law Group, P.C. as our agent to receive service of process in any action against us in any U.S. federal or state court arising out of this offering or any
purchase or sale of securities in connection with this offering. The address of our agent is 500 Fifth Avenue, Suite 938, New York, NY 10110.
We have been informed by our legal counsel in Israel, Yigal Arnon & Co., that it may be difficult to initiate an action with respect to U.S. securities law in Israel. Israeli courts may refuse
to hear a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum to hear such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and
not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact by expert witnesses which can be a time-consuming and costly process. Certain matters of procedure may also
be governed by Israeli law.
91
Subject to certain time limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain exceptions, is non-appealable, including judgments
based upon the civil liability provisions of the Securities Act and the Exchange Act and including a monetary or compensatory judgment in a non-civil matter, provided that:
| • |
the judgment was rendered by a court which was, according to the laws of the state of the court, and the rules of private international law currently prevailing in Israel competent to render the judgment;
|
| • |
the obligation imposed by the judgment is enforceable according to the rules relating to the enforceability of judgments in Israel and the substance of the judgment is not contrary to public policy; and
|
| • |
the judgment is executory in the state in which it was given.
|
Even if these conditions are met, an Israeli court may not declare a foreign civil judgment enforceable if:
| • |
the judgment was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases);
|
| • |
the enforcement of the judgment is likely to prejudice the sovereignty or security of the State of Israel;
|
| • |
the judgment was obtained by fraud;
|
| • |
the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli court;
|
| • |
the judgment was rendered by a court not competent to render it according to the laws of private international law as they apply in Israel;
|
| • |
the judgment is contradictory to another judgment that was given in the same matter between the same parties and that is still valid; or
|
| • |
at the time the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel.
|
If a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred out of Israel. The
usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the
judgment, but the judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest at the
annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.
92
We have filed a registration statement, including relevant exhibits, with the SEC on Form F-1 under the Securities Act with respect to the ordinary shares to be sold in this
offering. This prospectus, which constitutes a part of the registration statement on Form F-1, does not contain all of the information contained in the registration statement. You should read our registration statement and its exhibits and schedules
for further information with respect to us and our ordinary shares.
We are subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we are required to file
reports, including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC can be obtained over the internet at the SEC’s website at www.sec.gov or inspected and copied at the public reference facilities
maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You can request copies of documents, upon payment of a duplicating fee, by writing to the SEC.
93
Part II – Information Not Required In Prospectus
Item 6. Indemnification of Officers and Directors
Under the Companies Law, a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability
to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our articles of association include such
a provision. An Israeli company may not exculpate a director from liability arising out of a prohibited dividend or distribution to shareholders.
An Israeli company may indemnify an office holder in respect of the following liabilities and expenses incurred for acts performed as an office holder, either in advance of an event or following an
event, provided a provision authorizing such indemnification is contained in its articles of association:
| • |
financial liability imposed on him or her in favor of another person pursuant to a judgment, settlement or arbitrator's award approved by a court. However, if an undertaking to indemnify an office holder with respect to such liability is
provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company's activities when the undertaking to indemnify is given, and to an amount or
according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned events and amount or criteria;
|
| • |
reasonable litigation expenses, including attorneys' fees, incurred by the office holder (1) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or
proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability, such as a criminal penalty, was imposed upon him or her as a substitute for
the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent and (2) in connection with a
monetary sanction;
|
| • |
reasonable litigation expenses, including attorneys' fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf or by a third-party or in connection with criminal
proceedings in which the office holder was acquitted or as a result of a conviction for an offense that does not require proof of criminal intent; and
|
| • |
expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation to an administrative proceeding instituted against such office holder, or certain compensation payments made to an injured party
imposed on an office holder by an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law, 1968 (the "Israeli Securities Law").
|
II - 1
An Israeli company may insure an office holder against the following liabilities incurred for acts performed as an office holder if and to the extent provided in the company's articles of
association:
| • |
a breach of the duty of loyalty to the company, to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
| • |
a breach of the duty of care to the company or to a third-party, including a breach arising out of the negligent conduct of the office holder;
|
| • |
a financial liability imposed on the office holder in favor of a third-party;
|
| • |
a financial liability imposed on the office holder in favor of a third-party harmed by a breach in an administrative proceeding; and expenses, including reasonable litigation expenses and legal fees, incurred by the office holder as a
result of an administrative proceeding instituted against him or her, pursuant to certain provisions of the Israeli Securities Law.
|
An Israeli company may not indemnify or insure an office holder against any of the following:
| • |
a breach of the duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
| • |
a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;
|
| • |
an act or omission committed with intent to derive illegal personal benefit; or
|
| • |
a fine, monetary sanction or forfeit levied against the office holder.
|
Under the Companies Law, exculpation, indemnification and insurance of office holders must be approved by the compensation committee and the board of directors (and, with respect to directors and
the Chief Executive Officer, by shareholders
Our articles of association allow us to indemnify and insure our office holders for any liability imposed on them as a consequence of an act (including any omission) which was performed by virtue
of being an office holder.
We have entered into an agreement with our director and executive officer exculpating him, to the fullest extent permitted by law, from liability to us for damages caused to us as a result of a
breach of duty of care, and undertaking to indemnify him to the fullest extent permitted by law. This indemnification is limited to events determined as foreseeable by the board of directors based on our activities, and to an amount or according to
criteria determined by the board of directors as reasonable under the circumstances.
There is no pending litigation or proceeding against any of our office holder as to which indemnification is being sought, nor are we aware of any pending or threatened litigation that may result
in claims for indemnification by such office holder.
II - 2
Disclosure of Commission Position on Indemnification for Securities Act Liabilities
Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the “Act”) may be permitted to our directors, officers and controlling persons pursuant to the foregoing
provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by us of expenses incurred or paid by a director, officer or controlling person of us in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
Item 7. Recent Sales of Unregistered Securities
During the past three years, we have issued the following ordinary shares in connection with the incorporation of the Company without registering the securities under the Securities Act. We believe
that each of the following issuances was exempt from registration under the Securities Act in reliance on Regulation D under the Securities Act or pursuant to Section 4(2) of the Securities Act regarding transactions not involving a public offering
or in reliance on Regulation S under the Securities Act regarding sales by an issuer in offshore transactions. No underwriter or underwriting discount or commission was involved in any of these issuances of shares.
In April 2021, the Company issued 1,999,700 ordinary shares for an aggregate purchase price of NIS 19,997 to Menachem Shalom. In addition, we issued 10,000,000 preferred shares for an aggregate
purchase price of NIS 100,000 to Menachem Shalom.
Exhibits and Financial Statement Schedules
|
(a)
|
Exhibits
The Exhibit Index is hereby incorporated herein by reference. |
|
(b)
|
Financial Statement Schedules
Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the Consolidated
Financial Statements or the Notes thereto.
|
II - 3
Item 9. Undertakings
The undersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreements, certificates in such denominations and registered in such names as
required by the underwriter to permit prompt delivery to each purchaser.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in
Item 6, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
The undersigned registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A
and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
II - 4
EXHIBITS INDEX
|
Exhibit Number
|
|
Description
|
| |
||
|
|
|
|
| |
||
|
5.1
|
|
Opinion of Yigal Arnon & Co. regarding the validity of the ordinary shares being registered and certain State of Israel matters*
|
| |
||
|
|
|
|
|
|
|
|
|
|
||
| 23.2 |
Consent of Yigal Arnon & Co. (included in Exhibit 5.1)* | |
| |
* To be provided
II - 5
In accordance with the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and
authorized this registration statement to be signed on its behalf by the undersigned, in the State of Israel, on April 23, 2021.
|
HOLD ME LTD.
|
|
|
|
|
|
|
|
By:
|
/s/ Menachem Shalom
|
|
|
|
Menachem Shalom
|
|
|
|
Chief Executive Officer, Chief Financial Officer and Director
|
|
|
|
(Principal Executive Officer and Principal Financial and Accounting Officer)
|
|
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
By:
|
/s/ Menachem Shalom
|
|
||
|
|
Menachem Shalom
|
|
||
|
|
Chief Executive Officer, Chief Financial Officer and Director
|
|
||
|
|
(Principal Executive Officer and Principal Financial and Accounting Officer)
|
|
||
SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Hold Me Ltd. has signed this registration statement or amendment
thereto in New York, New York, on April 23, 2021.
|
|
The Crone Law Group P.C.
|
|
|
|
|
|
|
|
By:
|
/s/ Mark Crone
|
|
|
Name:
|
Mark Crone
|
|
|
Title:
|
Managing Partner
|
II - 6
Exhibit 3.1
תקנון חברה
הולד מי בע"מ
ח.פ. 513933218
חלק א' לתקנון החברה
|
שם החברה
|
.1 |
|
בעברית: הולד מי בע"מ
|
:שם החברה
|
|
|
Hold Me Ltd.: באנגלית
|
|
מטרות החברה
.לפי ס' 32(1) לחוק- לעסוק בכל עיסוק חוקי
|
.2 |
|
הון המניות הרשום של החברה
:ההון הרשום של החברה הוא 10,000,000 ₪ המחולק כדלהלן
|
.3 |
|
:א. 990,000,000 מניות רגילות בעלות ערך נקוב 0.01 ₪ כל אחת, וכן
|
|
|
ב. 10,000,000 מניות בכורה בעלות ערך נקוב 0.01 ₪ כל אחת, בנות המרה למניות רגילות ביחס של 1:100
|
|
|
אחריות מוגבלת
|
|
|
.אחריותם של בעלי המניות מוגבלת לפירעון סכום הון המניות הבלתי נפרע שברשותם
|
|
כל הזכויות והחובות הצמודות למניות, הזכויות והחובות של בעלי המניות וההסדרים בין בעלי המניות לבין עצמם ובינם לבין החברה יהיו בהתאם להוראות חלק ב' לתקנון זה שמהווה חלק בלתי-נפרד מתקנון זה ויראו בהן כהוראות
.תקנוניות לכל דבר ועניין. אין באמור כדי לגרוע מהזכויות והחובות של בעלי המניות והחברה על פי דין או הסכם
1
חלק ב' לתקנון החברה - הולד מי בע"מ
THE COMPANIES LAW
A COMPANY LIMITED BY SHARES
AMENDED AND RESTATED ARTICLES OF ASSOCIATION
of
HOLD ME LTD.
| 1. |
Preliminary
|
| 1.1 |
Construction. In these Articles, each of the following terms shall have the respective meaning appearing next to it, if not inconsistent with the subject or context:
|
| 1.1.1 |
“Articles” - These Articles of Association, as amended from time to time.
|
| 1.1.2 |
“Board” - The board of directors appointed under these Articles.
|
| 1.1.3 |
“Company” - Hold Me Ltd., or in Hebrew - הולד מי בע"מ
|
| 1.1.4 |
“Companies Law” - The Companies Law, 5759-1999 and any regulations promulgated thereunder.
|
| 1.1.5 |
“Shareholder Meeting” - An Annual Meeting or a Special Meeting as defined in Article 10.1.1.
|
| 1.1.6 |
“Shareholder” -
|
| (a) |
A holder of one or more of the shares of the Company; or
|
| (b) |
a person registered as such in the Register of Shareholders; or
|
| (c) |
a person who holds a valid and duly issued share certificate.
|
| 1.1.7 |
“Register of Shareholders” - The principal register of Shareholders specified in Article 13, to be kept in accordance with the Companies Law, and/or, if the Company shall have any additional or
branch register(s), any such additional or branch register(s) as the case may be.
|
| 1.1.8 |
“Year and Month” - A Gregorian (not Hebrew) month or year.
|
| 1.2 |
Any capitalized term used but not otherwise defined in these Articles shall have the meaning ascribed to it in the Companies Law.
|
| 2. |
Public Company
|
The Company is a Public Company as such term is defined in the Companies Law.
| 3. |
Share Capital
|
| 3.1 |
The authorized share capital of the Company is NIS 10,000,000 divided into 990,000,000 Ordinary Shares of nominal value NIS 0.01 per share (“Ordinary Shares”) and 10,000,000 Preferred Shares of
nominal value NIS 0.01 per share (“Preferred Shares”). Each Preferred Share shall be convertible into one hundred (100) Ordinary Shares (the “Conversion Ratio”)
upon the election of the holder of such Preferred Shares.
|
| 3.2 |
The holders of issued and outstanding Ordinary Shares shall have all the rights, powers and authorities associated with the shares of the Company, including the power to appoint directors, to receive notice of, and to vote in, General
Meetings of the Company, and to receive dividends and any surplus upon the liquidation of the Company in accordance with the provision of this Section 3 and 4.
|
| 3.3 |
The Preferred Shares shall not confer upon the holders thereof any voting rights or any right to appoint directors or any other right with respect to general meetings, including without limitation, attending, voting at or requesting to
convene, such general meetings or proposing matters for the agenda of such general meetings, except as expressly provided herein or required by Israeli law.
|
2
| 3.4 |
If at any time the share capital is divided into different classes of shares, then, unless the conditions of allotment of such class provide otherwise, the rights, additional rights, advantages, restrictions and conditions attached or
not attached to any class, at any given time, may be modified, enhanced, added or abrogated by the Company by resolution at a meeting of the holders of the shares of such class.
|
| 4. |
Preferred Shares
|
| 4.1 |
Each Preferred Share in the Company’s capital shall be entitled to receive upon distribution, and in preference to the Ordinary Shares of the Company, (i) dividends in excess of the general dividends issued to all shareholders including
holders of Ordinary Shares, and/or (ii) amounts paid in a distribution of the Company’s surplus assets on winding up, in an amount equal to the original issue price for such Preferred Shares as set forth in the Company’s share registrar
(adjusted for share combinations or subdivisions or other recapitalizations of the Company’s shares), and less the amount of any dividend previously paid in preference, all pro rata to the number of the Company’s Preferred Shares of each
specific class of Preferred Shares issued and outstanding at such time, without having regard to any premium paid or discount thereon, and all subject to the provisions hereof.
|
| 4.2 |
Furthermore, and after payment of the Preferred Shares’ dividend preferences or liquidation preferences as aforesaid, each Preferred Share in the Company’s capital shall be entitled to receive upon distribution, (i) a general dividend
issued to all Shareholders, (ii) bonus shares, and (iii) amounts paid in a distribution of the Company’s surplus assets on winding up, all pro rata to the number of the Company’s Shares (Ordinary Shares and Preferred Shares) issued and
outstanding at such time, without having regard to any premium paid thereon or discount, and all subject to the provisions hereof.
|
| 4.4 |
Conversion
|
| 4.4.1 |
Ratio. Each Preferred Share shall be convertible, at the option of the holder thereof, at any time, and without the payment of additional consideration by the holder thereof, into 100 fully paid and nonassessable Ordinary Shares.
|
| 4.4.2 |
Notice of Conversion. In order for a holder of Preferred Shares to voluntarily convert Preferred Shares into Ordinary Shares, such holder shall surrender the certificate or certificates for such Preferred Shares (or, if such
registered holder states that any such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Company to indemnify the Company against any claim that may be made against the
Company on account of the alleged loss, theft or destruction of such certificate), at the office of the transfer agent for the Preferred Shares (or at the principal office of the Company if the Company serves as its own transfer agent),
together with written notice that such holder elects to convert all or any number of the Preferred Shares represented by such certificate or certificates and, if applicable, any event on which such conversion is contingent (a “Contingency
Event”). Such notice shall state such holder’s name or the names of the nominees in which such holder wishes the certificate or certificates for Ordinary Shares to be issued. The close of business on the date of receipt by the transfer
agent (or by the Company if the Company serves as its own transfer agent) of such certificates (or lost certificate affidavit and agreement) and notice (or, if later, the date on which all Contingency Events have occurred) shall be the time
of conversion (the “Conversion Time”), and the Ordinary Shares issuable upon conversion of the shares represented by such certificate shall be deemed to be outstanding of record as of such time.
|
| 4.4.3 |
Effect of Voluntary Conversion. All Preferred Shares that shall have been surrendered for conversion as herein provided shall no longer be deemed to be outstanding and all rights with respect to such shares shall immediately
cease and terminate at the Conversion Time, except only the right of the holders thereof to receive Ordinary Shares in exchange therefor. Any Preferred Shares so converted shall be retired and cancelled and may not be reissued.
|
| 5. |
Issuance of Securities
|
| 5.1 |
The unissued shares of the Company shall be under the control of the Board.
|
| 5.2 |
The Board shall have the power to allot, issue or otherwise dispose of shares to such persons, at such times, on such terms and conditions, and either at par or less than par, at a premium, for cash or other consideration, in whole or in
part, at a discount or with payment of commission, with such preferred or deferred rights, restrictions or conditions, all in accordance with the provisions of the Companies Law and as the Board shall deem fit from time to time, provided
that such shares do not exceed the registered share capital of the Company. The Board of Directors shall also have the power to give any person the option to acquire from the Company any shares, either at par or less than par, at a premium,
for cash or other consideration, in whole or in part, at a discount or with payment of commission, all in accordance with the provisions of the Companies Law and as the Board shall deem fit from time to time.
|
3
| 5.3 |
The Board may resolve to issue one or more series of debentures; however, such borrowing power shall be limited to actions that do not unreasonably jeopardize the Company’s ability to pay its debt or to conduct its business as an entity
that seeks to maximize profits.
|
| 5.4 |
The Company may, subject to applicable law, issue redeemable shares and redeem the same.
|
| 6. |
Reorganization of Capital
|
| 6.1 |
Increase of Capital
|
| 6.1.1 |
The Company may, from time to time, by resolution of the Shareholders, whether or not all the shares then authorized have been issued, and whether or not all the shares issued have been called for payment, increase its authorized share
capital. Any such increase shall be in such amount and shall be divided into shares of such nominal amounts, with such rights and preferences and subject to such restrictions, as such resolution shall provide.
|
| 6.1.2 |
Except to the extent otherwise provided in such resolution, any new shares included in the authorized share capital increased under Article 6.1.1 shall be subject to all the provisions of these Articles which are applicable to shares
included in the existing share capital, without regard to class (and, if such new shares are of the same class as a class of shares included in the existing share capital, to all of the provisions that are applicable to shares of such class
included in the existing share capital).
|
| 6.2 |
Consolidation, Subdivision, Cancellation and Reduction of Capital. The Company may, from time to time, by resolution of the Shareholders (subject to applicable law):
|
| 6.2.1 |
consolidate all or any part of its issued or unissued share capital into shares of a per share nominal value that is greater than the per share nominal value of its existing shares;
|
| 6.2.2 |
subdivide its shares (issued or unissued) or any of them into shares of lesser nominal value than is fixed by these Articles;
|
| 6.2.3 |
cancel any shares that have not been issued or subscribed for, and decrease the amount of its authorized share capital by the amount of the shares so canceled, subject to any commitment (including a conditional commitment) given by the
Company in respect of such shares; or
|
| 6.2.4 |
reduce its share capital in any manner, and with and subject to any consent required by law.
|
| 6.3 |
Fractional Shares. With respect to any action that may result in fractional shares, the Board may settle any difficulty that may arise with regard thereto as it deems fit, and in connection with any such consolidation or other
action that may result in fractional shares may, without limitation:
|
| 6.3.1 |
determine, as to the holder of the shares so consolidated, which issued shares shall be consolidated into a share of a larger nominal value per share (as applicable);
|
| 6.3.2 |
allot, in contemplation of or subsequent to such consolidation or other action, shares or fractional shares sufficient to preclude or remove fractional share holdings;
|
| 6.3.3 |
redeem, in the case of redeemable shares and subject to the Companies Law, such shares or fractional shares sufficient to preclude or remove fractional share holdings; or
|
| 6.3.4 |
cause the transfer of fractional shares by certain Shareholders to other Shareholders so as most expediently to preclude or remove any fractional share holdings, and cause the transferees of such fractional shares to pay the transferors
of such fractional shares the fair value thereof, and the Board is hereby authorized to act in connection with such transfer as agent for the transferors and transferees of any such fractional shares, with full power of substitution, for
the purpose of implementing the provisions of this Article 6.3.
|
4
| 7. |
Transfer of Shares. The Company’s shares are transferable as provided in this Article 7.
|
| 7.1 |
Registration of Transfer. No transfer of shares shall be registered in the Register of Shareholders unless one of the following conditions has been met:
|
| 7.1.1 |
a proper writing or instrument of transfer (in any customary form or any other form satisfactory to the Board) signed by the transferee and the transferor, together with the share certificate(s) and such other evidence of title as the
Board may reasonably require, were submitted to the Company, and the relevant provisions in these Articles to effect a transfer of shares have been fully complied with. Until the transferee has been registered in the Register of
Shareholders in respect of the shares so transferred, the Company may continue to regard the transferor as the owner thereof;
|
| 7.1.2 |
the Company received a court order requiring the change in the Register of Shareholders;
|
| 7.1.3 |
the Company received proof that the legal requirements for the assignment of rights to any Shares were fulfilled; or
|
| 7.1.4 |
the occurrence of a condition that is sufficient, under these Articles, to effect the change in the Register of Shareholders.
|
| 7.2 |
Decedent’s Shares
|
| 7.2.1 |
In case of a share registered in the names of two or more holders, the Company may recognize the survivor(s) as the sole owner(s) thereof unless and until the provisions of Article 7.2.2 have been effectively invoked.
|
| 7.2.2 |
Any person becoming entitled to a share in consequence of the death of any person, upon producing evidence of the grant of probate or letters of administration or order of inheritance (or such other evidence as the Board may reasonably
deem sufficient), shall be registered as a Shareholder in respect of such share, or may, subject to the regulations as to transfer herein contained, transfer such share.
|
| 7.3 |
Receivers and Liquidators
|
| 7.3.1 |
The Company may recognize any receiver, liquidator or similar official appointed to wind up, dissolve or otherwise liquidate a corporate Shareholder, and a trustee, manager, receiver, liquidator or similar official appointed in
bankruptcy or in connection with the reorganization of, or similar proceeding with respect to a Shareholder or its properties, as being entitled to the shares registered in the name of such Shareholder.
|
| 7.3.2 |
Such receiver, liquidator or similar official appointed to wind up, dissolve or otherwise liquidate a corporate Shareholder, and such trustee, manager, receiver, liquidator or similar official appointed in bankruptcy or in connection
with the reorganization of, or similar proceeding with respect to, a Shareholder or its properties, upon producing such evidence as the Board may deem sufficient as to his authority to act in such capacity or under this Article, shall with
the consent of the Board (which the Board may grant or refuse in its absolute discretion) be registered as a Shareholder in respect of such shares, or may, subject to the regulations as to transfer contained in these Articles, transfer such
shares.
|
| 8. |
Limitation of Liability
|
The liability of each Shareholder shall be limited to the payment of the nominal value of its shares or the subscription price paid for such shares, if greater than the nominal
value. If the Company issues shares for consideration that is less than the nominal value of such shares, in accordance with, the terms and conditions set forth in Section 304 of the Companies Law, then the liability of each such Shareholder shall
be governed by the terms of Section 304 of the Companies Law.
| 9. |
Amendments to the Articles
|
The Company may amend these Articles by resolution adopted by the Shareholders by a regular majority of Shareholders present at the General or Special Meeting entitled to vote.
The Company shall not amend the Articles in a manner that adversely affects the rights of a Shareholder without obtaining the consent of the majority of the Shareholders that are adversely affected by such modification. For the avoidance of doubt,
any amendment that affects all the Shareholders in the same manner shall not be deemed to constitute a modification of rights associated with specific shares. Any amendment affecting the rights of the holders of Preferred Shares shall require the
approval of at least a majority of the Preferred Shares present and entitled to vote at a meeting called to discuss such amendment.
5
| 10. |
General Meetings
|
| 10.1. |
Annual Meetings and Special Meetings
|
| 10.1.1 |
An Annual Meeting shall be held at least once in every calendar year (within a period of not more than 15 months after the last preceding Annual General Meeting), at such time and at such place as determined by the Board. Such Annual
General Meetings shall be referred to as “Annual Meetings”. Any other Shareholders meetings shall be referred to as “Special Meetings”.
|
| 10.1.2 |
The agenda at an Annual Meeting shall include a discussion of the annual financial statements of the Company and of the report submitted by the Board that shall include explanations concerning the various events that had an influence on
the financial statements. The function of the meeting shall also be to elect Directors in accordance with these Articles, appoint auditors and transact any other business which under these Articles or applicable law may be transacted by
the shareholders of a company in general meeting.
|
| 10.2 |
Convening a General Meeting
|
| 10.2.1 |
The Board of Directors may whenever it thinks fit convene a Special General Meeting, and it shall be obliged to do so upon a request in writing as provided in the Companies Law.
|
10.2.2.
| 10.2.2.1 |
The Company shall not be required to deliver or serve notice ('Hodaa') of General Meetings or of any adjournments thereof to any Shareholder.
|
| 10.2.2.2 |
Without derogating from the provisions of Article 10.2.2(i) above, the Company will publicize the convening of General Meetings in any manner reasonably determined by the Company, such as by filing an appropriate periodic report with
the SEC, by posting a notice on the Company’s website or by publishing in one or more international wire services or in one or more newspapers, and any such publication shall be deemed duly made, given and delivered to all Shareholders on
the date on which it is first made, posted, filed or published in the manner so determined by the Company in its sole discretion.
|
|
10.3
|
Reserved
|
| 10.4 |
Proceedings at a General Meeting
|
| 10.4.1 |
The Agenda: The agenda for a General Meeting shall be determined by the Board, and shall include (i) in the case of a Special Meeting, the matters for which the Special Meeting was convened pursuant to Section 63 of the Companies
Law, and (ii) matters requested by a Shareholder or Shareholders holding not less than (1%) of the voting rights in the General Meeting, provided that such proposed matter is appropriate for discussion in a General Meeting. Only resolutions
on matters that are specified in the agenda shall be adopted at such Special Meeting.
|
| 10.4.2 |
Quorum:
|
| 10.4.2.1 |
No business shall be transacted at a General Meeting unless a legal quorum is present, and no resolution may be passed unless a legal quorum is present at the time such resolution is voted upon.
|
| 10.4.2.2 |
In the absence of a contrary provision in these Articles or in the Companies Law, two or more Shareholders who are entitled to vote, present in person or by proxy and holding shares conferring in the aggregate at least one third of the
outstanding voting power of the Company shall constitute a legal quorum at General Meetings.
|
| 10.4.2.3 |
If within half an hour from the time scheduled for a General Meeting a legal quorum is not present, the meeting shall be adjourned to the same day in the next week, at the same time and place, or to such other day and at such other time
and other place as the Board may determine in a notice to the Shareholders. If within half an hour from the time scheduled for the adjourned meeting a legal quorum is not present, then any two Shareholders entitled to vote, present in
person or by proxy, shall constitute a legal quorum for such adjourned meeting and shall be entitled to resolve any matters on the agenda of the meeting.
|
6
| 10.4.3 |
Chairman: The Chairman of the Board shall preside at every General Meeting of the Company and shall be appointed as the Chairman of the General Meeting. If a Chairman of the Board was not appointed, or if the Chairman of the Board
is not present within 15 minutes after the time scheduled for the meeting or is unwilling to take the chair, the Shareholders present shall choose someone of their number to be the chairman of such meeting. The office of Chairman of a
General Meeting shall not, by itself, entitle the holder to vote at any General Meeting nor shall it grant him a second or casting vote (without derogating, however, from the right of such Chairman to vote as a shareholder or proxy of a
shareholder if, in fact, he is also a shareholder or such proxy).
|
| 10.4.4 |
Power to Adjourn: The Chairman of a General Meeting at which a quorum is present may, with the consent of the holders of a majority of the voting power represented in person or by proxy and voting on the question of adjournment,
and shall if so directed by the meeting, adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting except business that might lawfully have been transacted at the meeting as
originally called.
|
| 10.4.5 |
Voting Power: Every matter submitted to the General Meeting shall be decided by a vote. Any vote in a General Meeting shall be conducted in accordance with the voting rights that each Shareholder is entitled to in accordance with
the number of shares granting voting rights that are held by such Shareholder.
|
| 10.4.6 |
Adoption of Resolutions at General Meetings: Subject to the provisions of the Companies Law and to Article 9 above, and unless otherwise expressly provided in these articles, a resolution proposed at any General Meeting shall be
deemed adopted if approved by a majority of the voting shares represented at such meeting in person or by proxy. A declaration by the Chairman of the General Meeting that a resolution has been carried unanimously, or carried by a particular
majority, or defeated, and an entry to that effect in the minute book of the Company shall be conclusive evidence of the fact without proof of the number or proportion of the votes recorded in favor of or against such resolution.
|
| 10.5 |
Resolutions in Writing.
|
A resolution in writing signed by the Shareholders holding at such time all the issued shares having the right to vote at General Meetings, or to which all such Shareholders had
agreed to in writing (by letter, telegram, email, telex, facsimile or otherwise), shall have the same force, for any purpose whatsoever, as if unanimously adopted by a General Meeting duly convened and held.
| 10.6 |
Voting Rights and Proxies
|
| 10.6.1 |
No Shareholder shall be entitled to vote in any General Meeting (or be counted as a part of the quorum) unless he fully paid any amounts due, whether with or without any demand for payment for his shares.
|
| 10.6.2 |
In the absence of contrary provisions in these Articles or in any condition or term annexed to any shares of any class, each Shareholder participating in a General Meeting shall have one vote for each share giving a right to vote in a
General Meeting that is held by such Shareholder.
|
| 10.6.3 |
If two or more persons are registered as joint holders of any share, the vote of the person first registered in the Register of Shareholders shall be accepted to the exclusion of the vote(s) of the other joint holder(s).
|
| 10.6.4 |
A company or other corporate body being a Shareholder of the Company may duly authorize any person to be its representative at any General Meeting or to authorize or deliver a proxy on its behalf. Any person so authorized shall be
entitled to exercise on behalf of such Shareholder all the power that the latter could have exercised if it were a natural person. Upon the request of the Chairman of the meeting, written evidence of such authorization (in form acceptable
to the Chairman of the meeting) shall be delivered to him.
|
|
10.6.5
|
Shareholders may vote either personally or by proxy, or, if the Shareholder is a company or other corporate body, by a representative pursuant
to 10.6.4 above or by a duly authorized proxy, as prescribed hereinafter.
|
7
| 10.6.6 |
Instrument of Appointment: An instrument appointing a proxy shall be in writing and shall be substantially in the following form:
|
“I_____________________ of ________________________
(Name of Shareholder) (Address of Shareholder)
being a Shareholder of Hold Me Ltd. hereby appoint
_______________________of_________________________
(Name of Proxy) (Address of Proxy)
as my proxy to vote for me and on my behalf at the General Meeting of the Company to be held on the ____ day of _____________, ______ and at any adjournment(s) thereof.
Signed this ______ day of _______, _______,
or in any usual or common form or in such other form as may be approved by the Board. Such proxy shall be duly signed by the appointor or such person’s duly authorized attorney
or, if such appointor is a company or other corporate body, under its common seal or stamp or the hand of its duly authorized agent(s) or attorney(s) in accordance with its constitutional documents.
| 10.6.7 |
The instrument appointing a proxy (and the power of attorney or other authority, if any, under which such instrument has been signed) shall either be delivered to the Company (at its principal place of business or at the offices of its
registrar or transfer agent, or at such place as the Board may specify) not less than 24 hours before the time fixed for the meeting at which the person named in the instrument proposes to vote, or presented to the Chairman at such General
Meeting. An instrument appointing a proxy that is not limited in time shall expire 12 months after the date of its execution. If the appointment shall be for a specified period, whether in excess of 12 months or not, the instrument shall be
valid for the period stated therein.
|
| 10.6.8 |
A vote cast in accordance with an instrument appointing a proxy shall be valid despite the prior death or bankruptcy of the appointing Shareholder (or of his attorney-in-fact, if any, who signed such instrument), or the transfer of the
share in respect of which the vote is cast, unless written notice of such matters shall have been received by the Company or by the Chairman of such General Meeting prior to such vote being cast.
|
|
10.6.9
|
A vote given in accordance with the terms of an instrument of appointment of proxy or representative shall be valid notwithstanding the
previous death of the principal, or revocation of the appointment, or transfer of the share in respect of which the vote is given, unless notice in writing of the death, revocation or transfer shall have been received at the Office or by
the chairman of the General Meeting before the vote is given.
|
| 11. |
The Board of Directors
|
| 11.1 |
Number of Directors
|
The Board shall be comprised of up to eleven (11) directors, including the outside directors (to the extent applicable).
| 11.2 |
Election and Removal of Directors
|
Directors shall be elected at the Annual General Meeting by the vote of the holders of a majority of the voting power represented at such meeting in person or by proxy and voting
on the election of directors, and each Director shall serve, subject to Article 11.8 hereof, and with respect to a Director appointed pursuant to Article 11.4 hereof subject to such Article, until the Annual General Meeting next following the
Annual General Meeting or General Meeting at which such Director was elected pursuant to this Article or Article 11.4 hereof and until his successor is elected, or until his earlier removal pursuant to this Article 11.2. The holders of a majority
of the voting power represented at a General Meeting in person or by proxy and voting thereon at such meeting shall be entitled to remove any Director(s) from office, to elect Directors instead of Directors so removed or to fill any vacancy,
however created (including any position to which a director was not elected), in the Board. In the case of an external director or any other director for whom the Companies Law prescribes a different method of election or removal from that
specified above, the provisions of the Companies Law shall govern.
8
| 11.3 |
Qualification of Directors
|
No person or entity shall be disqualified to serve as a director or an Alternate Director by reason of his not holding shares in the Company or by reason of his having served as
a director in the past.
| 11.4 |
Continuing Directors in the Event of Vacancies
|
In the event of one or more vacancies in the Board of Directors, the remaining Directors may continue to act in every matter and, pending the filling of any vacancy pursuant to
the provisions of Article 11.2, may appoint Directors to fill any such vacancy temporarily; provided, however, that if they number less than 3 Directors, they may act only in an emergency or to fill the office of Director that has become vacant up
to the minimum number or in order to call a General Meeting of the Company for the purpose of electing Directors to fill any or all vacancies, so that at least 3 Directors.
| 11.5 |
Remuneration of Directors
|
A Director shall be paid remuneration by the Company for his services as a Director, to the extent such remuneration shall have been approved by a General Meeting of the Company.
| 11.6 |
Conflict of Interests
|
Subject to the provisions of the Companies Law, no Director shall be disqualified by virtue of his office from holding any office or relationship of profit with the Company or
with any company in which the Company shall be a shareholder or have another interest, or from contracting with the Company as vendor, purchaser or otherwise, nor shall any such contract, or any contract or arrangement entered into by or on behalf
of the Company in which any Director shall in any way be interested, be avoided, nor, other than as required under the Companies Law, shall any Director be liable to account to the Company for any profit arising from any such office or relationship
of profit or realized from such contract or arrangement by reason only of such Director’s holding that office or of the fiduciary relations thereby established, but the nature of his interest, as well as any material fact or document, must be
disclosed by him at the meeting of the Board of Directors at which the contract or arrangement is first considered, if his interest then exists, or in any other case no later than the first meeting of the Board of Directors after the acquisition of
his interest.
| 11.7 |
Alternate Directors
|
| 11.7.1 |
A Director may, by written notice to the Company given in the manner set forth in Article 11.7.2 below, appoint any individual (whether or not such person is then a member of the Board of Directors) as an alternate for himself (in these
Articles referred to as an “Alternate Director”), remove such Alternate Director and appoint another Alternate Director in place of any Alternate Director appointed by him whose office has been
vacated for any reason. Unless the appointing Director, by the instrument appointing an Alternate Director or by written notice to the Company, limits such appointment to a specified period of time or restricts it to a specified meeting or
action of the Board of Directors, or otherwise restricts its scope, the appointment shall be for all purposes, and for a period of time, concurrent with the term of the appointing Director.
|
| 11.7.2 |
Any notice to the Company pursuant to Article 11.7.1 shall be given in person to, or by sending the same by mail to the attention of, the Chairman of the Board of the Company at the principal office of the Company or to such other person
or place as the Board shall have determined for such purpose, and shall become effective on the date fixed therein, or upon the receipt thereof by the Company at the place specified above, whichever is later.
|
| 11.7.3 |
An Alternate Director shall have all the rights and obligations of a director; provided, however, that (i) an Alternate Director shall have no standing at any meeting of the Board or any Committee of the Board while the director for whom
such Alternate Director was appointed is present; (ii) he may not in turn appoint an alternate for himself (unless the instrument appointing him otherwise expressly provides); and (iii) the Alternate Director is not entitled to
remuneration.
|
9
| 11.7.4 |
The office of an Alternate Director shall be vacated under the circumstances, mutatis mutandis, set forth in Article 11.8, and such office shall ipso facto be vacated if the director for whom the Alternate Director was appointed ceases
to be a director.
|
| 11.8 |
Termination of Office. Without derogating from any law, the office of a director shall automatically be vacated, ipso facto, prior the end of the term of his appointment upon the following:
|
| 11.8.1 |
Upon resignation, which shall become effective on the date a written notice of such resignation is delivered to the Company, or a later date specified in the notice;
|
| 11.8.2 |
If convicted of a felony, as provided in the Companies Law;
|
| 11.8.3 |
Pursuant to a court’s decision, as provided in the Companies Law;
|
| 11.8.4 |
Upon death or when declared bankrupt;
|
| 11.8.5 |
If he be found lunatic or becomes of unsound mind; or
|
| 11.8.6 |
As otherwise provided in the Companies Law.
|
| 11.9. |
No Corporate Director. A corporation will not be qualified to act as a director.
|
| 11.10 |
Chairman of the Board of Directors. The Board may from time to time elect one of its members to be Chairman of the Board, remove such Chairman from office, and appoint another in his place. The Chairman of the Board shall preside
at every meeting of the Board, but if there is no such Chairman, or if at any meeting the Chairman is not present within 15 minutes after the time fixed for holding the meeting or is unwilling to act as Chairman, the Directors present shall
choose someone of their number to be chairman of such meeting. The Chairman will not have any casting or additional vote by reason of his position as Chairman of the Board.
|
| 11.11 |
Powers of the Board and Delegation of Powers
|
| 11.11.1 |
The determination of the policy of the business of the Company and the supervision on the performance of the General Manager of the Company shall be vested in the Board, which may exercise all such powers and do all such acts and things
as the Company is authorized to exercise and do and which are not required by law or these Articles to be done by the Company by action of its Shareholders at a General Meeting. The authority conferred on the Board by this Article shall be
subject to the provisions of the Companies Law, these Articles and any resolution consistent with these Articles adopted from time to time by the Company at a General Meeting; provided, however, that no such resolution shall invalidate any
prior act done by or pursuant to a decision of the Board that would have been valid if such resolution had not been adopted.
|
| 11.11.2 |
Subject to the provisions of the Companies Law, the Board may from time to time, by power of attorney or otherwise, appoint any person, company, firm or body of persons to be the attorney or attorneys of the Company at law or in fact
for such purpose(s) and with such powers, authorities and discretions, and for such period and subject to such conditions, as it deems fit, and any such power of attorney or other appointment may contain such provisions for the protection
and convenience of persons dealing with any such attorney as the Board deems fit, and may also authorize any such attorney to delegate all or any of the powers, authorities and discretions vested in him.
|
| 11.12 |
Proceedings of the Board
|
| 11.12.1 |
Meetings
|
| 11.12.1.1 |
The Board may meet and adjourn its meetings and otherwise regulate such meetings and proceedings in accordance with the Company’s needs; provided, however, that the Board must meet at least once every 3 months.
|
10
| 11.12.1.2 |
i. The Chairman of the Board of Directors shall convene Board Meetings in accordance with the provisions of the Companies Law and may adjourn and otherwise regulate the proceedings of such meetings, as he thinks fit. Notice of any such meeting shall be given by mail, email, telex, telegram or facsimile or other form of electronic communication, a reasonable time before the meeting. The quorum for Board Meetings and/or for any matter to be brought before the Board shall be a majority of the Directors then in office and entitled to participate and vote with respect thereto. ii. Unless and to the extent provided otherwise in the Companies Law, a Director who is an interested party in any transaction shall be counted for purposes of a quorum despite his interest
iii. A Director may participate personally or by his alternate.
|
| 11.12.2 |
Failure to Deliver Notices: Despite anything to the contrary in these Articles, failure to deliver notice to a Director of any such meeting may be waived by such Director, and a meeting shall be deemed to have been duly convened
despite such defective notice if such failure or defect is waived prior to action being taken at such meeting by all Directors entitled to participate and vote in such meeting to whom notice was not duly given.
|
| 11.12.3 |
Board Meetings in Person or by Means of Telecommunication: A meeting of the Board may be conducted in person or by using any communication device, provided that all directors participating in such meeting can simultaneously hear
each other.
|
| 11.12.4 |
Quorum: No business shall be transacted at a meeting of the Board unless the requisite legal quorum is present (by means provided under Articles 11.12.3) when the meeting proceeds to business. Until otherwise decided by the Board,
a legal quorum at a meeting of the Board shall be constituted by the presence (by means provided under Article 11.12.3) of a majority of the number of directors then in office.
|
|
11.12.5.1
|
Exercise of Powers of the Board: A resolution proposed at any meeting of the Board shall be deemed adopted if approved by a majority of
the Directors present when such resolution is put to a vote and voting thereon.
|
|
11.12.6.1
|
The Agenda: The agenda for a meeting of the Board shall be determined by the Chairman of the Board, and shall include matters determined
by the Chairman of the Board, matters for which a meeting of the Board was convened pursuant to Article 11.12.1.2, and any matter requested by a director or the General Manager at least 3 days before the meeting.
|
| 11.13 |
Resolutions in Writing. A resolution in writing signed all the directors then in office and lawfully entitled to vote thereon, or to which all the directors have given their written consent (by letter, email, telegram, telex,
facsimile or otherwise) shall be deemed to have been unanimously adopted by a meeting of the Board duly convened and held.
|
| 11.14 |
Audit Committee
|
| 11.14.1 |
The Board shall appoint an Audit Committee that shall be composed of at least three members of the Board. All outside directors of the Company shall be members of the Audit Committee and the majority of the Audit Committee members will
be independent directors (as such term is defined in the Companies Law or any other laws or regulations, where applicable). The Chairman of the Board, any director that is employed by the Company or who provides the Company with services on
a regular basis, and any controlling shareholder (or a relative of a controlling shareholder) may not be members of the Audit Committee.
|
| 11.14.2 |
The Audit Committee shall have the duties set forth in Section 117 of the Companies Law.
|
| 11.14.3 |
Approval by the majority of the members of the Audit Committee shall be deemed approval of the Audit Committee.
|
| 11.15 |
Committees of the Board
|
|
11.15.1.
|
Subject to the provisions of the Companies Law, the Board may delegate any or all of its powers to committees, each consisting of two or more
persons who are directors, and it may from time to time revoke such delegation or alter the composition of any such committee. Any committee so formed (in these Articles referred to as a “Committee of the
Board”) shall, in the exercise of the powers so delegated, conform to any regulations imposed on it by the Board. The meetings and proceedings of any such Committee of the Board shall, mutatis mutandis, be governed by the
provisions of these Articles that regulate the meetings of the Board. Unless otherwise expressly provided by the Board in delegating powers to a Committee of the Board, such Committee shall not be empowered to further delegate such
powers.
|
| 11.15.2 |
The Board may revoke any resolution of any Committee of the Board; provided, however, that any such revocation shall not detract from the validity of any transaction entered into with a person that did not know of such revocation.
|
11
| 11.16 |
Validity of Acts Despite Defects
|
Subject to the provisions of the Companies Law, all acts done bona fide at any meeting of the Board, or of a Committee of the Board, or by any person(s) acting as Director(s),
shall, even if it is subsequently discovered that there was some defect in the appointment of the participants in such meeting or any of them or any person(s) acting as aforesaid, or that they or any of them were disqualified, be as valid as if
there were no such defect or disqualification.
| 12. |
General Manager
|
| 12.1 |
The Board shall from time to time appoint one or more persons, whether or not Directors, as General Manager or General Managers, and may confer upon such person(s), and from time to time modify, or revoke such title(s) and such
duties and authorities as the Board may deem fit, subject to such limitations and restrictions as the Board may from time to time prescribe. Such appointment(s) may be either for a fixed term or without any limitation of time, and the Board
may from time to time (subject to the provisions of the Companies Law and of any contract between any such person and the Company) fix his, her or their salaries and emoluments, remove or dismiss such persons from office and appoint another
or others in their place.
|
| 12.2 |
Unless otherwise determined by the Board, the General Manager shall have the authority with respect to the day to day management of the Company in the ordinary course of business, in the framework of, and subject to, the policy,
guidelines and instructions of the Board from time to time.
|
| 12.3 |
The General Manager shall have all the management and implementation authorities that are not expressly delegated in the Articles or by the Companies Law, to another organ of the Company, and will be subject to the supervision of the
Board.
|
| 12.4 |
The General Manager may, with the consent of the Board, delegate certain of his duties to another person who is subject to his supervision.
|
| 12.5 |
The General Manager shall notify the Chairman of the Board of any unusual event that is material to the Company; if the office of Chairman of the Board is vacant, or the Chairman of the Board refuses or is unable to act, such
notification shall be made to all the Directors then in office.
|
| 12.6 |
The General Manager shall periodically furnish the Board with reports in matters, times and format determined by the Board from time to time. When a notification or report of the General Manager require the performance of an action by
the Board, then a Board meeting shall be convened without delay.
|
| 12.7 |
The remuneration payable to the General Manager for his services shall be fixed from time to time (subject to any contract between the General Manager and the Company) by the Board, and may be fixed as a regular salary, commission on
dividends, profits or revenues of the Company or of any other company in which the Company has an interest, or by participation in the Company’s profits, combined or separately.
|
| 13. |
Register of Shareholders
|
| 13.1 |
The Company shall keep a Register in which it may record such information as may be deemed appropriate by the Board of Directors and/or as may be permitted by the Companies Law or these Articles. In addition, the Company shall record in
the Register the following information:
|
| i. |
The names and addresses of the Shareholders, the number of shares held by each Shareholder and the amount paid or the amount to be considered as paid on the shares of each Shareholder;
|
| ii. |
The day each person was registered in the Register as a Shareholder;
|
| iii. |
The amounts called, if any, that are due on the shares of each Shareholder; and
|
| iiii. |
Any other information required by the Companies Law or these Articles to be recorded in the Register.
|
| 13.2 |
The principal register shall be kept at the Office and, apart from the times the Register is closed in accordance with the provisions of the Companies Law or these Articles, shall be open to the inspection of any Shareholder free of
charge, and of any other person at such fee as the Company shall determine for each matter, during regular business hours.
|
12
| 13.3 |
The Register may be closed for such period, if any, as the Board of Directors shall determine from time to time, on the condition that the Register shall not be closed for a period exceeding 30 days during any calendar year.
|
| 14. |
Auditors
|
| 14.1 |
The Company shall appoint one or more certified public accountants to audit, and provide a report on, the annual financial statements of the Company (the “Auditors”).
|
| 14.2 |
The appointment, authorities, duties, responsibilities, rights, remuneration and powers of the Auditors shall be fixed by applicable law and under these Articles. The General Meeting shall have the power to appoint the Auditors for the
maximum time period provided under the Companies Law.
|
| 14.3 |
The Board shall cause accurate books of account to be kept in accordance with the provisions of any applicable law. Such books of account shall be kept at the principal office of the Company, or at such other place or places as the Board
may deem fit, and they shall always be open to inspection by all Directors.
|
| 15. |
Share Certificates
|
| 15.1 |
Share certificates shall be issued under the corporate seal of the Company (or facsimile thereof) and shall bear the signature (or facsimile thereof) of two Directors, or the signatures of a Director and the secretary of the Company,
specifically authorized by the Board for this purpose.
|
| 15.2 |
Each Shareholder shall be entitled to one numbered certificate for all the shares of any class registered in his name, and if the Board so approves, to several certificates, each for one or more of such shares. Each certificate shall
specify the serial numbers of the shares represented thereby and may also specify the amount paid up thereon.
|
| 15.3 |
A share certificate registered in the names of two or more persons shall be delivered to the person first named in the Register of Shareholders in respect of such co-ownership.
|
| 15.4 |
A share certificate that has been defaced, lost or destroyed may be replaced, and the Company shall issue a new certificate to replace such defaced, lost or destroyed certificate upon payment of such fee, and upon the furnishing of such
evidence of ownership and such indemnity, as the Board in its discretion deems fit.
|
| 16. |
Registered Holder
|
Except as otherwise provided in these Articles, the Company shall be entitled to treat the registered holder of each share as the absolute owner thereof, and accordingly shall
not, except as ordered by a court of competent jurisdiction or as required by statute, be obligated to recognize any equitable or other claim to, or interest in, such share on the part of any other person.
| 17. |
Calls on Shares
|
| 17.1 |
The Board may, from time to time, as it in its discretion deems fit, make calls for payment upon Shareholders in respect of any sum that has not been paid up in respect of shares held by such Shareholder and which is not, pursuant to the
terms of allotment or issuance of such shares or otherwise, payable at a fixed time. Each Shareholder shall pay the amount of every call so made upon him (and of each installment thereof if the same is payable in installments), to the
person(s) and at the time(s) designated by the Board, as any such time(s) may subsequently be extended or such person(s) or place(s) changed. Unless otherwise stipulated in the resolution of the Board (and in the notice referred to below),
each payment in response to a call shall be deemed to constitute a pro rata payment on account of all the shares of the Shareholder making payment in respect of which such call was made.
|
| 17.2 |
Notice of any call for payment by a Shareholder shall be given in writing to such Shareholder not less than 14 days prior to the time of payment fixed in such notice, and shall specify the time and place of payment, and the person to
whom such payment is to be made. Prior to the time for any such payment fixed in a notice of a call given to a member, the Board may in its absolute discretion, by notice in writing to such Shareholder, revoke such call in whole or in part,
extend the time fixed for payment of such call or designate a different place of payment or person to whom payment is to be made. In the event of a call payable in installments, only one notice thereof need be given.
|
13
| 17.3 |
If pursuant to the terms of allotment or issuance of a share, or otherwise, an amount is made payable at a fixed time (whether on account of such share or by way of premium), such amount shall be payable at such time as if it were
payable by virtue of a call made by the Board of Directors and for which notice was given in accordance with this Article, and the provisions of these Articles with regard to calls (and the non-payment thereof) shall be applicable to such
amount (and the non-payment thereof).
|
| 17.4 |
Joint holders of a share shall be jointly and severally liable to pay all calls for payment in respect of such share and all interest payable thereon.
|
| 17.5 |
Any amount called for payment that is not paid when due shall bear interest from the date fixed for payment until actual payment, at such rate (not exceeding the legal rate under any applicable law) and payable at such time(s) as the
Board may prescribe. The Board may waive any payment of such interest under this Article.
|
| 17.6 |
With the consent of the Board, any Shareholder may pay to the Company any amount not yet payable in respect of his shares, and the Board may approve the payment by the Company of interest on any such amount until the same would be
payable if it had not been paid in advance, at such rate and time(s) as may be approved by the Board. The Board may at any time cause the Company to repay all or any part of the money so advanced, without premium or penalty. Nothing in this
Article shall derogate from the right of the Board to make any call for payment before or after receipt by the Company of any such advance.
|
| 18. |
Forfeiture and Surrender
|
| 18.1 |
If any Shareholder fails to pay an amount payable by virtue of a call, or interest thereon as provided for in accordance with these Articles, on or before the day fixed for payment of the same, the Board may at any time after the day
fixed for such payment, so long as such amount or any portion thereof remains unpaid, forfeit all or any of the shares in respect of which such payment was called for. All expenses incurred by the Company in attempting to collect any such
amount or interest thereon, including without limitation attorney’s fees and costs of legal proceedings, shall be added to, and shall for all purposes (including the accrual of interest thereon) constitute a part of, the amount payable to
the Company in respect of such call.
|
| 18.2 |
Upon the adoption of a resolution as to the forfeiture of a Shareholder’s shares, the Board shall cause notice thereof to be given to such Shareholder, which notice shall state that, in the event of the failure to pay the entire amount
so payable by a date specified in the notice (which date shall be not less than 14 days after the date such notice is given and which may be extended by the Board), such shares shall ipso facto be forfeited; provided, however that prior to
such date the Board may nullify such resolution of forfeiture, but no such nullification shall estop the Board from adopting a further resolution of forfeiture in respect of the non-payment of the same amount.
|
| 18.3 |
Without derogating from any of the provisions of this Article 18, whenever shares are forfeited as herein provided, all dividends, if any, theretofore declared in respect thereof and not actually paid, shall be deemed to have been
forfeited at the same time.
|
| 18.4 |
Any share forfeited or surrendered as provided herein shall become the property of the Company, and the same, subject to the provisions of these Articles, may be sold, re-allotted or otherwise disposed of as the Board deems fit. From the
date of forfeiture until the date such forfeited shares are sold, re-allotted or otherwise disposed of, such forfeited shares shall be deemed “Dormant Shares” as defined in Section 308 of the Companies Law.
|
| 18.5 |
Any Shareholder whose shares have been forfeited or surrendered shall cease to be a Shareholder in respect of the forfeited or surrendered shares, but shall nonetheless be liable to pay, and shall promptly pay, to the Company all calls,
interest and expenses owing upon or in respect of such shares at the time of forfeiture or surrender, together with interest thereon from the time of forfeiture or surrender until actual payment at the rate prescribed in this Article 18,
and the Board, in its discretion, may enforce the payment of such moneys or any part thereof. In the event of such forfeiture or surrender, the Company, by resolution of the Board, may accelerate the date(s) of payment of any or all amounts
then owing to the Company by the Shareholder in question (but not yet due) in respect of all shares owned by such Shareholder, solely or jointly with another.
|
| 18.6 |
The Board may at any time, before any share so forfeited or surrendered shall have been sold, re-allotted or otherwise disposed of, nullify the forfeiture or surrender on such conditions as it deems fit, but no such nullification shall
estop the Board from re-exercising its powers of forfeiture pursuant to this Article 18.
|
14
| 18.7 |
If pursuant to the terms of allotment or issuance of a share, or otherwise, an amount is made payable at a fixed time (whether on account of such share or by way of premium), such amount shall be payable at such time as if it were
payable by virtue of a call made by the Board and for which notice was given in accordance with this Article, and the provisions of these Article shall be applicable to such amount as if a call was given at the date fixed for payment.
|
| 18.8 |
Except to the extent that the same may be waived or subordinated in writing, the Company shall have a first and paramount lien upon all the shares registered in the name of each Shareholder (without regard to any equitable or other claim
or interest in such shares on the part of any other person), and upon the proceeds of the sale thereof, for his debts, liabilities and obligations to the Company arising from any amount payable by such Shareholder in respect of any unpaid
or partly paid share, whether or not such debt, liability or obligation has matured. Such lien shall extend to all dividends from time to time declared or paid in respect of such share. Unless otherwise provided, the registration by the
Company of a transfer of shares shall be deemed to be a waiver on the part of the Company of any lien existing on such shares immediately prior to such transfer.
|
| 18.9 |
The Board may cause the Company to sell a share subject to such a lien when the debt, liability or obligation giving rise to such lien has matured, in such manner as the Board deems fit, but no such sale shall be made unless such debt,
liability or obligation has not been satisfied within 14 days after written notice of the intention to sell shall have been served on such Shareholder, his executors or administrators.
|
| 18.10 |
The net proceeds of any such sale, after payment of the costs thereof, shall be applied in or toward satisfaction of the debts, liabilities or obligations of such Shareholder in respect of such share (whether or not the same have
matured), and any residue shall be paid to the Shareholder, his executors, administrators or assigns.
|
| 18.11 |
Upon any sale of a share after forfeiture or surrender or for enforcing a lien, the Board may appoint person to execute an instrument of transfer of the share so sold and cause the purchaser’s name to be entered in the Register of
Shareholders in respect of such share. The purchaser shall be registered as the shareholder and shall not be bound to see to the regularity of the sale proceedings or to the application of the proceeds of such sale, and after his name has
been entered in the Register of Shareholders in respect of such share, the validity of the sale shall not be impeached by any person, and the remedy of any person aggrieved by the sale shall be in damages only and against the Company
exclusively.
|
| 19. |
Insurance, Indemnification and Exculpation
|
The Company may insure, indemnify and exculpate its Office Holders (as such term is defined in the Companies Law) to the fullest extent permitted by law, from time to time.
Without limiting the generality of the foregoing:
| 19.1 |
Subject to the provisions of the Companies Law, the Company may enter into a contract for the insurance of its Office Holders, for actions or omissions done in their capacity as Office Holders, in whole or in part, against any of the
following:
|
| 19.1.1 |
breach of the duty of care owed to the Company or a third party;
|
| 19.1.2 |
breach of the fiduciary duty owed to the Company, provided that the Office Holder acted in good faith and had reasonable grounds to believe that his action would not harm the Company’s interests;
|
| 19.1.3 |
monetary liability imposed on the Office Holder in favor of a third party; and
|
| 19.1.4 |
reasonable litigation expenses, including attorney fees, incurred by the Office Holder as a result of an administrative enforcement proceeding instituted against him. Without derogating from the generality of the foregoing, such expenses
will include a payment imposed on the Office Holder in favor of an injured party as set forth in Section 52(54)(a)(1)(a) of the Israel Securities Law, 5728-1968, as amended (the “Securities Law”), and expenses that the Office Holder
incurred in connection with a proceeding under Chapters H’3, H’4 or I’1 of the Securities Law, including reasonable legal expenses, which term includes attorney fees, or in connection with Article D of Chapter Four of Part Nine of the
Companies Law.
|
15
| 19.1.5 |
Expenses incurred by the Office Holder in connection with a proceeding under Chapter G'1, of the Israel Restrictive Trade Practices Law, 5748-1988 ("Restrictive Trade Law"), including reasonable
litigation expenses, including attorney's fees.
|
| 19.2 |
Subject to the provisions of the Companies Law, the Company is entitled retroactively to indemnify any Office Holder, or provide a prior undertaking to indemnify an Office Holder to the fullest extent permitted by law, where such prior
undertaking is limited to categories of events that the Board believes are foreseeable in light of the Company’s activities on the date of grant of the undertaking to indemnify, and to an amount or in accordance with guidelines determined
by the Board to be reasonable in the circumstances (and such undertaking includes the categories of events that the Board believes are foreseeable in light of the Company’s activities on the date of grant of the undertaking to indemnify and
to an amount or in accordance with guidelines determined by the Board to be reasonable in the circumstances), for any of the following events:
|
| 19.2.1 |
monetary liability imposed on an Office Holder in favor of a third party in a judgment, including a settlement or an arbitral award confirmed by a court, for an act that such Office Holder performed by virtue of his being an Office
Holder of the Company;
|
| 19.2.2 |
reasonable legal costs, including attorney’s fees, expended by an Office Holder as a result of i) an investigation or proceeding instituted against the Office Holder by a competent authority, provided that such investigation or
proceeding concludes without the filing of an indictment against the Office Holder and either (A) no financial liability was imposed on the Office Holder in lieu of criminal proceedings, or (B) financial liability was imposed on the Office
Holder in lieu of criminal proceedings but the alleged criminal offense does not require proof of criminal intent and ii) in connection with an administrative enforcement proceeding or a financial sanction. Without derogating from the
generality of the foregoing, such expenses will include a payment imposed on the Office Holder in favor of an injured party as set forth in Section 52(54)(a)(1)(a) of the Securities Law, and expenses that the Office Holder incurred in
connection with a proceeding under Chapters H’3, H’4 or I’1 of the Securities Law, including reasonable legal expenses, which term includes attorney fees, or in connection with Article D of Chapter Four of Part Nine of the Companies Law;
|
| 19.2.3 |
reasonable costs of litigation, including attorney’s fees, expended by an Office Holder or for which an Office Holder has been charged by a court, in an action brought against the Office Holder by or on behalf of the Company or a third
party, or in a criminal action in which an Office Holder was found innocent, or in a criminal offense in which an Office Holder was convicted and in which a proof of criminal intent is not required; and
|
| 19.2.4 |
Expenses incurred by the Office Holder in connection with a proceeding under Chapter G'1, of the Restrictive Trade Law, including reasonable litigation expenses, including attorney's fees.
|
| 19.2.4 |
for any other liability, obligation or expense indemnifiable or which may from time to time be indemnifiable by law.
|
| 19.3 |
Subject to the provisions of the Companies Law, the Company may exculpate an Office Holder in advance from liability, or any part of liability, for damages sustained by a breach of duty of care to the Company.
|
| 19.4 |
The provisions of Article 19 are not intended, and shall not be interpreted, to restrict the Company in any manner in respect of the procurement of insurance or in respect of indemnification (i) in connection with any person who is not
an Office Holder, including, without limitation, any employee, agent, consultant or contractor of the Company who is not an Office Holder, or (ii) in connection with any Office Holder to the extent that such insurance and/or indemnification
is not specifically prohibited under law; provided that the procurement of any such insurance or the provision of any such indemnification shall be approved by the Board and, to the extent required pursuant to the Companies Law, the
Shareholders.
|
| 19.5 |
Any amendment to the Companies Law, the Securities Law or any other applicable law, statute or rule adversely affecting the right of any Office Holder to be indemnified or insured pursuant to Article 19 shall be prospective in effect,
and shall not affect the Company’s obligation or ability to indemnify or insure an Office Holder for any act or omission occurring prior to such amendment, unless otherwise provided by the Companies Law, the Securities Law or such other
applicable law, statute or rule.
|
16
| 19.6 |
The Company may, as aforesaid, indemnify, insure and exempt from liability any Office Holder to the fullest extent permitted by applicable law. Accordingly: (i) any amendment to the Companies Law, the Securities Law, the Restrictive
Trade Law or any other applicable law expanding the ability of the Company to indemnify, insure or exempt from liability any Office Holder, or expanding the right of any Office Holder to be indemnified, insured or exempted from liability,
beyond or in addition to the provisions of these Articles, shall, to the fullest extent possible, automatically and immediately apply to the Office Holders of the Company and be deemed as included in these Articles to the fullest extent
permitted by applicable law; and (ii) any amendment to the Companies Law, the Securities Law, the Restrictive Trade Law or any other applicable law adversely affecting the ability of the Company to indemnify, insure or exempt from liability
any Office Holder or adversely affecting the right of any Office Holder to be indemnified, insured or exempted from liability as provided for in these Articles shall have no effect post factum and shall not affect the Company's obligations
or ability to indemnify, insure or exempt from liability an Office Holder for any act (or omission) carried out prior to such amendment, unless otherwise provided by applicable law.
|
| 20. |
Dividends
|
| 20.1 |
No dividend shall be paid otherwise than in accordance with the Companies Law.
|
| 20.2 |
Subject to the rights of Shareholders as to dividends, any dividend paid by the Company shall be allocated among the Shareholders entitled thereto, in proportion to the sums paid up or credited as paid up on account of the nominal value
of their respective holdings of the shares in respect of which such dividend is being paid without taking into account the premium paid up for the shares. The amount paid up on account of a share that has not yet been called for payment or
fallen due for payment and upon which the Company pays interest to the shareholder shall not be deemed, for the purposes of this Article, to be a sum paid on account of the share.
|
| 20.3 |
Subject to the provisions of Section 303 of the Companies Law, no dividend shall be paid otherwise than out of the Profits of the Company, as defined in Section 302(b) of the Companies Law.
|
| 20.4 |
No dividend shall carry interest as against the Company.
|
| 20.5 |
Subject to the provisions of these Articles and the Companies Law, the Company may cause any moneys, investments or other assets forming part of the undivided distributable profits of the Company to be capitalized and distributed among
such of the Shareholders as would be entitled to receive the same if distributed by way of dividend and in the same proportion.
|
| 20.6 |
For the purpose of giving full effect to any resolution under this Article 19, the Board may settle any difficulty that may arise in regard to the distribution as it deems expedient, and in particular may issue fractional certificates,
and may fix the value for distribution of any specific assets, and may determine that cash payments shall be made to any Shareholders upon the basis of the value so fixed, or that fractions of less value than the nominal value of one share
may be disregarded in order to adjust the rights of all parties, and may vest any such cash, shares, debentures, debenture stock or specific assets in trustees upon such trusts for the persons entitled to the dividend or capitalized fund as
may seem expedient to the Board.
|
| 20.7 |
Without derogating from this Article 20, the Board may give an instruction that shall prevent the distribution of a dividend to the holders of shares on which the full nominal amount has not been paid up.
|
| 20.8 |
The Board may retain any dividend or other moneys payable or property distributable in respect of shares on which the Company has a lien, and may apply the same in or toward satisfaction of the debts, liabilities or obligations in
respect of which the lien exists.
|
| 20.9 |
The Board may retain any dividend or other moneys payable or property distributable in respect of a share in respect of which any person is, under Article 7.2 or Article 7.3, entitled to become a Shareholder, or which any person is,
under such Articles, entitled to transfer, until such person shall become a Shareholder in respect of such share or shall transfer the same.
|
| 21. |
Minutes
|
| 21.1 |
Minutes of each General Meeting, of each meeting of the Board and of each meeting of a Committee of the Board shall be recorded and duly entered in books provided for that purpose, and shall be maintained by the Company at its principal
office or such other place as shall be determined by the Board. Such minutes shall, in all events, set forth the name of the persons at the meeting and all resolutions adopted at the meeting.
|
17
| 20.2 |
Any such minutes, if purporting to be signed by the chairman of the meeting or by the chairman of the next succeeding meeting, shall constitute prima facie evidence of the matters recorded therein.
|
| 22. |
Charitable Contributions
|
To the extent permitted by the Companies Law, the Company may elect to contribute reasonable amounts to worthy causes.
| 23. |
Notices
|
| 23.1 |
Any written notice or other document may be served by the Company upon any Shareholder either personally or by sending it by prepaid mail (airmail if sent internationally) addressed to such Shareholder’s address as it appears in the
Register of Shareholders or such other address as he may have designated in writing for the receipt of notices and other documents, provided however that the Board may resolve that any such address must be located within the State of
Israel.
|
| 23.2 |
Notwithstanding anything to the contrary contained herein, notice by the Company of a General Meeting as set forth under Article 10.2.2 hereof and containing the information required to be set forth in such notice under such Article
shall be deemed to be a notice of such meeting duly given, for purposes of these Articles, to any Shareholder.
|
| 23.3 |
Any written notice or other document may be served by any Shareholder upon the Company by tendering the same in person to the Secretary or the General Manager of the Company at the principal office of the Company or by sending it by
prepaid registered mail (airmail if posted internationally) to the Company at its principal office. Any such notice or other document shall be deemed to have been served when actually tendered if hand delivered, or 48 hours (7 business days
if sent internationally) after it has been posted (or when actually received by the addressee if sooner). Notice sent by telegram, telex, facsimile or e-mail shall be deemed to have been served when actually received by the addressee. A
notice that is defectively addressed or that otherwise fails to comply with the provisions of this Article 23.3 shall nevertheless be deemed to have been served if and when actually received by the addressee.
|
| 23.4 |
All notices to be given to the Shareholders shall, with respect to any share to which such persons are jointly entitled, be given to whichever of such persons is named first in the Register of Shareholders, and any notice so given shall
be sufficient notice to all the holders of such share.
|
| 23.5 |
Any Shareholder whose address is not listed in the Register of Shareholders, and who shall not have designated in writing an address for the delivery of notices, shall not be entitled to receive any notice from the Company.
|
| 23.6 |
Notwithstanding any other contrary provision of these Articles, the Board may fix a date, not exceeding forty (40) days prior to the date of any General Meeting, as the date as of which shareholders entitled to notice of and to vote at
such meetings shall be determined, and all persons who were holders of record of voting shares on such date shall be entitled to notice of and to vote at such meeting.
|
18
Exhibit 4.1
 |
 |
|
|
INCORPORATED UNDER THE LAWS OF THE STATE OF ISRAEL
HOLD ME LTD.
Reg. No. 51-393321-8
|
||
|
AUTHORIZED CAPITAL OF NIS 10,000,000 DIVIDED INTO
990,000,000 ORDINARY SHARES WITH NIS 0.01 PAR VALUE EACH,
10,000,000 PREFERRED SHARES WITH NIS 0.01 PAR VALUE EACH
|
|
This is to Certify that
|
is the owner of | ||
|
|
FULLY PAID AND NON-ASSESSABLE ORDINARY SHARES OF
|
HOLD ME LTD.
Reg. No. 51-3933218-8
|
||
|
Issued on the date below under the Company’s stamp and in accordance with the Articles of Association of the Company
|
||
|
Witness the signature of the Company’s dully authorized officer
|
|
|
||||
|
Menachem Shalom, Director
|
Date |
Exhibit 10.1
Agreement for Operation and Sale of Digital Wallets
Made and signed on 5.12.2019 in Tel Aviv
Between:
| 1. |
Hold Me Ltd. private company number: 513933218
Of 30 Golomb Street Nes Ziona
(Hereinafter referred to has: “Hold Me”), first party,
|
And:
| 2. |
Galileo Tech Ltd., public company number: 520043001
Of 9 Masada Street, Bnei Brak
(Hereinafter referred to as: “Galileo”), second party
|
| Whereas; |
Hold Me developed, among other things, the technology for all its various parts (as defined below), and has agreements and business activities that allow it to offer credit card transaction services to businesses (concentrator) in
Israel;
|
| And whereas; |
the parties wish to collaborate and allow Galileo to act to commercialize the technology exclusively in Israel, and unexclusively abroad;
|
| And whereas; |
Galileo maintains the connections and abilities to operate and implement the technology commercially in Israel, and for this purpose it wishes to receive, for itself and/or a subsidiary to be established by it (hereinafter jointly and
separately referred to as: “Galileo”), rights which will allow it to use, develop, market, and distribute applications, services and products that will be developed based on the technology in Israel,
according to the below detailed conditions;
|
| And whereas; |
the parties wish to settle their rights and obligations in this agreement;
|
Therefore, the following was agreed upon and stipulated between them:
| 1. |
The preface to the agreement and its appendixes, the language of the agreement and paragraph titles
|
| 1.1 |
The preface to this agreement and all of its appendixes constitute an inseparable part thereof.
|
| 1.2 |
The aforementioned in masculine form and feminine form are interchangeable. The aforementioned in singular form and plural form are interchangeable, all in accordance with the context ;
|
| 1.3 |
The titles of the paragraphs are for convenience only, and shall not be construed as interpreting this agreement;
|
Page 1 of 23
| 2. |
Definitions
|
|
The technology
|
Each of the below detailed and all of them jointly, as relevant, in their state on the day of the signing of this agreement and including routine updates made from time to time, as
relevant:
a. Payment application systems and digital wallets
b. A system for connecting payment applications and digital wallets (clearing house)
c. Developed applications
In addition, Galileo will be entitled to use the available developments that are the subject of Appendix A of the agreement, insofar as they will be developed.
It is hereby clarified that any other technology developed and/or to be developed by the company which is not a derivative or completion of the technology relevant to this agreement is not,
and shall not be subject to this agreement.
|
|
|
Systems for payment applications and digital wallets
|
Systems that enable development of payment applications and/or digital walls for banks, brands, retailers, and other entities.
http://www.webank.co.il/apidoc/index.html
https://sw-docs.serverlessbanking.com/
|
|
|
System for connecting payment applications and digital wallets (clearing house)
|
Communications protocol and system that enables connection/clearance/money transfers between various digital wallets (whether developed or to be developed by Hold Me or by a third party),
as well as connection of various digital wallets to business registers.
https://peypos-docs.serverlessbanking.com/
|
|
|
Applications
|
Pey application, Peystation application, and Kiss application developed by Hold Me.
|
| 3. |
Declarations and obligations of the parties
|
| 3.1 |
Galileo declares and undertakes as follows:
|
| 3.1.1 |
That it has the financial and legal capacity to sign this agreement and enter into the aforementioned contract and fulfill its obligations as detailed in this agreement.
|
| 3.1.2 |
That it chose to enter into this contract based on its review of the relevant market and its ability to act for the commercialization of the technology in Israel.
|
| 3.1.3 |
That it hereby undertakes to carry out any activity required for the execution of this agreement, the completion of the transaction and its execution, and to refrain from committing any deed and/or action that may hinder this transaction
and/or its completion. This includes its undertaking to sign any document, approval, agreement, notice, protocol etc. required for the completion of the transaction, and it undertakes to act in the framework of its authorized bodies and/or
of the company that will be established for the approval of the transaction, complete it and/or execute it in any way, decision, assembly, meeting, approval, etc. required for this purpose.
|
Page 2 of 23
| 3.2 |
Hold Me declares and undertakes as follows:
|
| 3.2.1 |
That it is the lawful owner of the technology and all intellectual property rights derived from the technology.
|
| 3.2.2 |
That all of the aforementioned technology was developed by it and/or for it only, and no third party has rights to it.
|
| 3.2.3 |
That the technology was tested and found to be operative. Notwithstanding the generality of the aforementioned, Hold Me undertakes to handle every bug and/or inadequacy between the systems for 3 months at its expense. This does not
create any obligation and/or undertaking on behalf of Hold Me to provide development services for features, characterizations and/or new abilities, and insofar as they will be required, Hold Me will forward a price quote for their
development to Galileo.
|
| 3.2.4 |
That Hold Me received a permit to provide financial services in Israel. It is hereby clarified that Hold Me has not received a final license to provide services as mentioned above, and does not know if and when it will receive this
license. Hold Me has stated that it is required to issue documents, approvals, etc., at the request of the Israel Money Laundering and Terror Financing Prohibition Authority, the receipt of part of which requires investment of time and/or
sums and/or work and/or employment of various experts for this purpose. To the best of Hold Me’s knowledge, as of the date of the signing of this agreement, there is no prevention to act according to the occupation permit it has received.
|
| 3.2.5 |
That Hold Me entered into contract with a supplier of connectors to sales registers across the country, as detailed in Appendix B of this agreement, to enable purchase from an application directly to the register. Hold Me’s contracts
with this supplier provides coverage of most of the leading register companies in Israel.
|
| 3.2.6 |
That it has the authority and power to sign this agreement and fulfill all its obligations accordingly, and there is no prevention according to any law and/or agreement to fulfill its obligations accordingly.
|
| 3.2.7 |
That here is no legal and/or other prevention from entering into this contract and completing the transaction according to the details of this agreement.
|
| 3.2.8 |
That Hold Me hereby undertakes to carry out any activity required for the execution of this agreement, complete and execute the transaction, and refrain from committing any deed and/or action that may hinder this transaction and/or its
completion. This includes Hold Me’s undertaking to sign any document, approval, agreement, notice, protocol, etc., required for the completion of the transaction.
|
Page 3 of 23
| 4. |
Nature of the transaction
|
| 4.1 |
Subject to the fulfillment of all pending warranties and the the parties’ obligations according to this agreement, Hold Me grants Galileo, and the subsidiary under the full ownership of, and which will be registered as Galileo, a license
to use the technology as developed up to the date of this agreement in its current as-is condition, as detailed below, for each of its components, for the purpose of developing services or products based on the technology, against the
below detailed payment. The aforementioned license shall allow Galileo to exclusively offer various services to companies and entities operating in Israel, and unexclusively to entities operating outside of Israel. Galileo’s activity with
entities outside of Israel will be coordinated with the company, to prevent double communication, as detailed in appendix C and/or procedures of these entities.
|
| 4.2 |
Galileo shall be entitled to use the technology to offer services and products to third parties. Galileo will bear all expenses, costs, licenses, adjustments etc. required for the execution of the transaction, as well as all development,
adjustment, maintenance, and other expenses related to it including human resources, communication, etc.
|
| 4.3 |
Galileo shall not be entitled to use the technology in any way whatsoever, whether by itself or through third parties with which it will enter into contract, in a manner that:
|
| 4.3.1 |
Violates the rights of third parties.
|
| 4.3.2 |
Facilitates trading in and/or businesses engaging in weapons, drugs, pornography, gambling and alcohol, except for cases agreed upon by the parties in advance and in writing.
|
| 4.3.3 |
Violates the privacy of any entity whatsoever.
|
| 4.3.4 |
Any manner that violates any law.
|
| 4.4 |
Notwithstanding the generality of the aforementioned in the previous paragraph, 4.3, Galileo shall bear sole responsibility for meeting the provisions of any law in relation to its business activity and/or commercialization of the
technology and/or the services to be offered to any entity whatsoever including, and without detracting from the generality of the aforementioned, registration of database, maintenance of privacy, complying to the law’s provisions against
money laundering, meeting the information section standards, etc.
|
| 4.5 |
Galileo undertakes that its commercial agreements with clients include paragraphs that stipulate that the applications, services and products developed and offered to the clients (a) shall not constitute a violation of the intellectual
property, moral rights and/or the publication rights of any third party whatsoever, (b) do not include any material that is slanderous, libel, crass, pornographic, inciting or offensive (c) meet all provisions of the law and the regulations
(d) do not collect or use information (including personal information) of the end users in a manner that contradicts the law, or that it was not brough to the attention of the end user (e) do not include or link to worms, viruses, spyware,
advertisement software or any malicious or infiltrative software. It is hereby clarified that Galileo shall not bear the responsibility for any damage of any type whatsoever, including as detailed above, caused to its client and/or end
users for a deed and/or omission not caused by Galileo, whether directly or indirectly.
|
Page 4 of 23
| 4.6 |
Galileo undertakes that in commercial agreements signed with the client, a paragraph of undertaking on the client’s behalf will be added, and will include usage agreements between the clients and end users, indicating that all end users
downloading or installing the application must agree to the license agreement for end users which (i) prohibits reverse engineering or any additional distribution of the API or the technology in any war (ii) instructs that the end user does
not obtain ownership of intellectual rights to the API or the technology (iii) indicates that there are no additional representations or obligations regarding the API or the technology beyond the aforementioned in this agreement, and rules
out any other liability beyond the maximum extent permitted by law, (iv) limits the liability of Hold Me to the maximum extent permitted by law, and (v) meets the provisions of all laws, regulations and rules, including online shop or
market requirements, where the application is offered to the end users (such as, but not limited to, the Apple Application Store and Google Play).
|
| 4.7 |
Notwithstanding the explicitly aforementioned in this agreement, Galileo will prevent, and not permit any third party, to carry out (a) reverse engineering, deciphering or attempt to locate the base code of the API or the technology (b)
change, adjust or create products derived from the API or the technology (c) grant secondary licenses, sell or distribute the API or the technology, or forward the API or technology to any third party other than what was permitted
explicitly in this agreement, (d) bypass all security means or access control of the API or technology, or (e) remove property rights or other notices from the API or technology. In any case, Galileo shall not distribute any source code
included in the API or the technology and shall not distribute the API or the technology as a stand-alone product.
|
| 4.8 |
It is hereby clarified that Galileo may forward and/or assign this agreement to any other entity whatsoever, provided that Galileo remains responsible for all obligations of this agreement and according to any law. It is hereby clarified
that in the case of an assignment as mentioned above, the aforementioned in paragraph 13 shall apply to this paragraph.
|
| 4.9 |
It is hereby clarified that all payment components detailed in this agreement are cumulative, and do not replace each other. In addition, it is hereby clarified that all sums stipulated in this agreement do not include VAT.
|
Page 5 of 23
| 4.10 |
It is hereby clarified that this agreement shall apply also to derived and/or related developments of Hold Me in the framework of the aforementioned technologies - unless these developments are developed for and at the request of another
specific client that did not agree that the developments be forwarded to any other entity. However, it is hereby clarified that this agreement does not apply, and shall not apply to other technologies in other fields of activities that Hold
Me developed and/or may develop in the future.
|
Appendix A of this agreement details future products and/or technologies that Hold Me may develop if it chooses to, and, at its sole discretion, Galileo shall have usage right to
them subject to payment of all development expenses required for this purpose and subject to Hold Me receiving licensing fees and proceeds for them. It is hereby clarified that this does not apply to Hold Me any obligation and/or undertaking to
develop these products and/or technologies and/or others.
| 4.11 |
Unless otherwise determined by Galileo, and without detracting from the aforementioned in paragraphs 4.4 above and 11 below, Hold Me will serve as the entity operating the applications in Israel, in accordance with the services requested
by Galileo from Hold Me. If Hold Me serves as the operating entity as mentioned above, this shall be against payment of all Hold Me’s operation expenses for this purpose. It is hereby clarified that this paragraph does not apply to Hold Me
any obligation and/or financial obligation in relation to the expenses incurred as a result of the operation of the technology and/or any of its parts in favor of Galileo and all related expense and/or incurred expenses shall be fully paid
by Galileo. Notwithstanding the aforementioned, these operational expenses include, among other things:
|
| 4.11.1 |
Payment of compliance and regulation expenses, fulfillment of the requirements for the receipt of the aforementioned license in paragraphs 3.2.4 above, including employment of a compliance officer as required.
|
| 4.11.2 |
Payment of credit card clearance costs.
|
| 4.11.3 |
Payment of storage expense, maintenance, and operation of the application servers.
|
| 4.11.4 |
Payment for the connections and/or services received from third parties including bank services, trusts, financial operation, connection to the inter-bank clearance, development services, design services, etc.
|
| 4.11.5 |
It is hereby clarified that insofar as the clients of Galileo and/or the subsidiary companies in its shoes wishes to receive characterization and/or design and/or development services and/or these operation services and/or other for
applications that will be developed for them - Hold Me will be entitled for a separate and additional payment for these services - as defined and agreed upon between the parties, and the payments detailed in this agreement do not constitute
payment for these services.
|
| 4.12 |
Galileo undertakes to act according to the provisions of the law, and specifically regarding the laws and regulation of money laundering in Israel and the USA, instructions regarding commercial embargo policy, international sanctions,
war on terrorism, etc.
|
Page 6 of 23
| 4.13 |
Galileo undertakes not to violate the provisions of the American Foreign Corrupt Practices Act of 1977 regarding payment of bribery to singles and entities around the world for the promotion of its businesses.
|
| 4.14 |
Galileo undertakes to avoid exporting technology and/or services to entities and/or sates to which a trade embargo is applied and/or are to be applied by the governments of Israel and the USA.
|
| 4.15 |
Insofar as Galileo wishes to do so, and subject to any law, Hold Me will allow Galileo to act according to Hold Me’s contract agreement with their parties, including the credit card clearance agreement, attached as Appendix D to this
agreement.
|
| 5. |
Licensing of payment application systems and digital wallets
|
| 5.1 |
Galileo shall be entitled to use the technology developed by Hold Me for establishing digital wallets and payment applications for itself and/or for clients and entities with which it will enter into contract for this purpose (white
label). In exchange for the receipt of license for the system’s technology to establish payment applications and digital wallets, Galileo shall pay Hold Me the following payment paragraphs:
|
| 5.1.1 |
Establishment fees of 800,000 NIS, which will be paid as follows:
|
| 5.1.1.1 |
100,000 NIS, which were paid to Hold Me prior to the signing of this agreement.
|
| 5.1.1.2 |
150,000 NIS will be paid within 3 months after the time of the signing of this agreement.
|
| 5.1.1.3 |
250,000 NIS will be paid within 6 months after the time of the signing of this agreement.
|
| 5.1.1.4 |
300,000 NIS will be paid within 9 months after the time of the signing of this agreement.
|
Galileo undertakes that it will act to recruit funds from the public to meet its obligations according to this agreement.
Galileo undertakes that upon the completion of recruitment of a cumulative sum of 3 million NIS, whether through private or public issuance, whether in one or several
transactions, Galileo will make the payments mentioned in paragraphs 5.1.1.2 and 5.1.1.4 earlier and transfer them to Hold Me within 30 days from the day of the receipt of the aforementioned recruited sum.
It is hereby clarified that Galileo’s obligation to pay the establishment fees and other payments according to this agreement is independent, final and obligatory, and does
not depend on a precondition and/or other entity, nor in the manner and scope of Galileo’s use of the technology or the scope of its commercialization.
Page 7 of 23
| 5.1.2 |
Annual licensing fees that are to be paid starting from the second contract year (i.e., starting from 12 months after the time of the signing of this agreement), as follows:
|
| 5.1.2.1 |
During the second and third year of activity, a sum of 100,000 NIS per year.
|
| 5.1.2.2 |
From the fourth year of activity, a sum of 150,000 NIS per year.
|
It is hereby clarified that the licensing fees for the first year of activity are included in the establishment fees that Galileo will pay as detailed above.
The licensing fees shall be paid in one lump sum upon the commencement of each additional year of activity - starting from the commencement of the second year of activity. It is
hereby clarified that the licensing fees do not include any development and/or services from Hold Me for which an additional and separate sum shall be paid as mentioned in paragraph 11 below.
It is hereby clarified that non-payment of the licensing fees shall constitute a fundamental breach of the entire agreement, which will entitle Hold Me to terminate the
agreement, unless the breach is amended within 14 business days - and not only in relation to the technology license for building wallets as mentioned in this paragraph.
| 5.1.3 |
Proceeds of 12% of all income charged by Galileo and/or the subsidiary to be established from all clients and/or third parts throughout the period of the commercial contract between Galileo and the third party.
|
| 5.1.3.1 |
In this paragraph, ‘income’ includes the proceeds, rights, assets, and payment - whether in cash or cash value, whether directly or indirectly for all types of services and/or income models (establishment, operation, management,
licensing, consultation, etc.) between Galileo and third parties including capital apartments such as compensation fees in lieu of the relationship between Galileo and the third party.
|
| 5.1.3.2 |
The proceeds shall be paid within 4 business days from the time of the receipt of the income by Galileo.
|
| 5.1.4 |
The parties hereby declare that Hold Me is in negotiation processes with several Israeli entities, including:
|
| 5.1.4.1 |
The Postal Bank
|
| 5.1.4.2 |
Mako-Keshet/ Easy application
|
| 5.1.4.3 |
Green Invoice
|
| 5.1.4.4 |
Bezek
|
| 5.1.4.5 |
ZizBank
|
| 5.1.4.6 |
Elezra Group (insurance training company, Alber, etc.)
|
Page 8 of 23
| 5.1.4.7 |
Bituach Yashir Group and Mimun Yashir
|
| 5.1.4.8 |
PCS
|
| 5.1.4.9 |
Castro Group
|
| 5.1.4.10 |
Meitav Dash
|
It is hereby agreed that Hold Me will have a three-month period to complete formal contracts with these entities. If the aforementioned contract is completed in the framework
of this period, Hold Me shall be entitled to receive 60% of the gross profit for these contracts.
It is hereby agreed upon that if the aforementioned period reaches its conclusion, or if Hold Me elects to divert these entities to a contract with Galileo for the
establishment of a digital wallet and/or use of a digital wallet clearance technology in the businesses registers (the aforementioned PEY clearing house in paragraph 6), then Hold Me will be entitled to proceeds (as mentioned in the previous
paragraph, 5.1.3 above and paragraph 6.1.1 below) at a rate of 20% of those mentioned in the aforementioned paragraphs.
| 5.1.5 |
If Agadir, with which Hold Me entered into a contract for the establishment of a digital wallet wishes to receive additional services and/or products that are not included in the original agreement of Hold Me with Agadir, as well as
routine maintenance, then Galileo will be entitled to provide these services, provided that it chooses to do so, and Hold Me will be entitled to receive 60% of the profits as defined above.
|
| 6. |
Licensing of a system for connecting payment applications, digital wallets, and clearance of payments from digital wallets (PEY clearing house)
|
| 6.1 |
Galileo shall be entitled to use the technology developed by Hold Me for clearing payments between various digital wallets and between the digital wallets and the businesses registers (the PEY clearing house) in Israel. In exchange for
the receipt of license for connecting between the digital wallets and between the digital wallets and the businesses registers, Galileo will pay Hold Me the following:
|
| 6.1.1 |
Proceeds of 10% of all gross profits and/or the aforementioned profits of Galileo and/or the subsidiary to be established by it from all clients and/or third parties throughout the period of the contract between Galileo and the third
party.
|
| 6.1.1.1 |
In this paragraph, ‘gross profit’ includes the proceeds, rights, assets, and payments - whether in cash or cash value, whether directly or indirectly for all types of services and/or income models (establishment, operation, management,
licensing, consultation, etc.) between Galileo and third parties including capital apartments such as compensation fees in lieu of the relationship between Galileo and the third party. It is hereby clarified that in the framework of the
calculation of the gross profit, indirect expenses, overhead, development expenses, operation, etc. shall not be calculated - only direct expenses and costs paid by Hold Me and/or Galileo to third parties for the transactions of the digital
wallets clearance to businesses registers.
|
Page 9 of 23
| 6.1.1.2 |
Every two calendar months, Galileo will forward to Hold Me a detailed report of all income generated during the preceding calendar month, as well as the direct expenses related to its generation. Galileo will forward to Hold Me the
proceeds paid to it for the preceding calendar month, plus VAT according to law, within 3 workdays after their receipt.
|
| 6.2 |
The parties hereby agreed that if Hold Me signs a CLC agreement with Shva company, then subject to any law and/or agreement and the contractual and/or legal possibility to do so, Hold Me shall assign the agreement to Galileo or
alternately, shall allow Galileo to act according to it, the provisions, obligations, and limitations that apply to Hold Me in the agreement. It is hereby clarified and agreed that in the aforementioned case, Galileo will bear all expenses,
costs and/or obligations according to the aforementioned agreement and/or required for its execution.
|
| 7. |
Applications licensing
|
| 7.1 |
Galileo shall be entitled to market and commercialize in Israel the applications developed by Hold Me and make changes and/or additions as it deems fit. In exchange for the receipt of a license for the application developed by Hold Me,
Galileo will pay Hold Me the following:
|
| 7.1.1 |
Establishment fees of 100,000 NIS, which will be paid as follows:
|
| 7.1.1.1 |
50,000 NIS will be paid within two months after the time of the signing of this agreement.
|
| 7.1.1.2 |
50,000 NIS will be paid within three months after the time of the signing of this agreement.
|
It is hereby clarified that Galileo’s obligation to pay the establishment fees is independent, final, and obligatory, and does not depend on a precondition and/or other factor,
nor in the manner and scope of Galileo’s use of the technology or the scope of its commercialization.
| 7.1.2 |
Proceeds of 10% of all gross profits and/or the aforementioned profits of Galileo and/or the subsidiary to be established by it from all clients and/or third parts throughout the period of the commercial contact between Galileo and the
third party.
|
| 7.1.2.1 |
In this paragraph, ‘gross profit’ includes the proceeds, rights, assets, and payment - whether in cash or cash value, whether directly or indirectly for all types of services and/or income models (establishment, operation, management,
licensing, consultation, etc.) between Galileo and third parties including capital payments such as compensation fees in lieu of the relationship between Galileo and the third party. It is hereby clarified that in the framework of the
calculation of the gross profit, indirect expenses, overhead, development expenses, operation, etc. shall not be calculated - only direct expenses and costs paid by Hold Me and/or Galileo to third parties for the transactions of the digital
wallets clearance to businesses registers.
|
Page 10 of 23
It is hereby clarified that insofar as Galileo uses these applications to sell products and/or other services in the future (whether developed and/or supplied by Hold Me or by
a third party) such as: insurance Products, pension savings, investments, pension services, etc. - then Hold Me shall be entitled also for 10% of Galileo’s gross profit from these future products. Hold Me undertakes to assist in the integrations
required for the additional products and/or third parties against payment for the development and integration services required for this purpose.
| 7.1.2.2 |
On the 5th of every calendar month, Galileo will forward to Hold Me a detailed report of all income generated during the preceding calendar month, as well as the direct expenses related to its generation. On the 10th
of every month, as mentioned above, Galileo will forward to Hold Me the proceeds paid to it for the preceding calendar month, plus VAT according to law.
|
| 7.2 |
Hold Me will deliver to Galileo the domains and marketing websites it developed for the aforementioned applications. Galileo will bear every expense and/or cost in relation to the maintenance and operation of the domains and the
websites.
|
| 8. |
Use of commercial agreements for clearance of credit cards (concentrator)
|
| 8.1 |
In exchange for the receipt of the right to offer credit card clearance services to businesses in the framework of Hold Me’s incorporating activity, Galileo will pay Hold Me the following:
|
| 8.1.1 |
Proceeds of 25% of all gross profits generated by Galileo and/or the subsidiary to be established by it from the sale for the clearance services from all clients and/or third parts throughout the period of the commercial contact between
Galileo and the third party.
|
| 8.1.1.1 |
In this paragraph, ‘gross profit’ includes the proceeds, rights, assets, and payments - whether in cash or cash value, whether directly or indirectly for all types of services and/or income models (establishment, operation, management,
licensing, consultation, etc.) between Galileo and third parties, including capital payments such as compensation fees in lieu of the relationship between Galileo and the third party minus direct related expenses/cost only. It is hereby
clarified that in the framework of the calculation of the gross profit, indirect expenses, overhead, development expenses, operation, etc. shall not be calculated - only direct expenses and costs paid by Hold Me and/or Galileo to third
parties for the transactions of the digital wallets clearance to businesses registers.
|
Page 11 of 23
| 8.1.1.2 |
On the 5th of every other month, Galileo will forward to Hold Me a detailed report of all income generated during the preceding calendar month, as well as the direct expenses related to its generation. On the 10th
of the aforementioned billing month, as mentioned above, Galileo will forward to Hold Me the proceeds owed to it, plus VAT according to law.
|
| 8.2 |
It must be clarified that the aforementioned clearance services are provided according to agreements made between Hold Me and Isracard and/or PayMe. Hold Me will allow Galileo to operate as its branch for the sale of the aforementioned
clearance services.
|
| 9. |
Warranty coverage
|
| 9.1 |
Hold Me shall not be deemed as the owners of the information and data accumulated as a result of the provision of the services and/or commercialization of the technology. Galileo shall be subject to any law and/or provision regarding the
manner of safeguarding, security, use and operation required for handling the information and data as mentioned above, including regarding the privacy protection laws, information confidentiality, databases, money laundering, etc.
|
| 9.2 |
Moreover, the technology was tested and found to be functional and operative. It must be clarified that it may have bugs and/or inadequacies. Hold Me clarifies that the software is not clear of failures and/or defects, and this agreement
and/or any of its provisions and/or other do not provide any guaranty, representation and/or undertaking that the software is clear of defects, bugs and/or inadequacies. Galileo and anyone on its behalf shall operate carefully and
professionally, and conduct routine, professional independent tests for the services, features and/or capabilities of the technology and its use. The technology and the entire API are provided ‘as is’. Hold Me undertakes to act to its best
ability and with reasonable means to amend any failure and/or inadequacy discovered in the technology within a reasonable timeframe, and in any case, the amendment of the failure shall be amended as soon as possible, and in any case, no
later than one workday. It must be clarified that Hold Me’s obligations according to this paragraph for the amendment and/or provision of services shall apply solely to the technology provided by it and shall not apply if Galileo changes
and/or adds additional developments of Galileo or anyone on its behalf.
|
| 9.3 |
Hold Me shall not be liable and/or responsible to Galileo or to any third party whatsoever for damages apparently caused by failures, inadequacies, bugs and/or errors discovered in the software - unless it was positively and
unequivocally proven that the company’s technology in its original condition is the direct exclusive cause for all damages as mentioned above, and that it could not have been prevented even if Galileo had conducted proper professional tests
for this issue.
|
Page 12 of 23
| 9.4 |
In any case, Hold Me (or any of its directorate members, its functionaries, partners, representatives, or workers) shall not bear the responsibility for any consequential, indirect, special or penalty damages derived from the technology
or the API or in relation to them. The liability of Hold Me (or any of its directorate members, functionaries, partners, representatives or workers) according to this agreement shall not exceed the actual sum paid by Galileo to Hold Me
according to this agreement.
|
| 9.5 |
Each party shall compensate the second party for any suit and/or expense and/or liability against the damaged party as a result of the services and/or products offered by Galileo to its clients, including, but not limited to, any claim
that the applications developed by any of the parties violate the intellectual property rights of any third party. In the case of a lawsuit, as mentioned above, the violation party will bear all legal expense and defense management expense
of the harmed party, as well as any expenses and/or payment applied to them in the framework of any judicial decision.
|
| 10. |
Audit rights
|
| 10.1 |
Every two months, the parties shall forward reports to each other in relation to the scope of activities, use, and derived income and profits, to calculate the proceeds owed to Hold Me for commercialization of the technology and/or use
of the agreements of Hold Me.
|
| 10.2 |
Every 6 months of activity, Galileo shall supply to Hold Me, at its expense, a certificate made and signed by Galileo’s accounting firm, detailing and auditing all sums of income and gross profits required for the calculation of the
proceeds according to all paragraphs above in relation to the aforementioned technology parts.
|
| 10.3 |
Hold Me shall have the rights to demand additional auditing by an accounting firm on its behalf once a year. It is hereby agreed upon that if Hold Me decides on the execution of the aforementioned audit and if discrepancies exceeding 5%
are found between the findings of the different accountants - Galileo shall bear the expense of the additional audit conducted.
|
| 10.4 |
In addition, if at any stage whatsoever, a concern is raised by Hold Me that the reports and/or current bills and/or routine activities between the parties are lacking and/or problematic - it shall be entitled to conduct an immediate
audit, and not only at the conclusion of every year of activity. If it is found that the aforementioned audit was justified - Galileo shall bear its costs.
|
| 11. |
Consultation and development services by Hold Me
|
| 11.1 |
It is hereby clarified that Hold Me’s obligations and undertaking according to this agreement are limited to granting Galileo a right to act for the commercialization of the technology as mentioned above. Hold Me and anyone on its behalf
are not bound to any development, consultation, management and/or other service. It is hereby clarified that Hold Me shall provide to Galileo training services in relation to the technology of up to 5 workdays. Insofar as Galileo wishes to
provide development/consultation/management and/or any other service, it shall contact Hold Me in this regard and subject to the parties’ agreement in relation to the nature, quality and scope of the requested services and their payment,
the parties shall formulate separate agreements for this purpose.
|
Page 13 of 23
| 11.2 |
Hold Me undertakes to participate in sale and/or investment and/or recruitment meetings lasting up to 24 hours without additional charge. In the event that Galileo wishes that a representative on the behalf of Hold Me participates in
additional meetings, Hold Me shall be entitled to payment in the sum of 1500 NIS for each meeting, plus VAT. It is hereby clarified that in any case, these meetings’ time and schedules shall be coordinated in advance with Hold Me.
|
| 11.3 |
Notwithstanding its confidentiality obligation, Galileo may carry out development work by itself and/or anyone on its behalf and at its expense based on the technology, applications, digital wallets, etc. - for itself and/or for its
clients. Insofar as Galileo and/or its clients wish to make changes in the capabilities and/or development of features and new capabilities, Galileo may request that they be carried out by Hold Me and/or anyone on its behalf according to a
characterized request delivered by Galileo and/or anyone on its behalf and subject to payment for these changes as directed by Hold Me after the receipt of the aforementioned request for developments.
|
| 11.4 |
Alternately or in addition, if Galileo wishes so, Hold Me will supply to Galileo development, maintenance, QA and other services - by its team of developers and/or anyone on its behalf. It is hereby clarified that if Galileo wishes so,
the parties shall sign a separate services and development agreement.
|
| 11.5 |
Hold Me’s development services shall be quoted in advanced according to a detailed and obligatory characterization of Galileo and/or anyone on its behalf. Alternately, unless otherwise agreed in writing by the parties, Hold Me shall
provide Galileo an experienced development team, knowledgeable in the technology, which will develop for Galileo capabilities as it may demand from time to time and as it will instruct the team. The development rates shall be as instructed
by Hold Me from time to time.
|
| 11.6 |
Insofar as the parties wish so, the parties shall negotiate for the receipt of general consultation services, including regarding business development, management of development teams, commercial agreements, etc., which Hold Me will
grant Galileo.
|
Page 14 of 23
| 12. |
Sales bonus
|
| 12.1 |
If after the signing of this agreement and for an unlimited period, a ‘transaction’ is carried out, as defined below, Hold Me shall be entitled to a bonus of 15% of the total payment received in the framework of the transaction, minus
the actual establishment fees paid as detailed in paragraph 5.1.1 above and the actual establishment fees, as detailed in paragraph 7.1.1.
|
In this paragraph, a ‘transaction’ means selling of a share, issuing a share, sale of a business activity, etc., whether in one transaction or in a series of transactions,
including each one of the below:
| a. |
A transaction in the framework of which Galileo’s control and/or its subsidiary is sold to a third party.
|
| b. |
A transaction in the framework of which Galileo and/or its subsidiary merge with another company - including reverse merging.
|
| c. |
A transaction in which the subsidiary is issued in a stock exchange in Israel or abroad.
|
| d. |
A transaction in the framework of which most (or more) of its assets and/or business activities are sold to a third party.
|
| e. |
A transaction in the framework of which a subsidiary’s shares are sold, including Hold Me’s activity
|
| f. |
A transaction and/or series of transactions after which the subsidiary ceases to be under the full ownership of Galileo.
|
In this paragraph, ‘exchange’ means the total payments, rights, assets, share - whether in cash or cash value, received in the framework of the transaction by Galileo and/or by
its shareowners. In cases in which an exchange is not received - the bonus shall be calculated as 15% of the total value of the subsidiary that includes the activity.
| 12.2 |
Upon Galileo’s and/or its subsidiary’s achievement of an overall cumulative gross profit of 50 million NIS for the commercialization of the technology, Hold Me shall be entitled to receive a bonus at a rate of 3% of the total
aforementioned gross profit.
|
| 13. |
Investment option in Hold Me
|
| 13.1 |
Galileo is granted the option to invest up to 4 million NIS in Hold Me via a convertible loan for a period of 9 months after the date of the signing of this agreement. The investment sums shall serve for Hold Me’s routine business
activity.
|
| 13.2 |
The investment shall be made through a convertible loan:
|
| 13.2.1 |
If Hold Me signs a capital raising agreement for 500,000 USD or more with a third party, during the period commencing on the time of to receipt of the convertible loan and ending 12 months later, the loan shall be converted automatically
to a regular Hold Me share in the framework of the same capital raising, so that Galileo receives a discount at a rate of 20% of the price for the share paid by the investor in the framework of the aforementioned investment agreement.
|
Page 15 of 23
| 13.2.2 |
In the event that the company does not sign an investment agreement during the aforementioned period, the loan shall be converted to the company’s regular shares according to company value as agreed between the parties through
negotiation in good faith. Insofar as the aforementioned agreement is not made, the company’s value shall be calculated by an independent value assessor.
|
| 14. |
Confidentiality
|
| 14.1 |
Confidential information in this agreement is any information which Hold Me may forward to Galileo form time to time in any way whatsoever (including in writing, in magnetic media or in any other tangible way, as well as orally or
visually).
|
| 14.2 |
Galileo will control access to the confidential information, protect its confidentiality and prevent unauthorized use of this information - at least in the same level of confidentiality, caution, and strictness it exercises for its own
information, but in any case, no less than a reasonable level of confidentiality, caution, and strictness.
|
| 14.3 |
Galileo shall not disclose to any third party whatsoever confidential information received from Hold Me, unless the aforementioned disclosure to a third party and/or its workers and/or anyone on its behalf is required for the objective
detailed in this agreement, and in the aforementioned case, Galileo shall be responsible for every third party and/or its workers and/or anyone on its behalf as mentioned above, sign a confidentiality agreement with Hold Me, and maintain
confidentiality of information. In the event that Galileo or a development entity on its behalf violate this obligation, Galileo shall be solely and exclusively responsible for all damages caused to Hold Me as a result.
|
| 14.4 |
Galileo shall be entitled to use the confidential information received for its review and assessment to examine the possibilities and objectives as indicated in this agreement and in the framework of the cooperation between it and Hold
Me, and not for any other purpose (hereinafter: “the Objective”).
|
| 14.5 |
Galileo’s obligation to maintain confidentiality and restrict use as detailed above shall not apply or shall cease to apply, as relevant, to any part of the confidential information which -
|
| 14.5.1 |
Constitutes general knowledge at the time of the signing of this agreement or after the signing of this agreement, which did not result from a deed or omission on behalf of Galileo.
|
| 14.5.2 |
Was at possession of Galileo prior to the date of the signing of this agreement as stated in written evidence.
|
| 14.5.3 |
Galileo received, after the time of the signing of this agreement, from a third party, which to Galileo’s knowledge, was not bound at the time of delivery to the company to a confidentiality obligation to Hold Me.
|
Page 16 of 23
| 14.5.4 |
Its disclosure is required from the company in accordance with an order or instruction of a competent authority, and provided that Galileo notifies Hold Me immediately regarding the receipt of the aforementioned order or instruction.
|
| 14.6 |
All rights to the information are and shall be granted at any time and for all matters and purposes to Hold Me only.
|
| 14.7 |
All documents, magnetic media, and other tangible means in which the confidential information is forwarded to Galileo, are, and shall be at all times and for all matters and purposes under the sole ownership of Hold Me and shall be
deemed as lent to Galileo for the purposes of this agreement. Galileo shall not copy nor duplicate in any other way the documents and/or any other means as mentioned above, unless for the purposes of this agreement.
|
| 14.8 |
It is hereby agreed that Hold Me shall have the ownership rights, property rights, and rights of any type whatsoever to any products whatsoever which will be developed or considered as a result of this contract and it shall be entitled
to handle these products as the owner, including use them, sell them and/or part of them to others and/or publish them and/or make changes and additions in them at its sole discretion (hereinafter: “the
Products”).
|
| 14.9 |
Galileo shall not forward to any third party whatsoever any copy of these Products and their associated documentation or for any part thereof, shall not publish, sell, market, nor make any other use of the aforementioned Products without
the advance written consent of Hold Me.
|
| 14.10 |
The parties hereby agree that in the event that any of the parties wishes to distribute or publish a notice to the press and/or any other notice, the aforementioned notice shall be phrased by them and coordinated by the parties and
distributed only after the receipt of the explicit consent of both parties. This does not compromise the obligations of any of the parties to forward any report and/or notice required from them according to any law.
|
| 14.11 |
Hold Me has the right to disclose the fact that Galileo is using the API or technology, including by displaying Galileo’s name and Galileo’s clients names and logos on Hold Me’s website, as well as other marketing content.
|
| 15. |
Completion of transaction
|
| 15.1 |
The transaction shall be completed on 19.12.2019 or on any other delayed date agreed in advance and in writing between the parties (hereinafter: “the Date of Completion”), at the location agreed
between the parties via phone, a week prior to completion.
|
Page 17 of 23
| 15.2 |
Hold Me undertakes that starting from the date of the signing of this agreement and until the completion of all activities derived from it, it shall not undertake any agreement or anything that contradicts this agreement.
|
| 15.3 |
Activities to be carried out by the Date of Completion and/or on it
|
On the Date of Completion and/or by the Date of Completion, as relevant - the following activities shall be carried out simultaneously, and shall be conditioned upon the
execution of all other activities:
| 15.3.1 |
Completion of appendix C of this agreement, regarding activity outside of Israel
|
| 15.3.2 |
Galileo shall open a storage account in amazon’s servers.
|
| 15.3.3 |
Galileo shall open a key account on Apple Appstore.
|
| 15.3.4 |
Galileo shall open a key account on Google Play.
|
| 16. |
Intellectual property
|
| 16.1 |
It is hereby clarified and agreed between the parties that all ownership and intellectual property rights to the technology and all improvements and their derivatives as may be from time to time shall remain in the exclusive possession
of Hold Me. This agreement does not assign and/or grant intellectual property rights as mentioned above to the technology to Galileo and/or anyone on its behalf unless otherwise stated in, and subject to this agreement.
|
| 16.2 |
Notwithstanding Galileo’s rights according to this agreement, Hold Me shall be entitled to use all of the technology and/or any of its parts and commercialize them, in their present condition and/or after making changes and/or updates in
them - and in any other way whatsoever in favor of any other entity whatsoever. Unless otherwise explicitly indicated, this agreement does not limit Hold Me in changing the technology and acting in any way it deems fit to commercialize it.
|
| 16.3 |
The ownership and intellectual property rights of Galileo to services and/or Products it will develop (applications) based on the technology will be under the ownership of Galileo only.
|
| 17. |
Exhaustive agreement
|
| 17.1 |
This agreement, upon its signing, exhausts all agreements between the parties and terminates any previous agreement, understanding or obligation, if any, between the parties and/or any of them - in writing or orally, explicitly and/or
implied, starting from the signing of this agreement.
|
Page 18 of 23
| 17.2 |
The parties hereby undertake to act in full cooperation for the completion of this transaction, its execution and operation of the company, and to act out of integrity, good faith, and loyalty to the other parties.
|
| 17.3 |
Subject to the exclusive usage right of Galileo to the technology in Israel, it is hereby clarified that this agreement does not prevent and/or limit Hold Me’s rights to the technology, as well as its rights to sell, assign, credit
and/or grant license and/or usage right to the technology and/or any of its parts to any other third party, whether with or without payment.
|
| 17.4 |
It is hereby clarified that Galileo and/or the subsidiary in its shoes shall bear all costs and/or routine expenses for the maintenance of the technology for their clients and/or for themselves, requested changes, as well as payment to
third parties, including to relevant service providers, etc.
|
| 17.5 |
It is hereby clarified that Galileo’s charges and obligations according to this agreement do not depend on, nor are conditioned upon the scope and/or use of the technology and/or any part thereof - whether for itself or for third
parties.
|
| 17.6 |
Galileo does not and shall not be entitled to assign the agreement to any third party whatsoever, unless to a subsidiary under its full ownership.
|
| 17.7 |
The dates stipulated in this agreement constitute its principles and constitute a significant and main aspect of it.
|
| 18. |
Period and termination of the agreement
|
| 18.1 |
Subject to the fulfillment of the parties’ obligations according to the agreement and according to any law, this agreement shall be valid from the day of its signing onward, without a time limit, unless terminated according to law.
|
| 18.2 |
If a party to the agreement makes a fundamental breach that is not amended within 30 days, the harmed party shall be entitled to terminate the agreement. The termination of the agreement shall not compromise the rights of third parties
formulated prior to the termination. It is hereby agreed that the entire agreement is deemed as one unit and cannot be terminated and/or operated partially in relation to any of the technology. Violation of any of the payment paragraphs
detailed above shall entitle Hold Me to terminate the entire agreement.
|
| 18.3 |
In addition, Hold Me shall have the right to terminate the contract permanently in any case in which there is a real concern of a criminal offense being committed by Galileo and/or the subsidiary and/or any of their managers including,
and notwithstanding the aforementioned, regarding fraudulent crimes, breach of trust, bribery, etc. In the aforementioned case, the termination will be with immediate effect.
|
Page 19 of 23
| 18.4 |
If Hold Me terminates the agreement due to a violation on behalf of Galileo and/or the subsidiary or anyone on their behalf, then despite the termination, Hold Me shall be entitled to receive the entire payment stipulated in paragraphs
5,6,7 for all their sub-paragraphs, specifically the establishment fees for any of the technology's parts - despite the termination. In the aforementioned case, there shall be no return obligation for the establishment fees that were paid
and/or were supposed to be paid, and the termination of the agreement shall not compromise Galileo’s obligation to continue paying the full establishment fees for the various technology parts, fully. In addition, Hold Me shall be entitled
to terminate and/or cancel general and maintenance services, act as owners regarding every server, service, asset, rights, account, etc., related to the technology and/or relevant for its operation.
|
| 18.5 |
In the case of a termination as mentioned in paragraph 18.4, all clients and business activities created and/or accumulated by Galileo shall be forwarded to Hold Me and Galileo shall not be entitled to any compensation and/or reward for
this matter.
|
| 18.6 |
Notwithstanding the aforementioned, the parties hereby agree that this agreement shall be concluded if a receiver and/or liquidator is appointed for Galileo and/or the subsidiary (including a temporary one), and/or a trustee was
appointed for its/their property, and/or if there is a reasonable concern that they may not be able to fulfill the financial and other obligation according to this agreement.
|
| 18.7 |
It is hereby agreed that if Galileo does not sign a commercial agreement with a client within 24 months after the signing of this agreement, the agreement shall be terminated. In the aforementioned case, all rights granted to Galileo
according to this agreement shall be returned to Hold Me. It is hereby clarified that in the aforementioned case, Galileo shall not be entitled to receive any return, refund, or payment for the aforementioned termination.
|
| 18.8 |
If Hold Me wishes to raise funds in the Israeli stock market, this shall be done with advance, written consent, under the conditions agreed with Galileo. The aforementioned does not limit Hold Me’s right to raise funds in stock markets
outside of Israel, or in any private issuance whatsoever.
|
| 19. |
Remedies and reliefs
|
| 19.1 |
The Provisions of the Contracts (Remedies for Breach of Contract) Law of 1970 shall apply to this agreement.
|
| 19.2 |
It is hereby agreed upon by the parties that the provisions of paragraphs 3,4,5,6,7,8,9,10,11,12,13,14,16, and 18 are fundamental to this contract. To remove all doubt, it is hereby clarified that the dates stipulated in this agreement
are fundamental.
|
Page 20 of 23
| 20. |
Negotiation in the case of a dispute
|
| 20.1 |
It is hereby agreed that if a dispute and/or disagreement arises between the parties regarding this agreement and/or anything derived from it, then the parties undertake to hold at least 2 negotiation meetings for solving the dispute
between them before turning to legal proceedings.
|
| 20.2 |
If upon the conclusion of both of the aforementioned meetings the parties do not reach an agreement regarding their dispute, each one of them shall be entitled to turn to legal proceedings to inquire about its legal rights.
|
| 21. |
Miscellaneous
|
| 21.1 |
All sums detailed in this agreement, including establishment fees, licensing fees, proceeds and/or other payments do not include VAT, if and insofar as VAT shall apply to them.
|
| 21.2 |
This agreement substitutes any previous agreement and/or contract between the parties, including the memorandum of understanding from the 8th of November 2019, which is hereby terminated.
|
| 21.3 |
The parties agree that the Israeli substantive law shall apply to this agreement and the Tel Aviv court shall have exclusive jurisdiction in Israel over any dispute related to it.
|
| 21.4 |
The addresses of the parties are as detailed in the preface of this agreement.
|
| 21.5 |
Every extension and/or delay and/or use of arbitration and/or reliefs and/or rights granted to a party according to this agreement - shall not be deemed as the relinquishment of this party of its rights as detailed in this agreement.
|
| 21.6 |
This agreement and/or any of it paragraphs and/or provisions do not constitute an agreement in favor of any third party whatsoever.
|
| 21.7 |
Each of the individuals of the parties to this agreement declares and confirms that he read and/or reviewed this agreement by himself and/or via a lawyer on his behalf and that he has no, and shall have no claims against any of the
parties and/or their lawyers regarding anything related to this agreement and/or his representation in the transaction.
|
| 21.8 |
Any change in the provisions of this agreement shall be valid only if made in advance and in writing and signed by the parties to this agreement.
|
Page 21 of 23
| 21.9 |
Any notice sent by one party to the other shall be deemed as received 3 business days after the delivery of the notice via registered mail from a post office in Israel, or immediately if sent via facsimile or email, and the sender
ensures receipt and documents the receipt and the receiver of the notice, as well as the date and time of receipt.
|
In witness whereof the parties have affixed their signatures
| /s/ Menachem Shalom | illegible signature |
|
|
Hold Me Ltd.
|
Galileo Tech Ltd.
|
Page 22 of 23
Appendix - Possible Future Developments
| 1. |
Register for businesses (code purchase + its adaptation to Hebrew + adaptation to the local market in terms of regulation)
|
| 2. |
Application for money saving plans (requires completion of development)
|
| 3. |
Application for business owners/freelancers (invoice + pockets for taxes) (requires completion of development)
|
| 4. |
Application for investment in securities (characterization and preliminary licensing work were completed >> requires completion of development)
|
| 5. |
Provision of private loans+ loans to businesses (requires licensing of the credit service provider + completion of development)
|
| 6. |
International money transfer services (Transpay)
|
| 7. |
Connection to crypto coin stock exchanges
|
Future possible integrations
| 1. |
Tax authorities for tax payments
|
| 2. |
Bank payment applications (Paybox, Pepper, Bit)
|
| 3. |
Shva (CLC)
|
| 4. |
Change software/Post Bank - enable cash deposit to digital wallets
|
| 5. |
Service bureau for bank standing orders (an agreement was formulated and an approval provided - integration and implementation are required)
|
Agreements
| 1. |
Isracard
|
| 2. |
Development companies (Empower, Assembly, Qdesk, Perfected Tech, AXON)
|
| 3. |
IPOS
|
Page 23 of 23
Exhibit 10.2
Addendum to the Agreement for Operation and Sale of Digital wallets
From the 5th of December 2019
Made and signed in Tel Aviv on the 27th of December 2020
|
Between
|
Hold Me Ltd.
|
Private company number: 513933218
Of 30 Golomb Street Nes Ziona
(Hereinafter: “Hold Me Ltd.”)
The first party;
|
And
|
Galileo Tech Ltd.
|
Public company number: 520043001
Of 9 Masada Street, Bnei Brak
(Hereinafter: “Galileo” or “the Company”)
The second party;
| Whereas: |
the parties signed an Agreement for Operation and Sale of Electronic Wallets (hereinafter: “the Agreement”) on the 5th of December 2019;
|
| And Whereas: |
in the framework of the Agreement, Hold Me granted Galileo, for a subsidiary under Galileo’s full ownership, a license to use the technology, as defined in the provisions of the Agreement;
|
| And Whereas: |
the parties wish to update and regulate the new Agreements made between them;
|
Therefore, the following was declared, stipulated, and agreed upon by the parties:
| 1. |
The preface to this addendum constitutes an inseparable part thereof.
|
| 2. |
As of the time of this addendum, in accordance with paragraph 5 of the Agreement Galileo owes a sum of 450 thousand NIS to Hold Me for the establishment fees as defined in the Agreement. The
parties hereby agree that the balance shall be paid as detailed below, despite the aforementioned in paragraph 5 of the Agreement:
|
| a. |
40% of the aforementioned debt, meaning, a sum of 180,000 NIS, shall be converted to regular shares without the par value of Galileo according to the rate of 1.4 NIS per share - 128,571 regular Company shares, which shall be allocated to
Hold Me and/or anyone on its behalf (hereinafter: “the Allocated Shares”).
|
If, in June 2021 the shares’ rate is less than 1.4 NIS, Galileo shall allocate to Hold Me and/or anyone on its behalf an additional sum of shares to complete the compensation for
the conversion of the debt to the aforementioned 180,000 NIS as mentioned above, at the rate of 1.2 NIS per share (hereinafter: “the Compensation Shares”).
It must be clarified that the allocation of these shares and the Compensation Shares (insofar as their allocation will be required) shall be subject to all approvals required by
law, including the approval of the parties’ directorates and the approval of the Tel Aviv Stock Exchange Ltd. for their trade listing.
In addition, the Allocated Shares and the Compensation Shares (insofar as their allocation will be required) shall be subject to the Capping Provisions stipulated in Paragraph
15C of the Securities Law of 1968 and the Securities Regulations (Details with regard to Sections 15A to 15C of the Law) of 2000.
| b. |
A total of 120 thousand NIS plus VAT shall be paid by the end of December 2020.
|
| c. |
A total of 150 thousand NIS plus VAT shall be paid by the end of January 2021.
|
| d. |
The annual registration fees for the second year of activity which commenced on 5.12.2020 in the sum of 100 thousand NIS, in accordance with paragraph 5.1.2.1. of the Agreement, shall be frozen and paid in the course of June 2021 and/or
at a later date, provided that the Company enters into at least one contract for a significant payment transaction related to the field of digital wallets, and in any case, even in the absence of such a transaction, these licensing fees
shall be paid no later than 5.12.2021.
|
| 3. |
The parties hereby agree that the remainder of the Agreement provisions shall remain without change and that the addendum to this Agreement does not change the remainder of the provisions of the original Agreement signed between the
parties and the parties’ rights according to it.
|
| 4. |
This addendum shall constitute an inseparable part of the Agreement and shall be valid as long as the Agreement is in force.
|
In witness whereof the parties have affixed their signatures:
| /s/ Menachem Shalom | illegible signature |
|
|
Hold Me Ltd.
|
Galileo Tech Ltd.
|
Exhibit 10.3
Management agreement
Made and signed in Nes Ziona on 30.12.2017
Between:
Hold Me Ltd. private company/ID no. 513933218
Of 30 Golomb Street Nes Ziona
(Hereinafter: “the Client”)
The first party
And:
Menachem Shalom, ID no. 031912595 of 30 Golomb Street Nes Ziona
(Hereinafter: “the Manager”)
The second party
| Whereas |
the Client is a company that intends to engage in the development of technology for digital wallets and payment systems (hereinafter “Field of Engagement”).
|
| And whereas |
the Manager has the knowledge, education, professional licensing, experience, and skills appropriate for the provision of management services in the Field of Engagement.
|
| And whereas |
the Client requested from the Manager, and the Manager agreed to provide management services to the Client including the handling of anything related to marketing, sales, regulation, technology, and other aspects.
|
| And whereas |
the parties wish to define the legal relationship between them in the framework of the provisions of this agreement.
|
Therefore, the following has been declared, stipulated, and agreed upon by the parties:
| 1. |
Introduction
|
| 1.1. |
The preface to this agreement constitutes an inseparable part thereof and is as binding as the remainder of its provisions.
|
| 1.2. |
The section titles are for convenience only and shall not serve for the interpretation of any of this agreement’s provisions.
|
| 2. |
Declarations of the Manager
|
The Manager hereby declares and undertakes as follows:
| 2.1. |
That he has the technical and professional ability to fulfill all provisions of this agreement and that there is no impediment according to any law and/or agreement and/or otherwise to his entering into this contract.
|
| 2.2. |
That he has the professional knowledge, experience and expertise required for the fulfillment of this agreement.
|
| 2.3. |
That there is no legal lawsuit whatsoever against him, and that no actions were carried out and/or no obligations exist which prevent and/or may prevent him from fulfilling his obligations according to this agreement, and that there is
no conflict of interest in his provision of management services as mentioned in this agreement.
|
| 3. |
The Contract
|
| 3.1. |
The Manager shall provide the Client management services in his Field of Engagement, shall fulfill his roles faithfully and with dedication, and shall invest his full time as required by his position.
|
| 3.2. |
It is hereby agreed and clarified that the Manager acts to fulfill the provisions of this agreement as an independent contractor and he has no, and shall have no employer-employee relationship with the Client.
|
| 3.3. |
The Manager hereby undertakes that he shall not claim nor raise claims in any forum and on any date whatsoever that dispute his status as an independent contractor or the absence of an employer-employee relationship between himself and
the Client.
|
| 3.4. |
The Manager hereby declares and agrees that raising any claim whatsoever by himself or via his attorneys and/or anyone on his behalf that an employer-employee relationship existed between himself and the Client, shall be deemed, among
other things, a lack of good faith on their behalf and/or misleading of the Client and/or a fundamental breach of this agreement.
|
| 3.5. |
The Manager hereby undertakes to compensate the Client for any damage caused to the Client if the Client is charged any fee whatsoever for an employer-employee relationship between the Client and the Manager.
|
| 4. |
Remuneration to the Manager
|
| 4.1. |
During the validity period of this agreement, the Client shall pay the Manager monthly management fees of 35,000 NIS (hereinafter: “the Management Fees”), plus VAT according to law. Upon the
completion of the development of the system and the commencement of the sales stage, the Manager shall be entitled to monthly Management Fees of 45,000 NIS plus VAT. Upon the completion of fundraising in the sum of 500,000 NIS or more, the
Manager shall be entitled to payment of monthly Management Fees of 60,000 NIS plus VAT.
|
| 4.2. |
The Management Fees shall be paid to the Manager within ten days after the conclusion of each month for the preceding month against a duly made tax invoice.
|
| 4.3. |
The parties hereby agree that the Manager’s Management Fees according to paragraph 6.1 above are the full and final renumeration for the fulfillment of the provisions of this agreement, except for that which is detailed in paragraph 7.2
below, and any payment of tax or fee that applies to his income according to this agreement and/or for the management of his business, shall apply to the Manager only.
|
| 4.4. |
It is hereby agreed and declared that the Manager has no and shall have no rights of set-off or lien whatsoever.
|
| 5. |
Expenses
|
| 5.1. |
It is hereby agreed that the Manager shall be entitled to receive a reimbursement for travel expenses, as well as a reimbursement for all of his expenses related to the execution of this agreement in Israel and/or abroad.
|
| 5.2. |
the Client shall bear the travel expense of the Manager abroad in the framework of the management services in accordance with a predetermined budget approved in advance by the Client and against the issuance of the appropriate receipts.
|
| 6. |
The contract period and its conclusion
|
| 6.1. |
This agreement shall enter into force from 1.1.2018 onward (hereinafter: “the Contract Period”)
|
| 6.2. |
The Client shall be entitled to terminate the contract between the parties with a six-month notice. The advance notice period shall increase by a month for every year of service.
|
| 6.3. |
Notwithstanding the aforementioned, the parties hereby agree that this agreement shall be terminated if and when the Manager is deceased or declared as incompetent. In addition, the parties hereby agree that the Client may shorten the
Contract Period if the Manager committed breach of trust and/or an infamous crime and/or was declared as bankrupt and/or a trustee was appointed for his property and/or has fallen ill beyond 120 consecutive days and/or was absent from his
work beyond 4 months for any reason whatsoever and/or violated any of this agreement’s provisions and the violation was not amended and/or removed within 45 days after the receipt of a notice from the Client and/or anyone on its behalf in
writing for the aforementioned breach.
|
| 6.4. |
The Manager undertakes to amend any violation of any of the agreement’s provisions within 45 days after the delivery of a notice from the Client regarding the breach.
|
| 7. |
Scope of the agreement
|
| 7.1. |
This agreement is exhaustive and details all that was agreed between the parties regarding the provision of management services by the Manager, and it terminates and supersedes any other settlement, document or understanding between the
parties which preceded this agreement.
|
| 8. |
Confidentiality
|
| 8.1. |
For the purpose of this agreement, “information” is any information or knowledge of any type and kind regarding technical, commercial or professional knowledge, business plans, projects, marketing processes and methods, sales and
manufacturing, organization, specifications, procedures, names of clients and suppliers, contracts, agreements, pricing, businesses activities, applications, ideas, descriptions, financial data, speculations, technologies, material
compositions, patents, plans, work and operation methods, equipment, systems, developments, inventions, improvements, whether in writing or orally, which were brought to the supplier’s knowledge regarding the company during the provision of
services to the company or during or following any contact between the supplier and the company or anyone on its behalf, including following negotiations and businesses discussions that take place and/or took place between the supplier and
the company or in their regard, including according to the agreements that will be signed between the supplier and the company or in their regard, except for information that became public knowledge, and provided that it did not become
public knowledge due to a violation of the supplier’s undertaking to maintain confidentiality as mentioned above.
|
| 8.2. |
The supplier hereby declares and undertakes that during the Contract Period and after its conclusion, for any reason whatsoever, and without a time limit-
|
| 8.2.1. |
He shall maintain confidentiality and shall not use, forward or disclose the information to any third party whatsoever, whether directly or indirectly, and shall not use the information or permit or allow others to use it, unless for the
provision of the services to the company and/or unless he receives the advance approval of the company’s directorate to do so.
|
| 8.2.2. |
Shall strictly protect the information, and shall not copy, duplicate, photocopy or publish this information, and shall use all reasonable means to prevent the information from reaching another party unless for the provision of the
services to the company and/or unless he received the advance approval of the company’s directorate to do so.
|
| 8.2.3. |
Shall avoid any entrance into the company’s databases for any purpose whatsoever including - viewing, extraction in any manner whatsoever, entering information, making changes in the information, deleting it, and changing its location in
the database except for the purposes of providing the services to the company and/or if he received an advance approval from the company’s directorate to do so.
|
| 8.2.4. |
Shall use a personal password provided to him and/or which is to be provided to him from time to time to access the database in accordance with the password use instructions, and shall maintain strict confidentiality of the password and
avoid any action that may expose the password to others, including registration of the password in any visible location.
|
| 8.2.5. |
shall return to the company immediately upon its first request or upon termination of the agreement, as relevant, the information and its copies that were delivered to him, prepared by him and/or anyone on his behalf, in any manner
whatsoever during the provision of the services to the company or following the provision of the services to the company.
|
| 8.2.6. |
Shall act at his best capability to prevent any person from infiltrating the computation systems and database, including via physical infiltration and/or communication, and shall avoid disclosure of information about the computer access
procedures, including its access password and/or others, and report to the company directorate about any Infiltration and/or disclosure and/or information leakage and/or concern for such an event.
|
| 8.2.7. |
Shall avoid copying a computer output content including excerpts, except for the purpose of providing services to the company; shall avoid publishing, disclosing, or delivering an output to any third party whatsoever without the explicit
agreement of the company’s directorate, and upon the completion of the output’s use, shall handle it according to the company directorate’s instructions.
|
| 9. |
Designation of rights and charges
|
| 9.1. |
The supplier shall not be entitled to endorse and/or assign and/or transfer to another party his rights or obligations according to this agreement, whether in full or in part.
|
| 10. |
Miscellaneous
|
| 10.1. |
This agreement exhausts all agreements between the parties and terminates any previous agreement, consent, memorandum, representation or any other obligation.
|
| 10.2. |
The supplier is not entitled to any payment and/or right and/or benefit in addition to what is explicitly mentioned in this agreement unless the agreement for the above between the parties is in writing and signed between both parties.
|
| 10.3. |
Any change of this agreement, or relinquishment of the fulfillment of any provision stipulated in it require a written document, with the signature of both parties, otherwise they shall not have force.
|
| 10.4. |
The company shall be entitled to deduct from any sum owed to it by the supplier according to this agreement or from any other source any sum owed to the supplier according to this agreement.
|
| 11. |
Notices
|
| 11.1. |
The addresses of the parties to this agreement are as stipulated in this preface. Any notice sent via registered mail, to any of the aforementioned addresses shall be deemed as if received by the addressee 3 days after its delivery via a
post office in Israel and if delivered by hand - upon its delivery.
|
In witness whereof the parties have affixed their signatures at the place and on the date stipulated above:
 |
||||
| /s/ Menachem Shalom | ||||
|
The Manager
|
The Client
|
Exhibit 10.4
|
Hold Me Ltd.
|
April 22, 2021
Dear Mr. Menachem Shalom,
Re: Indemnification Agreement
You are or have been appointed as a director or office holder (‘Nose Misra’ as defined in the Companies Law) (the "Office Holder") of Hold Me Ltd. (the “Company”), and in order to enhance your service to the Company in an effective manner, the
Company desires to provide hereunder for your indemnification to the fullest extent permitted by law.
In consideration of your continuing to serve the Company; the Company hereby agrees as follows:
1. The Company hereby undertakes to indemnify you to the maximum extent permitted by the Companies Law – 1999 (the “Companies Law”) in respect of
the following:
1.1. any financial obligation imposed on, or incurred by you in favor of another person by, or expended by you as a result of, a court judgment, including a settlement
or an arbitrator’s award approved by court, in respect of any act or omission (“Action”) taken or made by you in your capacity as a director or officer of the Company or of any subsidiary of the Company ("Subsidiary"); and
1.2. all reasonable litigation expenses expended by you or charged to you by a court, including reasonable attorneys’ fees and all other costs, expenses and obligations
incurred in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend to be a witness in or participate, in any action, suit, proceeding, alternative dispute resolution mechanism,
hearing, inquiry or investigation instituted against you by the Company or on its behalf or by another person, or in any criminal proceedings in which you are acquitted, or in any criminal proceedings of a crime which does not require proof of mens rea (criminal intent) in which you are convicted, all in respect of actions taken by you in your capacity as a director and/or officer of the Company or of any Subsidiary; and
1.3. all reasonable litigation expenses, including reasonable attorneys’ fees, actually expended by you due to an investigation or a proceeding instituted against you,
by an authority qualified to administrate such investigation or proceeding, where such investigation or proceeding is “concluded without the filing of an indictment against you” (as defined in the Companies Law) and “without any financial
obligation imposed on you in lieu of criminal proceedings” (as defined in the Companies Law), or that is concluded without indictment of the Office Holder but with financial obligation imposed on him in lieu of criminal proceedings with respect to
a crime that does not require proof of mens rea (criminal intent) all in respect of actions taken by you in your capacity as a director and/or office holder of the Company or of any Subsidiary; and
1.4 any payment you may be obligated to make to an injured party as set forth in Section 52(54)(a)(1(a) of the Israeli Securities Law, 5728-1968 (the “Securities Law”), and expenses that you may incur in connection with a proceeding under Chapters H'3, H'4, or I'1 of the Israeli Securities Law, including reasonable legal expenses, which term includes attorney
fees, or in connection with Article D of Chapter Four of Part Nine of the Companies Law.
1.5 expenses incurred in connection with a proceeding under Chapter G'1, of the Restrictive Trade Practices Law, 5748-1988 (the “Restrictive
Trade Practices Law”), including reasonable legal expenses, including without limitation attorney fees.
The Company may, as aforesaid, indemnify, insure and exempt from liability any Office Holder to the fullest extent permitted by applicable law. Accordingly: (i) any amendment to
the Companies Law, the Securities Law, the Restrictive Trade Practices Law or any other applicable law expanding the ability of the Company to indemnify, insure or exempt from liability any Office Holder, or expanding the right of any Office Holder
to be indemnified, insured or exempted from liability, beyond or in addition to the provisions of this Indemnification Agreement, shall, to the fullest extent possible, automatically and immediately apply to the Office Holders of the Company and be
deemed as included in this Indemnification Agreement to the fullest extent permitted by applicable law; and (ii) any amendment to the Companies Law, the Securities Law, the Restrictive Trade Law or any other applicable law adversely affecting the
ability of the Company to indemnify, insure or exempt from liability any Office Holder or adversely affecting the right of any Office Holder to be indemnified, insured or exempted from liability as provided for in this Indemnification Agreement
shall have no effect post factum and shall not affect the Company's obligations or ability to indemnify, insure or exempt from liability an Office Holder for any act (or omission) carried out prior to such amendment, unless otherwise provided by
applicable law.
2. Notwithstanding the aforesaid, the Company will not indemnify you for any amount you may be obligated to pay in respect of:
2.1. a breach of your duty of loyalty to the Company or any Subsidiary, except, to the extent permitted by the Companies Law, for a breach of a duty of loyalty to the
Company or any Subsidiary while acting in good faith and having reasonable cause to assume that such act would not prejudice the interests of the Company or any Subsidiary, as applicable;
2.2. a willful or reckless breach of the duty of care, unless such breach was done solely in negligence;
2.3. an action taken or not taken with the intent of unlawfully realizing personal gain;
2.4. a fine or penalty imposed upon you for an offense; and
2.5. a counterclaim made by the Company or in its name in connection with a claim against the Company or any Subsidiary filed by you, other than by way of defense or by
way of third party notice in connection with claim brought against you, or in specific cases in which the Company’s Board of Directors has approved the initiation or bringing of such suit by yourself, which approval shall not be unreasonably
withheld.
In any such case under this Section 2, a determination of non-indemnification by the Company shall only be made if it is determined upon final adjudication of a court of
competent jurisdiction that you are not lawfully entitled to such indemnification.
3. To the fullest extent permitted by law, the Company shall make available all amounts needed in accordance with Section 1 above on the date on which such amounts are first payable by you
(“Time of Indebtedness”), and with respect to items referred to in Section 1.2 above, even prior to a court decision, but has no duty to advance payments in less than five (5) business days following delivery
of a written request therefor by you to the Company. Advances given to cover legal expenses in criminal proceedings will be repaid by you to the Company, within ten (10) business days as of the court's decision, if you are found guilty of a crime
which requires proof of criminal intent or if a financial liability was imposed in lieu of a criminal proceeding for a crime which requires a finding of criminal intent. Other advances will be repaid by you to the Company if it is determined by a
court of competent jurisdiction that you are not lawfully entitled to such indemnification. Any undertaking made by you pursuant to this Section 3 shall be unsecured and without consideration of your ability to repay any such advance. For purposes
of this Agreement, "Business Day" or "Business Days” means a day, or days, on which customer services are provided by a majority
of the major commercial banks in Israel.
As part of the aforementioned undertaking, the Company will make available to you any security or guarantee that you may be required to post in accordance with an interim
decision given by a court or an arbitrator, including for the purpose of substituting liens imposed on your assets.
4. The Company will indemnify you even if at the relevant Time of Indebtedness you are no longer a director or office holder of the Company or any Subsidiary, provided that the obligations
are in respect of actions taken by you while you were a director or office holder of the Company or any Subsidiary as aforesaid, and in such capacity.
2
5. The indemnification will be limited to the matters mentioned in Section 1 above insofar as they result from, or are connected to, your actions in the matters listed in Exhibit A
hereto (the “Indemnifiable Events”), which are deemed by the Company's Board of Directors, based on the current activity of the Company, to be foreseeable at the date hereof.
6. The indemnification that the Company undertakes towards all persons whom it has resolved to indemnify for the matters and in the circumstances described herein, jointly and in the
aggregate, shall be $1,000,000 (one million U.S. Dollars), provided however that, if such amount is insufficient to cover all the indemnity amounts payable with respect to all persons, then such amount shall be allocated to such persons pro rata
according to the percentage of their culpability, as finally determined by a court in the relevant claim, or, absent such determination or in the event such persons are parties to different claims, based on an equal pro rata allocation among such
persons.
7. The Company will not indemnify you for any liability with respect to which you have received payment by virtue of an insurance policy or another indemnification agreement other than for
amounts which are in excess of the amounts actually paid to you pursuant to any such insurance policy or other indemnity agreement (including deductible amounts not covered by insurance policies), within the limits set forth in Section 6 above.
8. Subject to the provisions of Sections 6 and 7 above, the indemnification hereunder will, in each case, cover all sums of money that you will be obligated to pay, in those circumstances
for which indemnification is permitted under the law and under this Indemnification Agreement.
9. The Company will be entitled to any amount collected from a third party in connection with liabilities indemnified hereunder to be paid by you to the Company within fifteen (15) days
following the receipt of the said amount. Such reimbursement shall not exceed the amount the Company has paid to you under Section 3 hereto.
10. In all indemnifiable circumstances, indemnification will be subject to the following:
10.1 You shall promptly notify the Company in writing of any legal proceedings initiated against you and of all possible or threatened legal proceedings without delay
following your first becoming aware thereof, however, your failure to notify the Company as aforesaid shall not derogate from your right to be indemnified as provided herein except and to the extent that such failure to provide notice materially
and adversely prejudices the Company’s ability to defend against such action. You shall deliver to the Company, or to such person as it shall advise you, without delay all documents you receive in connection with these proceedings or possible or
threatened proceedings.
10.2. Other than with respect to proceedings that have been initiated against you by the Company or in its name, the Company shall be entitled to undertake the conduct
of your defense in respect of such legal proceedings and/or to hand over the conduct thereof to any attorney which the Company may choose for that purpose, except to an attorney who is not, upon reasonable grounds, acceptable to you.
The Company and/or your attorney as aforesaid shall be entitled, within the context of the conduct as aforesaid, to conclude such proceedings, all as it shall see fit, including
by way of settlement. At the request of the Company, you shall execute all documents required to enable the Company and/or your attorney as aforesaid to conduct your defense in your name, and to represent you in all matters connected therewith, in
accordance with the aforesaid. Notwithstanding the aforesaid, at your discretion and on your expenses, you may employ your own legal counsel in addition to the attorney chosen by the Company.
For the avoidance of doubt, in the case of criminal proceedings the Company or the attorneys as aforesaid will not have the right to plead guilty in your name or to agree to a
plea-bargain in your name without your written consent. Furthermore, in a civil proceeding (whether before a court or as a part of a compromise arrangement), the Company and/or its attorneys will not have the right to admit to any occurrences that
are not indemnifiable pursuant to this Indemnification Agreement and/or pursuant to law, without your written consent. However, the aforesaid will not prevent the Company or its attorneys as aforesaid, with the approval of the Company, to come to a
financial arrangement with a plaintiff in a civil proceeding without your consent so long as such arrangement will not be an admittance of an occurrence not fully indemnifiable pursuant to this Indemnification Agreement or pursuant to law and
further provided that any such settlement or arrangement does not impose on you any liability or limitation. The Company shall not, without your prior written consent, consent to the entry of any judgment against you or enter into any settlement or
compromise which (i) includes an admission of your fault, (ii) does not include, as an unconditional term thereof, the full release of you from all liability in respect of such proceeding or (iii) is not fully indemnifiable pursuant to this
Indemnification Agreement and pursuant to law.
3
10.3. You will fully cooperate with the Company and/or any attorney as aforesaid as is reasonably required of you within the context of their conduct of such legal
proceedings, including but not limited to the execution of power(s) of attorney and other relevant documents, provided that the Company shall cover all costs incidental thereto such that you will not be required to pay the same or to finance the
same yourself.
10.4. If, in accordance with Section 10.2, the Company has taken upon itself the conduct of your defense, the Company will have no liability or obligation pursuant to
this Indemnification Agreement or the above resolutions to indemnify you for any legal expenses, including any legal fees, that you may expend in connection with your defense, unless (i) the Company shall not have assumed the conduct of your
defense as contemplated, (ii) the Company refers the conduct of your defense to an attorney who is not, upon reasonable grounds, acceptable to you, (iii) the named parties to any such action (including any impleaded parties) include both you and
the Company, and joint representation is inappropriate under applicable standards of professional conduct due to a conflict of interest between you and the Company, or (iv) the Company shall agree to such expenses in either of which events
reasonable fees and expenses of your counsel shall be borne by the Company.
10.5. The Company will have no liability or obligation pursuant to this Indemnification Agreement to indemnify you for any amount expended by you pursuant to any
compromise or settlement agreement reached in any suit, demand or other proceeding as aforesaid without the Company’s prior written consent to such compromise or settlement, such consent not to be unreasonably withheld or delayed.
11. The Company hereby exempts you, to the fullest extent permitted by law, from any liability for damages caused as a result of a breach of your duty of care to the Company, provided that
in no event shall you be exempt with respect to any actions listed in Section 2 above or for a breach of your duty of care in connection with Distribution of Company's assets (as said term is defined in the
Companies Law). Your rights of indemnification hereunder shall not be deemed exclusive of any other rights you may have under the Amended and Restated Articles of Association of the Company or applicable law or otherwise.
12. If for the validation of any of the undertakings in this Indemnification Agreement any act, resolution, approval or other procedure is required, the Company undertakes to cause them to
be done or adopted in a manner which will enable the Company to fulfill all its undertakings as aforesaid.
13. For the avoidance of doubt, it is hereby clarified that nothing contained in this Indemnification Agreement derogates from the Company’s right (but in no way obligation) to indemnify
you post factum for any amounts which you may be obligated to pay as set forth in Section 1 above without the limitations set forth in Sections 5 and 6 above.
14. If any undertaking included in this Indemnification Agreement is held invalid or unenforceable, such invalidity or unenforceability will not affect any of the other undertakings which
will remain in full force and effect. Furthermore, if such invalid or unenforceable undertaking may be modified or amended so as to be valid and enforceable as a matter of law, such undertaking will be deemed to have been modified or amended, and
any competent court or arbitrator are hereby authorized to modify or amend such undertaking, so as to be valid and enforceable to the maximum extent permitted by law.
15. This Indemnification Agreement and the agreements herein shall be governed by and construed and enforced in accordance with the laws of the State of Israel and the competent courts of
Tel-Aviv shall have exclusive jurisdiction over any dispute arising between the parties with respect of this Indemnification Agreement.
4
16. This Indemnification Agreement cancels any preceding letter of indemnification that may have been issued to you. The Company undertakes that to the extent that the Company, in any time
in the future, shall grant broader indemnification undertakings to any directors or office holders of the Company, such broader indemnification undertakings shall apply to you as well, whether or not a new indemnification agreement is in effect
granted to you.
17. This Indemnification Agreement constitutes the entire agreement between the parties with respect to its subject matter, and supersedes and cancels all prior agreements, proposals,
representations and communications between the parties regarding the subject matter hereof. No amendment, modification, termination or cancellation of this Indemnification Agreement shall be effective unless it is in writing and signed by the
parties hereto.
18. No waiver of any of the provisions of this Indemnification Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such
waiver constitute a continuing waiver. Any waiver shall be in writing.
19. This Indemnification Agreement may be executed in two or more counterparts, each of which shall be deemed an original and enforceable against the parties actually executing such
counterpart, and all of which when taken together shall constitute one and same instrument.
20. This Indemnification Agreement and the rights and obligations of the parties hereunder shall inure to the benefit of, and be binding upon, their respective heirs, successors, assigns
and legal representatives.
21. All notices and other communications required or permitted under this Indemnification Agreement shall be in writing, shall be effective (i) if mailed, three (3) business days after
mailing (unless mailed abroad, in which case it shall be effective five (5) business days after mailing), (ii) if by air courier, two (2) business days after delivery to the courier service, (iii) if sent by messenger, upon delivery, and (iv) if
sent via facsimile, upon transmission and electronic (or other) confirmation of receipt or (if transmitted and received on a non-business day) on the first business day following transmission and electronic (or other) confirmation of receipt and
(v) if sent by email, on the date of transmission or (if transmitted and received on a non-business day) on the first business day following transmission, except where a notice is received stating that such mail has not been successfully delivered.
This letter is being issued to you pursuant to the resolutions adopted by the Board of Directors of the Company on April 21, 2021, and by the shareholders of the Company on April
21, 2021. The Board of Directors has determined, based on the current activity of the Company, that the amount stated in Section 6 is reasonable and that the events listed in Exhibit A are reasonably anticipated.
Kindly sign and return the enclosed copy of this letter to acknowledge your agreement to the contents hereof.
|
|
Very truly yours,
/s/ Menachem Shalom
Menahem Shalom, CEO Hold Me Ltd. |
Accepted and agreed to:
/s/ Menachem Shalom
Name: Menachem Shalom
Date: April, 2021
Name: Menachem Shalom
Date: April, 2021
5
EXHIBIT A*
Any reference in this Exhibit A to the Company shall include the Company and any entity in which you serve in a Corporate Capacity. “Corporate
Capacity” shall mean an act performed by you, either prior to or after the date hereof, in your capacity as an Office Holder, including, without limitation, as a director, officer, employee, agent or fiduciary of the Company, any
subsidiary thereof or any other corporation, collaboration, partnership, joint venture, trust or other enterprise, in which you serve at any time at the request of the Company
|
Indemnifiable Events
|
|
|
1.
|
Claims in connection with employment or engagement relationships with and/or by employees or consultants of the Company or any employee union or similar or comparable organization, and in
connection with business relations of any kind between the Company and its employees, independent contractors, customers, suppliers, partners, distributors, agents, resellers, representatives, licensors, and various other service providers
and business associates.
|
|
2.
|
Negotiations, execution, delivery and performance of agreements of any kind or nature, anti-competitive acts, acts of commercial wrongdoing, approval of corporate actions including the
approval of the acts of the Company’s management, their guidance and their supervision, actions concerning the approval of transactions with Office Holders or shareholders, including controlling persons and claims of failure to exercise
business judgment and a reasonable level of proficiency, expertise and care with respect to the Company’s business.
|
|
3.
|
Approval of and recommendation or information provided to shareholders with respect to any and all corporate actions, including the approval of the acts of the Company’s management, their
guidance and their supervision, matters relating to the approval of transactions with Office Holders (including, without limitation, all compensation related matters) or shareholders, including controlling persons and claims and allegations
of failure to exercise business judgment, reasonable level of proficiency, expertise, care or any other applicable standard, with respect to the foregoing or otherwise with respect to the Company’s business, strategy, operations and
prospective outlook, and any discussions, deliberations, reviews or other preparatory or preliminary phases relating to any of the foregoing.
|
|
4.
|
Violation, resolution, infringement, misappropriation, dilution and/or other actions or omissions relating to any other misuse of copyrights, patents, designs, trade secrets, confidential
information, proprietary information, and any other intellectual property rights, acts in connection with the registration, assertion or protection of rights to intellectual property and the defense of claims related to intellectual
property, breach of confidentiality obligations, acts in regard of invasion of privacy or any violation of privacy or privacy-related right, including with respect to databases or handling, collection or use of private information, acts in
connection with slander and defamation, and claims in connection with publishing or providing any information, including any filings with any governmental authorities, whether or not required under any applicable laws.
|
|
5.
|
Violations of or failure to comply with securities laws, and any regulations or other rules promulgated thereunder, of any jurisdiction, including without limitation, claims under the U.S.
Securities Act of 1933 or the U.S. Exchange Act of 1934 or under the Israeli Securities Law, fraudulent disclosure claims, failure to comply with any securities authority or any stock exchange disclosure or other rules and any other claims
relating to relationships with investors, debt holders, shareholders, option holders, holders of any other equity or debt instrument of the Company, and otherwise with the investment community (including without limitation any such claims
relating to merger, change in control, issuances of securities, restructuring, spin out, spin off, divestiture, recapitalization or any other transaction relating to the corporate structure or organization of the Company); claims relating
to or arising out of financing arrangements, any breach of financial covenants or other obligations towards investors, lenders or debt holders of the Company, class actions, violations of laws requiring the Company to obtain regulatory and
governmental licenses, permits and authorizations in any jurisdiction, including in connection with disclosure, offering or other transaction related documents; actions taken in connection with the issuance, purchase, holding or disposition
of any type of securities of Company, including, without limitation, the grant of options, warrants or other rights to purchase any of the same or any offering of the Company’s securities (whether on behalf of the Company or on behalf of
any holders of securities of the Company) to private investors, underwriters, resellers or to the public, and listing of such securities, or the offer by the Company to purchase securities from the public or from private investors or other
holders, and any undertakings, representations, warranties and other obligations related to any such offering, listing or offer or to the Company’s status as a public company or as an issuer of securities.
|
6
|
6.
|
Liabilities arising in connection with any products or services developed, distributed, rendered, sold, provided, licensed or marketed by the Company or any affiliate thereof, whether
performed by the Company or by third parties on behalf of the Company, and any actions or omissions, and any actions in connection with the distribution, provision, sale, marketing, license or use of such products or services, including
without limitation in connection with professional liability and product liability claims.
|
|
7.
|
The offering of securities by the Company (whether on behalf of itself or on behalf of any holder of securities and any other person) to the public and/or to private investors or the offer
by the Company to purchase securities from the public and/or from private investors or other holders pursuant to a prospectus, offering documents, agreements, notices, reports, tenders and/or other processes or proceedings.
|
|
8.
|
Events, facts or circumstances in connection with change in ownership or in the structure of the Company, its reorganization, dissolution, winding up, any decision concerning creditors’
rights, or any decision concerning any of the foregoing, including but not limited to, merger, sale or acquisition of assets, division, change in control, issuances of securities, restructuring, spin out, spin off, divestiture,
recapitalization or any other transaction relating to the corporate structure or organization of the Company, and the approval of failure to approve of any corporate actions and any matters relating to corporate governance, capital
structure, the Amended Articles (as may be amended from time to time) or other charter or governance documents, appointment or dismissal of office holders or compensation thereof and appointment or dismissal of auditors, internal auditor or
any other person performing any services for the Company.
|
|
9.
|
Any claim or demand made in connection with any transaction not in the ordinary course of business of the Company, as well as the sale, lease or purchase of, or the receipt or grant of any
rights with respect to, any assets or business. Without derogating from the generality of the above, actions in connection with the purchase or sale of companies, legal entities or assets, licensing or acquisition of rights in products,
assets or technologies of other persons or legal entities, and the sale, licensing or grant of license in the same to other persons or legal entities, and the division or consolidation thereof.
|
|
10.
|
Any claim or demand made by any third party suffering any personal injury and/or bodily injury or damage to business or personal property or any other type of damage through any act or
omission attributed to the Company, or its employees, agents or other persons acting or allegedly acting on its behalf, including, without limitation, failure to make proper safety arrangements for the Company or its employees and
liabilities arising from any accidental or continuous damage or harm to the Company’s employees, its contractors, its guests and visitors as a result of an accidental or continuous event, or employment conditions, permanent or temporary, in
the Company’s offices.
|
|
11.
|
Any claim or demand made directly or indirectly in connection with complete or partial failure, by the Company or its directors, officers and employees, to pay, report, keep applicable
records or otherwise, of any foreign, federal, state, county, local, municipal or city taxes or other compulsory payments of any nature whatsoever, including, without limitation, income, sales, use, transfer, excise, value added,
registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security, unemployment, disability, payroll or employee withholding or other withholding, including any interest, penalty
or addition thereto, whether disputed or not.
|
7
|
12.
|
Any administrative, regulatory, judicial or civil actions orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance
or violation by any governmental entity or other person alleging potential responsibility or liability (including potential responsibility or liability for costs of enforcement investigation, cleanup, governmental response, removal or
remediation, for natural resources damages, property damage, personal injuries or penalties or for contribution, indemnification, cost recovery, compensation or injunctive relief) arising out of, based on or related to (a) the presence of,
release, spill, emission, leaning, dumping, pouring, deposit, disposal, discharge, leaching or migration into the environment (each a “Release”) or threatened Release of, or exposure to, any
hazardous, toxic, explosive or radioactive substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing material, polychlorinated biphenyls (“PCBs”)
or PCB-containing materials or equipment, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any environmental law, at any location, whether or not owned, operated, leased or
managed by the Company or any of its subsidiaries, or (b) circumstances forming the basis of any violation of any environmental law or environmental permit, license, registration
or other authorization required under applicable environmental law.
|
|
13.
|
Any administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or
violation by any governmental entity or other person alleging the failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental entity applicable to the Company or any of its businesses, assets or
operations, or the terms and conditions of any operating certificate or licensing agreement.
|
|
14.
|
Participation and/or non-participation at Board meetings, expression of opinion or view and/or voting and/or abstention from voting at the Company’s Board meetings including, in each case,
any committee thereof, as well as expression of opinion publicly in connection with the service as an Office Holder (as applicable).
|
|
15.
|
Review and approval of the Company’s financial statements and any specific items or matters within, including any action, consent or approval related to or arising from the foregoing,
including, without limitations, engagement of or execution of certificates for the benefit of third parties related to the financial statements.
|
|
16.
|
Violation of laws, rules or regulations requiring the Company to obtain regulatory and governmental licenses, permits and authorizations (including without limitation relating to export,
import, encryption, antitrust or competition authorities) or laws related to any governmental grants in any jurisdiction.
|
|
17.
|
Resolutions and/or actions relating to investments in the Company and/or its subsidiaries and/or affiliated companies and/or the purchase and sale of assets, including the purchase or sale
of companies and/or businesses, and/or investment in corporate or other entities and/or investments in any traded or non-traded securities and/or any other form of investment.
|
|
18.
|
Liabilities arising out of advertising, including misrepresentations regarding the Company's products or services and unlawful distribution of emails.
|
8
|
19.
|
An announcement or statement, including a position taken or an opinion or representation made in good faith by the Office Holder in the course of his duties or in conjunction with his
duties, whether in public or in private, including during a meeting of the Board of Directors of the Company or any of the committees thereof.
|
|
20.
|
Management of the Company’s bank accounts, including money management, foreign currency deposits, securities, loans and credit facilities, credit cards, bank guarantees, letters of credit,
consultation agreements concerning investments including with portfolio managers, hedging transactions, options, futures, and the like.
|
|
21.
|
All actions, consents and approvals, including any prior discussions, reviews and deliberations, relating to a distribution of dividends, in cash or otherwise, or to any other
“distribution” as such term is defined under the Companies Law.
|
|
22.
|
Any administrative, regulatory, judicial, civil or criminal, actions orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of
noncompliance, violation or breaches alleging potential responsibility, liability, loss or damage (including potential responsibility or liability for costs of enforcement, investigation, cleanup, governmental response, removal or
remediation, property damage or penalties, or for contribution, indemnification, cost recovery, compensation or injunctive relief), whether alleged or claimed by customers, consumers, regulators, shareholders or others, arising out of,
based on or related to: (a) cyber security, cyber attacks, data loss or breaches, unauthorized access to databases and use or disclosure of information contained therein, not preventing or detecting the breach or failing to otherwise
disclose or respond to the breach; (b) circumstances forming the basis of any violation of any law, permit, license, registration or other authorization required under applicable law governing data security, data protection, network
security, information systems, privacy or any cyber environment (including, users, networks, devices, software, processes, information systems, databases, information in storage or transit, applications, services, and systems that can be
connected directly or indirectly to networks); (c) failure to implement a reporting system or control, or failure to monitor or oversee the operation of such a system; (d) data destruction, extortion, theft, hacking, and denial of
service attacks; losses or liabilities to others caused by errors and omissions, failure to safeguard data or defamation; or (e) security-audit, post-incident public relations and investigative expenses, criminal reward funds,
data breach/privacy crisis management (including, management of an incident, investigation, remediation, data subject notification, call management, credit checking for data subjects, legal costs, court attendance and regulatory fines),
extortion liability (including, losses due to a threat of extortion, professional fees related to dealing with the extortion), or network security liability (including, losses as a result of denial of access, costs related to data on
third-parties and costs related to the theft of data on third-party systems).
|
|
23.
|
Actions taken pursuant to or in accordance with the policies and procedures of the Company (including tax policies and procedures), whether such policies and procedures are published or
not.
|
|
24.
|
To the maximum extent permitted by law, any claim or demand, not covered by any of the categories of events described above, which, pursuant to any applicable law, a person serving in a
capacity of an Office Holder of the Company may be held liable to any government or agency thereof, or any person or entity, in connection with actions taken by such person serving in such Office Holder.
|
|
25.
|
Any action violating the Amended and Restated Articles of Associations of the Company.
|
9
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation in this Registration Statement on Form F-1 of our report dated April 22, 2021, relating to the
financial statements of Hold Me Ltd., as of December 31, 2020 and 2019 and to all references to our firm included in this Registration Statement.
Certified Public Accountants
Lakewood, CO
April 22, 2021